
<html lang="en"     class="pb-page"  data-request-id="3f602eaa-2863-4518-b60b-35f806cdf9cd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400122f;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist" /></meta><meta name="dc.Creator" content="Heinz  Fretz" /></meta><meta name="dc.Creator" content="Anja  Valdenaire" /></meta><meta name="dc.Creator" content="Julien  Pothier" /></meta><meta name="dc.Creator" content="Kurt  Hilpert" /></meta><meta name="dc.Creator" content="Carmela  Gnerre" /></meta><meta name="dc.Creator" content="Oliver  Peter" /></meta><meta name="dc.Creator" content="Xavier  Leroy" /></meta><meta name="dc.Creator" content="Markus A.  Riederer" /></meta><meta name="dc.Description" content="Herein we describe the discovery of the novel CRTh2 antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 28 (setipiprant/ACT-129968), a clinical development..." /></meta><meta name="Description" content="Herein we describe the discovery of the novel CRTh2 antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 28 (setipiprant/ACT-129968), a clinical development..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 13, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400122f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400122f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400122f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400122f" /></link>
        
    
    

<title>Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400122f" /></meta><meta property="og:title" content="Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0007.jpeg" /></meta><meta property="og:description" content="Herein we describe the discovery of the novel CRTh2 antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 28 (setipiprant/ACT-129968), a clinical development candidate for the treatment of asthma and seasonal allergic rhinitis. A lead optimization program was started based on the discovery of the recently disclosed CRTh2 antagonist 2-(2-benzoyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 5. An already favorable and druglike profile could be assessed for lead compound 5. Therefore, the lead optimization program mainly focused on the improvement in potency and oral bioavailability. Data of newly synthesized analogs were collected from in vitro pharmacological, physicochemical, in vitro ADME, and in vivo pharmacokinetic studies in the rat and the dog. The data were then analyzed using a traffic light selection tool as a visualization device in order to evaluate and prioritize candidates displaying a balanced overall profile. This data-driven process and the excellent results of the PK study in the rat (F = 44%) and the dog (F = 55%) facilitated the identification of 28 as a potent (IC50 = 6 nM), selective, and orally available CRTh2 antagonist." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400122f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400122f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400122f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400122f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400122f&amp;href=/doi/10.1021/jm400122f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4899-4911</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400048v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400156p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heinz++Fretz">Heinz Fretz</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anja++Valdenaire">Anja Valdenaire</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julien++Pothier">Julien Pothier</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kurt++Hilpert">Kurt Hilpert</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmela++Gnerre">Carmela Gnerre</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Peter">Oliver Peter</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Leroy">Xavier Leroy</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus+A.++Riederer">Markus A. Riederer</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Unit, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41-61-565-6208. E-mail: <a href="/cdn-cgi/l/email-protection#731b161a1d095d150116070933121007161f1a1c1d5d101c1e"><span class="__cf_email__" data-cfemail="0f676a66617521697d6a7b754f6e6c7b6a63666061216c6062">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400122f&amp;href=/doi/10.1021%2Fjm400122f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4899â4911</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 30, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 January 2013</li><li><span class="item_label"><b>Published</b> online</span>13 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400122f" title="DOI URL">https://doi.org/10.1021/jm400122f</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4899%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHeinz%2BFretz%252C%2BAnja%2BValdenaire%252C%2BJulien%2BPothier%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D12%26contentID%3Djm400122f%26title%3DIdentification%2Bof%2B2-%25282-%25281-Naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2BAcid%2B%2528Setipiprant%252FACT-129968%2529%252C%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BChemoattractant%2BReceptor-Homologous%2BMolecule%2BExpressed%2Bon%2BTh2%2BCells%2B%2528CRTH2%2529%2BAntagonist%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4911%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400122f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1611</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400122f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Heinz&quot;,&quot;last_name&quot;:&quot;Fretz&quot;},{&quot;first_name&quot;:&quot;Anja&quot;,&quot;last_name&quot;:&quot;Valdenaire&quot;},{&quot;first_name&quot;:&quot;Julien&quot;,&quot;last_name&quot;:&quot;Pothier&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;Hilpert&quot;},{&quot;first_name&quot;:&quot;Carmela&quot;,&quot;last_name&quot;:&quot;Gnerre&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Peter&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Leroy&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;A. Riederer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4899-4911&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400122f&quot;},&quot;abstract&quot;:&quot;Herein we describe the discovery of the novel CRTh2 antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 28 (setipiprant/ACT-129968), a clinical development candidate for the treatment of asthma and seasonal allergic rhinitis. A lead optimization program was started based on the discovery of the recently disclosed CRTh2 antagonist 2-(2-benzoyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid 5. An already favorable and druglike profile could be assessed for lead compound 5. Therefore, the lead optimization program mainly focused on the improvement in potency and oral bioavailability. Data of newly synthesized analogs were collected from in vitro pharmacological, physicochemical, in vitro ADME, and in vivo pharmacokinetic studies in the rat and the dog. The data were then analyzed using a traffic light selection tool as a visualization device in order to evaluate and prioritize candidates displaying a balanced overall profile. This data-driven process and the exce&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400122f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400122f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400122f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400122f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400122f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400122f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400122f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400122f&amp;href=/doi/10.1021/jm400122f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400122f" /></input><a href="/doi/pdf/10.1021/jm400122f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (631 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400122f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400122f%26sid%3Dliteratum%253Aachs%26pmid%3D23721423%26genre%3Darticle%26aulast%3DFretz%26date%3D2013%26atitle%3DIdentification%2Bof%2B2-%25282-%25281-Naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2BAcid%2B%2528Setipiprant%252FACT-129968%2529%252C%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BChemoattractant%2BReceptor-Homologous%2BMolecule%2BExpressed%2Bon%2BTh2%2BCells%2B%2528CRTH2%2529%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D12%26spage%3D4899%26epage%3D4911%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jmcmar.2013.56.issue-12/production/jmcmar.2013.56.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we describe the discovery of the novel CRTh2 antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>28</b> (setipiprant/ACT-129968), a clinical development candidate for the treatment of asthma and seasonal allergic rhinitis. A lead optimization program was started based on the discovery of the recently disclosed CRTh2 antagonist 2-(2-benzoyl-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>5</b>. An already favorable and druglike profile could be assessed for lead compound <b>5</b>. Therefore, the lead optimization program mainly focused on the improvement in potency and oral bioavailability. Data of newly synthesized analogs were collected from in vitro pharmacological, physicochemical, in vitro ADME, and in vivo pharmacokinetic studies in the rat and the dog. The data were then analyzed using a traffic light selection tool as a visualization device in order to evaluate and prioritize candidates displaying a balanced overall profile. This data-driven process and the excellent results of the PK study in the rat (<i>F</i> = 44%) and the dog (<i>F</i> = 55%) facilitated the identification of <b>28</b> as a potent (IC<sub>50</sub> = 6 nM), selective, and orally available CRTh2 antagonist.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Allergic disorders, such as asthma, allergic rhinitis, and atopic dermatitis, represent an increasing global health problem,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and despite clear advances in therapy, the disease of many patients is not adequately controlled. There is a clear medical need for additional, efficacious, safe, and orally active drugs for allergic disorders.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a></div><div class="NLM_p">Prostaglandin D2 (PGD<sub>2</sub>) <b>1</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) is a lipid mediator synthesized from arachidonic acid via the cyclooxygenase (COX) and prostaglandin D2 synthase (PGDS) pathway. PGD<sub>2</sub> is produced in the brain where it is involved in regulating central nervous functions such as sleep and pain perception. In the periphery, mast cells are the initial source of PGD<sub>2</sub>. These tissue-resident cells are presenting allergen-specific IgE-antibodies on their surface. Upon encounter with allergens, clustering of IgE antibodies induces an intracellular signaling cascade, leading to the generation of PGD<sub>2</sub>.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> In patients suffering from allergic asthma, PGD<sub>2</sub> and its metabolites are increased in the lung, plasma, and urine.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">Chemoattractant receptor-homologous molecule expressed on T helper 2 cells (CRTh2) is a G-protein-coupled receptor (GPCR) for PGD<sub>2</sub>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The expression of CRTh2 is limited to eosinophils, basophils, Th2 cells, and innate lymphoid cells.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Activation of CRTh2 induces a marked increase in mobility, degranulation, and expression of adhesion molecules in eosinophils and basophils.<a onclick="showRef(event, 'ref8 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref10 ref11">(8, 10, 11)</a> In addition, upon activation of CRTh2 by PGD<sub>2</sub>, Th2 cells can secrete Th2-specific cytokines, such as interleukin (IL) 4, IL-5, and IL-13,<a onclick="showRef(event, 'ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref12">(10, 12)</a> responsible for enhancing eosinophilia, tissue remodeling, and airway hypersensitivity.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">Mice deficient in CRTh2 have been described to be resistant to experimentally induced allergic asthma, suggesting that CRTh2 might play a central role in the pathogenesis of allergic diseases.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, low molecular weight antagonists of CRTh2 were expected to counteract pathophysiological effects of PGD<sub>2</sub> and thus to display controlling effects on allergic inflammation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">The first non-prostanoid CRTh2 modulators have already been described a decade ago. For example, <b>2</b> (indomethacin), a nonsteroidal anti-inflammatory drug (NSAID) acting as a nonselective inhibitor of COX-1 and COX-2 enzymes that participate in prostaglandin synthesis from arachidonic acid,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was discovered to act as a partial agonist on CRTh2,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> whereas <b>3</b> (ramatroban, BAY u3405), a human thromboxane A2 (TXA<sub>2</sub>) receptor (<i>h</i>TP<sub>2</sub>) antagonist with clinical efficacy in asthma and allergic rhinitis,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> was the first small molecule CRTh2 antagonist disclosed, displaying inhibitory activity of in vitro PGD<sub>2</sub>-induced eosinophil migration.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Meanwhile the discovery of numerous CRTh2 antagonists have been described and are currently in early proof-of-concept clinical studies for treating the signs and symptoms of both asthma and allergic rhinitis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structure of Endogenous CRTh2 Agonist PGD<sub>2</sub> (<b>1</b>), Partial Agonist Indomethacin (<b>2</b>), Antagonist Ramatroban (<b>3</b>), Primary Screening Hit <b>4</b>, Lead Compound <b>5</b>, and Clinical Development Candidate Setipiprant/ACT-129968 (<b>28</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, the lead optimization of a novel chemotype series providing potent, selective, and orally available CRTh2 antagonists is described. Initially identified as a singleton out of 80â000 compounds from a GPCR focused library, high-throughput screening hit <b>4</b> was confirmed as a true hit belonging to a cluster of close analogues that displayed a clear structureâactivity relationship (SAR).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Attempts to eliminate potentially unwanted structural features led to the successful design of novel CRTh2 antagonist scaffolds. From this work, 2-(2-benzoyl-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>5</b> evolved as a novel druglike lead compound devoid of any structural alerts.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The goal of the subsequent lead optimization program was mainly focused on the improvement in potency and oral bioavailability. In vitro pharmacological and physicochemical and in vitro absorption, distribution, and metabolism (ADME) properties of the novel CRTh2 antagonists as well as in vivo pharmacokinetic studies in the rat and the dog will be presented. Furthermore, the data driven process will be discussed which led to the decision to select 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>28</b> (setipiprant/ACT-129968), as a clinical development candidate for the treatment of asthma and seasonal allergic rhinitis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Biological Assays</h3><div class="NLM_p">Following our screening cascade, a competitive radioligand displacement assay was used as a biological in vitro test system to establish the structureâactivity relationship (SAR) for all synthesized potential human (<i>h</i>) CRTh2 modulators of this novel 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid series. The receptor binding assay was performed with human embryonic kidney (HEK-293) cells stably expressing <i>h</i>CRTh2 using [<sup>3</sup>H]PGD<sub>2</sub> (2.5 nM, 170 Ci/mmol) as radioligand. Quantification of intracellular Ca<sup>2+</sup> liberation (Ca<sup>2+</sup> flux, FLIPR) or cyclic (c) AMP were used to give evidence that the compounds are truly antagonizing <i>h</i>CRTh2 mediated downstream signaling. The results from both assays are reported as IC<sub>50</sub> values. Cross-selectivity with other prostanoid receptors was addressed by counterscreening the compounds against the human PGD<sub>2</sub> receptor <i>h</i>DP<sub>1</sub>, against the human prostaglandin E2 (PGE<sub>2</sub>) receptor subtypes <i>h</i>EP<sub>1</sub>, <i>h</i>EP<sub>2</sub>, <i>h</i>EP<sub>3</sub>, and <i>h</i>EP<sub>4</sub>, and against the human thromboxane A2 receptor <i>h</i>TP<sub>2</sub>. Cell lines stably expressing recombinant human receptors were used: Chinese hamster ovary (CHO) and HEK-293 cells for <i>h</i>EP<sub>1</sub> and <i>h</i>EP<sub>3</sub> receptors, respectively, membranes from HEK-293 cells containing <i>h</i>EP<sub>2</sub> or <i>h</i>EP<sub>4</sub> receptors, and HEK-293 cells stably expressing human <i>h</i>TP<sub>2</sub> receptors. Reported are IC<sub>50</sub> values defined as half-maximal inhibition of receptor stimulation using an agonist concentration previously determined to trigger 80% of maximal response. Selectivity of the antagonists toward the <i>h</i>DP<sub>1</sub> receptor was determined by using a competitive receptor binding assay with CHO cells stably expressing high levels of recombinant <i>h</i>DP<sub>1</sub> receptor, employing [<sup>3</sup>H]PGD<sub>2</sub> as ligand.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Reported are the respective IC<sub>50</sub> values and the selectivity factor (<i>f</i><sub>Sel</sub>) between <i>h</i>DP<sub>1</sub> and <i>h</i>CRTh2 which is expressed as the IC<sub>50</sub>(<i>h</i>DP<sub>1</sub>)/IC<sub>50</sub>(<i>h</i>CRTh2) ratio. Furthermore, the potential of 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid analogues to inhibit COX enzymes was addressed because of the structural similarity with NSAID <b>2</b>, a nonselective inhibitor of COX enzymes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> COX inhibition was assessed using a commercially available ovine COX-1 assay kit from Cayman Chemicals (catalog no. 760111). The compounds were tested in duplicate at 10 Î¼M final concentration according to the protocol provided by the kit manufacturer.</div><div class="NLM_p last">Potent antagonists with binding IC<sub>50</sub> < 100 nM were further verified in a competitive radioligand displacement assay in the presence of 0.5% human serum albumin (HSA) in order to identify those antagonists that retained potency under conditions where binding to plasma proteins occurs. The positives were subsequently tested in the eosinophil shape change (<i>h</i>ESC) assay.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> In brief, human eosinophils were isolated from whole blood of healthy volunteers and were subsequently stimulated with 15 nM PGD<sub>2</sub> in the presence of 50% human plasma at 37 Â°C for 5 min. Stimulation was stopped by adding fixation solution, and increase in light scattering reflecting changes in cell shape was measured by flow cytometry. A dose dependent inhibition of this shape change could be demonstrated with potent antagonists by preincubating the cells with increasing concentrations of the respective antagonist for 10 min prior to stimulation with PGD<sub>2</sub>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p last">About 200 novel 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid analogues were synthesized in four and five steps as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> starting with 2,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole analogues <b>6a</b>â<b>l</b>, all available from commercial sources or synthetically accessible following well established procedures. Classical <i>N</i>-Boc-protection was followed by an alkylation step of <b>7a</b>â<b>l</b> with ethyl bromoacetate in the presence of potassium carbonate in DMF at 80 Â°C or in acetone at room temperature. Removal of the Boc group in <b>8a</b>â<b>l</b> using 4 N HCl in 1,4-dioxane gave the corresponding hydrochloride salts <b>9a</b>â<b>l</b>, which were subsequently reacted with the respective acid chloride R-COCl in DCM at 0 Â°C in the presence of DIPEA as a base to provide amides <b>10a</b>â<b>l</b>. Saponification of the ethyl ester with 0.2 M aqueous NaOH solution in THF and preparative reverse-phase LCâMS purification provided 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid derivatives <b>5</b> and <b>11</b>â<b>36</b> with >95% purity in 18â93% yield.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> SAR Studies</h3><div class="NLM_p">An initial SAR was established with 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid analogues <b>11</b>â<b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The focus of this set of compounds was directed toward the tolerability of a substituent R<sup>1</sup> attached to the indole unit. As illustrated with <b>12</b>, <b>15</b>, <b>16</b>, and <b>18</b>, compounds were obtained that were by a factor of 2â3 slightly more potent in the radioligand binding assay than lead compound <b>5</b>, displaying IC<sub>50</sub> values of 5, 11, 7, and 9 nM if R<sup>1</sup> at C(8) represented chlorine, methyl, fluorine, and trifluoromethyl, respectively. Methoxy or isopropyl at C(8) seemed to be less favorable (IC<sub>50</sub> of 62 and 42 nM) as illustrated with <b>19</b> and <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Generally, up to 10-fold less potent compounds were obtained if R<sup>1</sup> represented chlorine or methyl connected to C(6) or if R<sup>1</sup> was methyl-attached to C(7), as exemplified with <b>11</b>, <b>13</b>, or <b>14</b>, respectively. Combining two fluorine atoms in the same molecule, one connected to the more favorable C(8) position and a second attached to the suboptimal C(6) position, resulted in a more than 5-fold drop in binding affinity as demonstrated with <b>17</b>. The results of the SAR study exploring R<sup>1</sup> at the indole moiety were in accordance with the data disclosed for the (<i>E</i>)-2-cyano-3-(1<i>H</i>-indol-3-yl)acrylamide hit series.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme for the Preparation of 2-(3,4-Dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid Derivatives <b>5</b> and <b>11</b>â<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Boc<sub>2</sub>O, DIPEA or Et<sub>3</sub>N, DCM or THF, room temperature, 53â100%; (b) BrCH<sub>2</sub>CO<sub>2</sub>Et, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C or acetone, room temperature, 41â88% yield; (c) 4 N HCl in 1,4-dioxane, DCM, room temperature, 16â99% yield; (d) R-COCl, DIPEA, DCM, 0 Â°C to room temperature, 28â98% yield; (e) 0.2 N aqueous NaOH, THF, room temperature, 18â93% yield.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial SAR Study Exploring R<sup>1</sup> at the Indole Moiety<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>CRTh2 IC<sub>50</sub> [nM]<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="char" char=".">820</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">8-Cl</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="char" char=".">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">7-Me</td><td class="colsep0 rowsep0" align="char" char=".">1590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">8-Me</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">6,8-F<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">8-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">8-MeO</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">8-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Listed are the IC<sub>50</sub> values of the <i>h</i>CRTh2 receptor radioligand binding in buffer.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">The data represent the means from at least four independent experiments.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Study Exploring R and R<sup>1</sup>, with IC<sub>50</sub> Binding Data for <i>h</i>CRTh2 of Selected Compounds in Comparison with Lead Compound <b>5</b>, Measured in the Presence and Absence of Human Serum Albumin (HSA) in the Assay Buffer<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0004.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0005.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are given for the effects in the cell based Ca<sup>2+</sup> flux assay, the cAMP homogeneous time resolved fluorescence (HTRF) assay, and the human eosinophil shape change assay. Data are given to demonstrate selectivity against prostanoid receptors hDP1, hEP<sub>1-4</sub>, and hTP2. The IC<sub>50</sub> values represent the mean from at least three independent experiments if not stated otherwise.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Human serum albumin shift factor <i>f</i><sub>HSA</sub> = IC<sub>50</sub>(HSA)/IC<sub>50</sub>(buffer).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Selectivity factor <i>f</i><sub>Sel</sub> = IC<sub>50</sub>(<i>h</i>DP1)/IC<sub>50</sub>(<i>h</i>CRTh2).</p></div></div><div></div></div><div class="NLM_p">In another subset of analogues, preferred R<sup>1</sup> residues were combined with various R groups. One-third of those compounds displayed a potent interaction with <i>h</i>CRTh2, inhibiting [<sup>3</sup>H]PGD<sub>2</sub> binding in a competitive manner with IC<sub>50</sub> â¤ 15 nM. A representative selection is listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> for a continuing discussion of the SAR. From this list it became evident that hydrophobic R groups were crucial for potent <i>h</i>CRTh2 binding, for example, monocyclic five- and six-membered aromatic rings as represented by thiophene and phenyl, directly attached to the carbonyl group, as well as fused aromatic ring systems as illustrated with naphthalene or the nitrogen-containing nonbasic indole, connected either directly or via a methylene or an ethylene bridge to the carbonyl group. The most potent antagonist, <b>35</b>, was obtained if R represented a biphenyl moiety. Compared to <b>5</b>, a significant drop in potency was observed if R represents an alkyl group, for example, methyl (IC<sub>50</sub> = 1.6 Î¼M) or pentyl (IC<sub>50</sub> = 0.2 Î¼M).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Furthermore, a 5-fold drop in potency was noticed for the respective cyclohexyl analogue <b>21</b> (IC<sub>50</sub> = 70 nM), consolidating the importance of an aromatic ring system at this site of the molecule. In Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the previously discussed beneficial contributions of fluorine, chlorine, methyl, or trifluoromethyl at C(8) could be strengthened with additional examples listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Also the less favorable effect of C(6) substitution was further established with <b>25</b>, <b>31</b>, and <b>36</b>. These examples displayed an approximately 20-, 12-, and 6-fold drop in potency, respectively, if compared with their relatives <b>24</b>, <b>28</b>, and <b>35</b> that were not substituted at C(6).</div><div class="NLM_p">Acidic compounds tend to bind to basic serum albumin. Therefore, not surprisingly the compounds discussed herein displayed high plasma protein binding in an in vitro plasma protein binding assay (PPB > 97%, data not shown). Since targeted <i>h</i>CRTh2 is located on circulating cells, the impact of plasma protein binding on the potency of the <i>h</i>CRTh2 antagonists was assessed by adding 0.5% human serum albumin (HSA) to the binding assay buffer. Generally, a less than 10-fold HSA shift factor <i>f</i><sub>HSA</sub>, defined as the ratio IC<sub>50</sub>(HSA)/IC<sub>50</sub>(buffer), was noticed. With the exceptions of <b>30</b> and <b>31</b>, a substantially higher albumin shift up to a factor <i>f</i><sub>HSA</sub> of 57 was observed in the cases where R was a naphthyl or a naphthylmethyl moiety. No obvious correlation between <i>f</i><sub>HSA</sub> and physicochemical parameters of the antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) could be established. However, a comparable shift effect was observed for the inhibition of the PGD<sub>2</sub> induced morphological shape change of human eosinophils measured in the presence of human plasma.</div><div class="NLM_p">Since agonistic activity on the CRTh2 receptor was reported for structurally related indolylacetic acid <b>2</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid derivatives <b>5</b> and <b>11</b>â<b>36</b> were consequently tested for their agonistic potential. It could be demonstrated that all compounds were solely antagonists on <i>h</i>CRTh2, fully antagonizing the PGD<sub>2</sub> induced effects with the IC<sub>50</sub> values given in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> for both cell based functional assays, the Ca<sup>2+</sup> flux and the cAMP assay. Moreover, species selectivity was addressed in a concomitant study by testing the compounds in a FLIPR assay against mouse, rat, guinea pig, and dog CRTh2 using cells expressing the respective recombinant species CRTh2. Antagonistic effects with comparable potencies were found as for <i>h</i>CRTh2 except for <b>24</b>, <b>26</b>, and <b>28</b>. Unexpectedly, these three examples were identified as partial agonists on the mouse and the guinea pig receptor (data not shown), limiting the choice of potential in vivo animal models for efficacy studies.</div><div class="NLM_p">In addition, all antagonists inhibited the PGD<sub>2</sub> induced shape change of human eosinophils in the <i>h</i>ESC assay. Compounds <b>22</b>â<b>24</b> and <b>33</b> were discovered to antagonize <i>h</i>ESC most effectively with IC<sub>50</sub> < 100 nM. In fact, these antagonists belong to the group that exhibited only a minor serum albumin shift <i>f</i><sub>HSA</sub> in the binding assay.</div><div class="NLM_p">Selectivity against other prostanoid receptors was considered important in order to avoid unwanted adverse effects from off-target effects. All compounds were tested against the human PGD<sub>2</sub> receptor <i>h</i>DP<sub>1</sub>, the human PGE<sub>2</sub> receptors <i>h</i>EP<sub>1</sub>, <i>h</i>EP<sub>2</sub>, <i>h</i>EP<sub>3</sub>, and <i>h</i>EP<sub>4</sub>, and the human TXA<sub>2</sub> receptor <i>h</i>TP<sub>2</sub>. Many of the antagonists were highly selective with a selectivity factor <i>f</i><sub>Sel</sub> > 1000 in favor of <i>h</i>CRTh2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, a few antagonists were identified that manifested considerable affinities in the low micromolar to submicromolar range for the <i>h</i>DP<sub>1</sub> receptor. Those compounds could be classified mainly into two groups. For example, molecules where R<sup>1</sup> is representing a chlorine atom connected to C(6), as exemplified with <b>25</b>, <b>31</b>, and <b>36</b>, could be assigned to one group. In these cases, a selectivity factor <i>f</i><sub>Sel</sub> in the range between 4 and 20 was obtained. This narrow selectivity window originates from an up to 20-fold loss in potency for <i>h</i>CRTh2 on one hand and from a considerable gain in affinity for the <i>h</i>DP<sub>1</sub> receptor on the other. The second group contained molecules with R representing the large lipophilic naphthyl, as illustrated with <b>26</b>â<b>30</b>, or biphenyl, exemplified by <b>35</b>. These compounds were identified as being highly potent on <i>h</i>CRTh2 but were also found to inhibit the <i>h</i>DP<sub>1</sub> receptor in the low micromolar to submicromolar range, resulting in a selectivity factor in the range 80 < <i>f</i><sub>Sel</sub> < 1000. A selectivity factor of <i>f</i><sub>Sel</sub> > 200 in favor of <i>h</i>CRTh2 was applied as a selection criterion in order to further profile a compound. Some minor cross-selectivity was observed in the single digit micromolar range with PGE<sub>2</sub> receptor <i>h</i>EP<sub>2</sub> measured in the Î²-arrestin assay (IC<sub>50</sub> > 10 Î¼M in the binding assay); however, the selectivity factors <i>f</i><sub>Sel</sub> were all >400 in favor of the CRTh2 antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The compounds were found to be highly selective against the other EP receptors (<i>h</i>EP<sub>1</sub>, IC<sub>50</sub> > 25 Î¼M (Ca<sup>2+</sup>); <i>h</i>EP<sub>3</sub>, IC<sub>50</sub> > 25 Î¼M (Ca<sup>2+</sup>); <i>h</i>EP<sub>4</sub>, IC<sub>50</sub> > 10 Î¼M (Î²-arrestin and binding). In contrast to structurally related <b>3</b>, no inhibition of <i>h</i>TP<sub>2</sub> receptor was observed for this compound series (IC<sub>50</sub> > 25 Î¼M (Ca<sup>2+</sup>)).</div><div class="NLM_p last">The inhibitory potential of 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid analogues <b>5</b> and <b>11</b>â<b>36</b> for enzymes that are involved in the prostaglandin synthesis, for example, the COX enzymes, was addressed because of the structural similarity with NSAID <b>2</b>, a nonselective COX inhibitor.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> All <i>h</i>CRTh2 antagonists reported herein reduced COX-1 enzyme activity by less than 30% at 10 Î¼M compound concentration (no detailed data shown); hence, all IC<sub>50</sub> values were determined well above 10 Î¼M.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Physicochemical and in Vitro ADME Properties</h3><div class="NLM_p">Physicochemical properties of the antagonists selected for further profiling are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The molecular weights were all below 450 Da, in an optimal range between 358 and 438 Da as targeted for small druglike molecules. Furthermore, the attractive ligand efficiencies (LE) with values between 0.35 and 0.46 placed the compounds in the envisaged range of that for oral drug candidates.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The cLogP values were calculated between 2.0 and 4.4 as a measure of molecular hydrophobicity, and these values were well below 5, in accordance with Lipinskiâs rule of five.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Generally, the low to medium molecular weights (MWs) ranging from 358 to 416 Da, cLogP values between 2.0 and 3.3, and logÂ <i>D</i><sub>7.4</sub> values ranging from â0.3 to +0.2 provided compounds that were highly soluble in buffered aqueous solution at pH 7 with solubility values between 560 and 1000 Î¼g/mL. Still an acceptable solubility was obtained in buffer at pH 4 (21â180 Î¼g/mL) or even in pure water (25â335 Î¼g/mL). Unsurprisingly, the most hydrophobic compound <b>35</b> listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> displayed the highest cLogP value of 4.4 and the highest logÂ <i>D</i><sub>7.4</sub> value of 1.8 in this series and consequently was found to be insoluble in buffer at pH 4 and water (1 and 2 Î¼g/mL, respectively). Only poor solubility was measured in buffer at pH 7 (30 Î¼g/mL).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Physicochemical Properties and Ligand Efficiency of Selected Antagonists in Comparison with Lead Compound <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="3" align="center">solubility (Î¼g/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MW (Da)</th><th class="colsep0 rowsep0" align="center" char=".">LE<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center" char=".">logÂ <i>D</i><sub>7.4</sub></th><th class="colsep0 rowsep0" align="center">water (pH)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">buffer, pHÂ 4</th><th class="colsep0 rowsep0" align="center" char=".">buffer, pHÂ 7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">334.37</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">2.09</td><td class="colsep0 rowsep0" align="char" char=".">â1.2</td><td class="colsep0 rowsep0" align="left">64Â (4.3)</td><td class="colsep0 rowsep0" align="char" char=".">515</td><td class="colsep0 rowsep0" align="char" char=".">810</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">358.39</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">50Â (3.9)</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">930</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">368.82</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">â0.5</td><td class="colsep0 rowsep0" align="left">110Â (3.8)</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">815</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">386.81</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">â0.3</td><td class="colsep0 rowsep0" align="left">25Â (4.9)</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">384.43</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">335 (nd)</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">830</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">402.42</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">50Â (4.3)</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">880</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">416.45</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">28Â (5.7)</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">405.43</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">â0.3</td><td class="colsep0 rowsep0" align="left">45Â (3.8)</td><td class="colsep0 rowsep0" align="char" char=".">115</td><td class="colsep0 rowsep0" align="char" char=".">800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">438.53</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="left">2Â (4.3)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Ligand efficiency (LE): relative free binding energy in kcal/mol per non-H atom, calculated from IC<sub>50</sub> values.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">pH of the final aqueous solution.</p></div></div></div><div class="NLM_p">The drugâdrug interaction potential for the selected antagonists in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> was assessed in vitro by measuring the inhibition of the cytochrome P450 isoforms 2C9, 2D6, and 3A4. Since all IC<sub>50</sub> values were well above 10 Î¼M, a low drugâdrug interaction potential was considered for those compounds.</div><div class="NLM_p">Chemical stability in various media was evaluated by incubating the compounds in rat and human plasma for up to 4 h, in simulated gastric fluid (SGF) for 1 h, and in simulated intestinal fluid (SIF) for 4 h.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Recovery of unchanged parent compound was determined by LCâMS. The compounds were stable under the described conditions. The elimination half-life (<i>T</i><sub>1/2</sub>) was found to be >4 h after exposure in rat as well as in human plasma, and <i>T</i><sub>1/2</sub> > 1 h in SGF, and <i>T</i><sub>1/2</sub> > 4 h in SIF (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">Metabolic stability was assessed by incubating the compounds with human and rat liver microsomes as well as with plated rat hepatocytes (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). With the exception of <b>35</b> all compounds displayed a very low intrinsic clearance (Cl<sub>int</sub>) with values below 10 Î¼L min<sup>â1</sup> (mg protein)<sup>â1</sup> after incubation with human liver microsomes. An increased clearance (Cl<sub>int</sub> = 85 Î¼L min<sup>â1</sup> (mg protein)<sup>â1</sup>) was observed for <b>35</b>. Only <b>22</b>, <b>24</b>, and <b>28</b> provided similarly low Cl<sub>int</sub> values in rat liver microsomes, whereas <b>23</b>, <b>26</b>, <b>32</b>, <b>33</b>, and <b>35</b> were found to be more prone to oxidative metabolism, providing Cl<sub>int</sub> values in the range between 23 and 63 Î¼L min<sup>â1</sup> (mg protein<sup>â1</sup>). A low clearance was observed in rat hepatocytes with all Cl<sub>int</sub> values not exceeding 5.3 Î¼L min<sup>â1</sup> (10<sup>6</sup> cells)<sup>â1</sup>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro ADME Properties of Selected Potent Antagonists in Comparison with Lead Compound <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Cl<sub>int</sub><br /></br>(Î¼LÂ min<sup>â1</sup>(mgÂ protein)<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C9,<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><br /></br>IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">HLM</th><th class="colsep0 rowsep0" align="center" char=".">RLM</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub>(Î¼LÂ min<sup>â1</sup><br /></br>(10<sup>6</sup>Â cells)<sup>â1</sup>),Â RHepa</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="left">5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">CYP inhibition: IC<sub>50</sub>(2D6,3A4) > 50 Î¼M.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p">Pharmacokinetic studies with a representative set of potent and selective CRTh2 antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) were carried out in the Wistar rat at intravenous doses of 0.2, 1, and 2 mg/kg and at oral doses of 2 and 10 mg/kg. Among the six antagonists presented, <b>28</b> and its des-fluoro analogue <b>26</b> displayed the most favorable pharmacokinetic properties with an excellent exposure (AUC<sub>0âlast</sub>) of 58â500 and 57â300 ng h<sup>â1</sup> mL<sup>â1</sup>, low plasmatic clearance of 1.3 and 1.1 mL min<sup>â1</sup> kg<sup>â1</sup>, and an oral bioavailability of 44% and 36%, respectively. In comparison, a 5-fold higher plasma clearance was observed for <b>24</b>. Indeed, despite low plasmatic clearance of 5.9 mL min<sup>â1</sup> kg<sup>â1</sup>, only a moderate exposure of 6450 ng h<sup>â1</sup> mL<sup>â1</sup> was determined, leading to an oral bioavailability of 23%. With <b>33</b>, the exposure dropped to 62 ng h<sup>â1</sup> mL<sup>â1</sup>, giving rise to a bioavailability of only 2%. The moderate plasmatic clearance of 11 mL min<sup>â1</sup> kg<sup>â1</sup> was not considered the only parameter attributed to the low bioavailability of <b>33</b>. Other additional effects like incomplete absorption or active secretion into the gut lumen could also be reasons for the low bioavailability. Compounds <b>22</b> and <b>35</b> displayed the highest clearance within this series, with values of 35 and 36 mL min<sup>â1</sup> kg<sup>â1</sup>. Consequently, their exposures were well below 500 ng h<sup>â1</sup> mL<sup>â1</sup> and their respective oral bioavailability did not exceed the 5% threshold. For all the antagonists tested, a low volume of distribution <i>V</i><sub>ss</sub> typical for acidic drugs (e.g., warfarin, aspirin) was found within a range of 0.4â0.8 L/kg.</div><div class="NLM_p">Pharmacokinetic studies with <b>24</b> and <b>28</b> were performed in male Beagle dogs. Both compounds were administered orally at a dose of 10 mg/kg and intravenously at a dose of 1 mg/kg as solutions containing 10% propylene glycol (PG). The acquired data are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The exposure after oral administration of <b>24</b> and <b>28</b> was higher than in the rat with values of 9620 and 91â100 ng h<sup>â1</sup> mL<sup>â1</sup>, respectively. Both compounds showed a similar bioavailability with 55% for <b>28</b> and 64% for <b>24</b> despite a 10-fold difference in plasmatic clearance after intravenous administration. Indeed, while <b>28</b> was found to be a low clearance compound with a value of 1.3 mL min<sup>â1</sup> kg<sup>â1</sup>, the clearance for <b>24</b> was elevated to 11 mL min<sup>â1</sup> kg<sup>â1</sup>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of Selected Potent Antagonists, Determined in Male Wistar Rats (Three Animals for Each Experiment) after Intravenous (iv) and Oral (po) Administrations as Solutions<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0âlast</sub>(ngÂ h<sup>â1</sup>Â mL<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center">CL (mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub>Â (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">6300</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">244</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">6450</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">57300</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">58500</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">171</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last"><i>V</i><sub>ss</sub> = 0.4â0.8 L/kg for all compounds tested. iv: 2 mg/kg (<b>28</b>, <b>35</b>), 1 mg/kg (<b>5</b>, <b>22</b>, <b>24</b>, <b>26</b>), 0.2 mg/kg (<b>33</b>). po: 10 mg/kg (<b>5</b>, <b>22</b>, <b>24</b>, <b>26</b>, <b>28</b>, <b>35</b>), 2 mg/kg (<b>33</b>).</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Profile of <b>24</b> and <b>28</b> Determined in Male Beagle Dogs (Three Animals for Each Experiment) after Intravenous and Oral Administrations at a Dose of 1 and 10 mg/kg, Respectively</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0âlast</sub>(ngÂ h<sup>â1</sup>Â mL<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center">CL<sub>iv</sub>(mLÂ min<sup>â1</sup>Â kg<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>Â (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">9620</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="char" char=".">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">91100</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="char" char=".">55</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Applying Traffic Lights (TL) as a Tool for the Data-Driven Selection of the Clinical Candidate<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0006.gif" alt="" id="GRAPHIC-d167e2445-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>Table a</sup><p class="last">Color coded thresholds (green, go; yellow, alert; red, no go) are given for selected properties of antagonist <b>24</b>, <b>26</b>, and <b>28</b> in comparison with lead compound <b>5</b>.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Discussion</h3><div class="NLM_p last">The optimization program of the 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid lead series with the main focus on the improvement in potency and oral bioavailability offered numerous <i>h</i>CRTh2 antagonists with interesting characteristics. A visualization device was considered useful in order to simplify a data-driven analysis of the collected data and to evaluate and prioritize candidates showing a balanced profile with a great promise for further development. Therefore, a traffic light (TL) selection tool,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> basically a conditional formatting with the color coding red, yellow, and green, was applied (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Threshold ranges were defined and applied for the more than 30 parameters that were presented throughout Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>â<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and discussed in the corresponding paragraphs. A red TL was used to visualize values in a less favored range as a âno goâ. A yellow TL was set as an alert for moderate data, whereas a green TL was employed to highlight a âgoâ for excellent parameter data. The threshold ranges were applied on the full data set of eligible antagonists. However, only the eight parameters that differed most for <b>5</b>, <b>24</b>, <b>26</b>, and <b>28</b> were listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> as TLs, including their respective threshold ranges; the TLs of the remaining parameters were not registered in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> because they all appeared in the green range for the best candidates. This assessment revealed that lead structure <b>5</b> already displayed a favorable and overall druglike profile. No red flags appeared, and only 6 out of the 33 parameters really offered potential room for improvement (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Applying the threshold ranges with the respective color coding uncovered not more than three close analogues (<b>24</b>, <b>26</b>, and <b>28</b>) with more green TLs than <b>5</b>. Ultimately, the envisaged optimization effort concluded with the three potential candidates <b>24</b>, <b>26</b>, and <b>28</b>. For example, four parameters of <b>26</b> were clearly improved, as shown with four yellow TL changing to green. However, at the same time three other parameters changed for the worse; for example, the TL for <i>f</i><sub>HSA</sub> changed from green to yellow, the TL <i>f</i><sub>Sel</sub> from green to red, and TL <i>h</i>ESC from yellow to red. More importance was attached to the worsening of the last two parameters, especially the shift toward much lower potency with IC<sub>50</sub> > 1 Î¼M in the relevant functional <i>h</i>ESC assay, than to the positive almost 10-fold improved exposure, and thus, <b>26</b> was not considered a probable candidate. Actually, antagonist <b>24</b> was identified as the most balanced candidate with the most green, the least yellow, and with no red TLs. Example <b>28</b> scored second with one yellow TL more for the serum albumin shift factor <i>f</i><sub>HSA</sub>. A closer look at the TL alert for <i>h</i>ESC of <b>28</b> revealed a 4-fold drop in potency if compared with <b>24</b>. However, by comparison of the plasma exposure of <b>28</b> (green TL) with <b>24</b> (yellow TL), it became obvious that <b>28</b> outperformed <b>24</b> by a factor of 10 in this respect, thus compensating the aforementioned 4-fold potency drop by more than a factor of 2. Well knowing that the shift to lower potency in plasma and consequently in whole blood could compromise in vivo efficacy, <b>28</b> was nevertheless selected for further development mainly because of its excellent oral uptake and the high exposure that could be reached. It was believed that therapeutically relevant drug levels still could be obtained, especially at higher dosage. The full pharmacokinetic and pharmacodynamic profile of <b>28</b> will be presented in a forthcoming publication.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, an optimization process with the main focus to improve potency and oral bioavailability of a novel <i>h</i>CRTh2 antagonist series was presented starting with the recently disclosed 2-(2-benzoyl-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>5</b> as lead compound. Data were collected on more than 30 parameters for a set of about 200 newly synthesized analogues. A traffic light analysis was conducted to visualize and to compare the data and to evaluate and prioritize candidates displaying a balanced profile. This data-driven process and the excellent results of the PK study in the rat (<i>F</i> = 44%) and the dog (<i>F</i> = 55%) facilitated the identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic acid <b>28</b> (setipiprant/ACT-129968) as a potent, selective, and orally available <i>h</i>CRTh2 antagonist. Unfortunately, it was not feasible to rely on the efficacy in animal asthma models as a selection criterion for the development candidate because the most balanced <i>h</i>CRTh2 antagonists <b>24</b>, <b>26</b>, and <b>28</b> turned out to act as partial agonists on the mouse or guinea pig receptor. This fact limited the choice of animal asthma models. For that reason and because of the complex challenges concerning the in vivo pharmacological profiling of <b>28</b> in animal models as well as the cell based in vitro studies with cells originating from various species, no further particulars on pharmacological data were discussed herein. These data will be presented and discussed in a dedicated publication (paper in preparation). Since the treatment of patients has been the ultimate goal, selection priority was based on the activity of the antagonists on relevant CRTh2 expressing human cells and oral bioavailability. Ultimately, <b>28</b> was selected for further studies and proposed as a clinical development candidate for the treatment of asthma and seasonal allergic rhinitis. At the time of selection, <b>28</b> was among the first <i>h</i>CRTh2 antagonists available, and therefore, we decided to commence clinical profiling in order to obtain proof of concept for CRTh2 inhibition in humans, to evaluate safety aspects, and to gain further experience with such a novel treatment modality, however, being well aware of the fact that the observed blood plasma shift to lower potency, especially in the more important cellular test systems, could compromise the outcome of clinical efficacy. Therapeutically relevant drug levels were expected to be reached, especially at higher dosage, because of the excellent oral uptake of <b>28</b> and hence its high systemic exposure. Moreover, in the course of our subsequent discovery and development efforts more emphasis was put on the plasma protein effect in order to identify antagonists with highly potent inhibitory activity on CRTh2 expressing human cells and exhibiting no or only a minor shift to lower potency in the presence of human blood plasma and human whole blood. The clinical program and the generated novel understanding concerning CRTh2 antagonism in human volunteers and patients will be discussed in future reports.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents and solvents were used as purchased without any further purification. Reactions were performed under inert Ar or N<sub>2</sub> atmosphere unless stated otherwise. NMR data were recorded at room temperature on a Bruker Avance II 400 MHz spectrometer equipped with a BBO 5 mm probe head unless stated otherwise. Chemical shifts (Î´) are reported in parts per million (ppm) relative to proton resonances resulting from incomplete deuteration of the NMR solvent, e.g., for dimethylsulfoxide Î´(H) 2.49 ppm, for chloroform Î´(H) 7.24 ppm. The abbreviations s, d, t, q, m, and b refer to singlet, doublet, triplet, quartet, multiplet, and broad, respectively.</div><div class="NLM_p">The following instruments and conditions were used. For analytical LC(1)/ESI-MS: Dionex HPG-3200RS pump system; MS, Thermo MSQ Plus MS detector; (DAD)/ (ELSD), DAD-3000RS detector equipped with Sedere Sedex 85 ELS detector; column, Zorbax SB-Aq, 3.5 Î¼m, 4.6 mm Ã 50 mm, 40 Â°C; eluent A, water containing 0.04% TFA; eluent B, acetonitrile; gradient, 5â95% B over 1 min; flow rate, 4.5 mL/min. For analytical LC(2)/ESI-MS: Dionex HPG-3200RS pump system; MS, Thermo MSQ Plus MS detector; DAD/ELSD, DAD-3000RS detector equipped with Sedere Sedex 85 ELS detector; column, Atlantis T3, 5 Î¼m, 4.6 mm Ã 30 mm, 40 Â°C; eluent A, water containing 0.04% TFA; eluent B, acetonitrile; gradient, 5â95% B over 1 min; flow rate, 4.5 mL/min. For analytical LC(3)/ESI-MS: Waters Acquity binary pump system; MS, Waters Aquity SQD; DAD/ELSD, Waters Acquity PDA and ELS detector; column, UPLC BEH C18 1.7 Î¼m, 2.1 mm Ã 50 mm; eluent A, water containing 0.05% formic acid; eluent B, acetonitrile containing 0.05% formic acid; gradient, 2â95% B over 1.4 min and then 95â98% B over 0.4 min; flow rate, 1.2 mL/min. For preparative HPLC: Gilson 333/334 binary high pressure gradient pump system equipped with Sedere Sedex V.F.S variable flow splitter, Dionex P680 isocratic make-up pump; DAD, Dionex UVD340U DAD detector; MS, Finnigan AQA MS detector; fraction collection, Gilson 215 autosampler and fraction collector; column, Atlantis Prep C18 (30 mm Ã 75 mm OBD); eluent A, water containing 0.05% formic acid; eluent B, acetonitrile; flow rate, 75 mL/min. For HR-LCâMS: Waters Acquity binary pump system, solvent manager; MS, SYNAPT G2MS; source temperature, 150 Â°C; desolvatation temperature, 400 Â°C; desolvatation gas flow, 400 L/h; cone gas flow, 10 L/h; extraction cone, 4 RF; lens, 0.1 V; sampling cone, 30; capillary, 1.5 kV; high resolution mode; gain, 1.0; MS function, 0.2 s per scan; 120â1000 amu in full scan, centroid mode; lock spray, leucine enkephalin 2 ng/mL (556.2771 Da); scan time, 0.2 s with interval of 10 s and average of 5 scans; DAD, Acquity UPLC PDA detector; column, Waters Acquity UPLC BEH C18, 1.7 Î¼m, 2.1 mm Ã 50 mm, thermostated in the Acquity UPLC column manager at 60 Â°C; eluent A, water containing 0.05% formic acid; eluent B, acetonitrile containing 0.05% formic acid; gradient, 2â98% B over 3.0 min; flow rate, 0.6 mL/min; detection, UV 214 nm and MS. Melting points were measured on a Sanyo Gallenkamp digital apparatus and are uncorrected.</div><div class="NLM_p">All compounds tested for biological activity are reported as having at least 95% purity as judged by HPLC method LC(1).</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Synthesis of <b>7a</b>â<b>l</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Stage a)</h3><div class="NLM_p last">To suspensions of the respective 2,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole hydrochloride salts <b>6a</b>â<b>l</b> (18.4 mmol) in DCM (100 mL) were added DIPEA (22.1 mmol, 2.85 g, 3.78 mL) and di-<i>tert</i>-butyl dicarbonate (19.3 mmol, 4.22 g). The resulting white solutions were allowed to stir at ambient temperature for 1 h. Saturated aqueous NH<sub>4</sub>Cl solution was added, and the resulting aqueous phases were extracted twice with DCM. The combined organic phases were washed with water and brine and then dried over MgSO<sub>4</sub>. The solvent was evaporated in vacuo, and the resulting solids were dried under high vacuum and used as such in the next step.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 3,4-Dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate (<b>7a</b>, R<sup>1</sup> = H)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h3><div class="NLM_p last">Boc protection of <b>6a</b> provided <b>7a</b> as a white solid in 83% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 1.00 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 273.07. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 7.83 (s), 7.45 (d, <i>J</i> = 7.3 Hz, 1 H), 7.31 (m, 1 H), 7.13 (m, 2 H), 4.64 (s, 2 H), 3.82 (bs, 2 H), 2.83 (bs, 2 H), 1.50 (s, 9 H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub> [M + H<sup>+</sup>] 273.1603, found 273.1598.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 8-Fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate (<b>7b</b>, R<sup>1</sup> = 8-F)<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></h3><div class="NLM_p last">Boc protection of <b>6b</b> provided <b>7b</b> as a brown solid in 96% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.91 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 291.20. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 10.99 (s, 1 H), 7.28 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>HâF</sub> = 4.5 Hz, 1 H), 7.18 (dd, <i>J</i><sub>HâF</sub> = 9.9 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1 H), 6.86 (ddd, <i>J</i><sub>HâF</sub> = 9.9 Hz, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1 H), 4.50 (s, 2 H), 3.70 (<i>t</i>, <i>J</i> = 5.7 Hz, 2 H), 2.78 (<i>t</i>, <i>J</i> = 5.7 Hz, 2 H), 1.45 (s, 9 H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>F [M + H<sup>+</sup>] 291.1509, found 291.1515.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Synthesis of <b>8a</b>â<b>l</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Stage b)</h3><div class="NLM_p">To solutions of the respective <i>tert</i>-butyl 3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate derivatives <b>7a</b>â<b>l</b> (1.17 mmol) and ethyl bromoacetate (1.4 mmol, 239 mg, 0.159 mL) in DMF (3 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (2.34 mmol, 761 mg). The resulting reaction mixtures were allowed to stir at 80 Â°C for 1 h. After the mixtures were cooled, 10 mL of water and 10 mL of brine were added and the resulting aqueous phases were extracted three times with DCM. The combined organic phases were washed with water and brine and dried over MgSO<sub>4</sub>. Evaporation of the solvent in vacuo yielded brown pastes from which the pure products <b>8a</b>â<b>l</b> were isolated by flash chromatography on silica gel using EtOAc/<i>n</i>-heptane as eluent or by precipitation from cyclohexane.</div><div class="NLM_p last">For the preparation of <b>8b</b>, <b>8d</b>, and <b>8i</b>, acetone was used as solvent instead of DMF and the reaction was performed at room temperature.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 5-(2-Ethoxy-2-oxoethyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate (<b>8a</b>, R<sup>1</sup> = H)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></h3><div class="NLM_p last">Alkylation of <b>7a</b> provided <b>8a</b> as a yellow oil in 58% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.97 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 359.29. <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´: 7.42 (d, <i>J</i> = 7.7 Hz, 1 H), 7.26 (m, 1 H), 7.15 (m, 1 H), 7.07 (m, 1 H), 4.89 (s, 2 H), 4.62 (s, 2 H), 4.19 (q, <i>J</i> = 7.3 Hz), 3.83 (<i>t</i>, <i>J</i> = 5.6 Hz, 2 H), 2.76 (<i>t</i>, <i>J</i> = 5.6 Hz, 2 H), 1.52 (m, 9 H), 1.26 (<i>t</i>, <i>J</i> = 7.1 Hz, 3 H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) Î´: 169.4, 155.6 (bs), 137.1, 133.6 (bs), 125.5, 121.1, 119.2, 117.0, 108.5, 106.9 (bs), 80.1, 61.2, 43.8, 41.6â40.5 (m), 27.4, 21.7 (bs), 13.1. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> [M + H<sup>+</sup>] 359.1971, found 359.1977.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 5-(2-Ethoxy-2-oxoethyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate (<b>8b</b>, R<sup>1</sup> = 8-F)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p last">Alkylation of <b>7b</b> provided <b>8b</b> after precipitation from cyclohexane as a white solid in 70% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.97 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 377.20. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 7.13 (m, 2 H), 6.94 (td, <i>J</i><sub>HâF</sub> = 9.1 Hz, <i>J</i><sub>1</sub> = 9.1 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1 H), 4.73 (s, 2 H), 4.62 (bs, 2 H), 4.23 (q, <i>J</i> = 7.1 Hz, 2 H), 3.87 (bs, 2 H), 2.77 (bs, 2 H), 1.53 (s, 9 H), 1.29 (<i>t</i>, <i>J</i> = 7.1 Hz, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): Î´ 168.4, 158.0 (d, <i>J</i><sub>CâF</sub> = 235 Hz), 155.1 (bs), 135.5 (m), 133.4, 125.9 (m), 109.5 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 109.2 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 108.1 (m), 103.3 (d, <i>J</i><sub>CâF</sub> = 24 Hz), 80.0, 61.8, 44.8, 41.1â40.4 (m), 28.5, 22.5 (bs), 14.2. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>F [M + H<sup>+</sup>] 377.1876, found 377.1871.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for the Synthesis of <b>9a</b>â<b>l</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Stage c)</h3><div class="NLM_p last">To solutions of the respective <i>tert</i>-butyl 5-(2-ethoxy-2-oxoethyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole-2(5<i>H</i>)-carboxylate derivatives <b>8a</b>â<b>l</b> (2 mmol) in DCM (5 mL) were added dropwise a solution of 4 N HCl in 1,4-dioxane (5 mL) at ambient temperature. The resulting mixtures were allowed to stir at ambient temperature for 3 h. Then the solvents were removed under reduced pressure and the crude solids were dried under high vacuum and used without further purification in the next step.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Ethyl 2-(3,4-Dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate Hydrochloride (<b>9a</b>)</h3><div class="NLM_p last">Deprotection of <b>8a</b> provided <b>9a</b> as a white solid in 88% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.59 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 259.28. <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´: 7.50 (d, <i>J</i> = 7.8 Hz, 1 H), 7.36 (m, 1 H), 7.23 (<i>t</i>, <i>J</i> = 7.7 Hz, 1 H), 7.14 (<i>t</i>, <i>J</i> = 7.6 Hz, 1 H), 5.01 (s, 2 H), 4.47 (s, 2 H), 4.23 (q, <i>J</i> = 7.1 Hz, 2 H), 3.66 (m, 2 H), 3.13 (<i>t</i>, <i>J</i> = 6.1 Hz, 2 H), 1.29 (<i>t</i>, <i>J</i> = 7.1 Hz, 4 H).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Ethyl 2-(8-Fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate Hydrochloride (<b>9b</b>)</h3><div class="NLM_p last">Deprotection of <b>8b</b> provided <b>9b</b> as a white solid in 96% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.63 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 277.22. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 9.52 (m, 2 H), 7.46 (dd, <i>J</i><sub>1</sub> = 9.2 Hz, <i>J</i><sub>HâF</sub> = 4.4 Hz, 1 H), 7.34 (dd, <i>J</i><sub>HâF</sub> = 9.7 Hz, <i>J</i><sub>1</sub> = 2.5 Hz, 1 H), 7.00 (td, <i>J</i><sub>HâF</sub> = 9.3 Hz, <i>J</i><sub>1</sub> = 9.2 Hz, <i>J</i><sub>2</sub> = 2.6 Hz, 1 H), 5.12 (s, 2 H), 4.30 (bs, 2 H), 4.16 (q, <i>J</i> = 7.1 Hz, 2 H), 3.48 (s, 2 H), 2.99 (<i>t</i>, <i>J</i> = 5.9 Hz, 2 H), 1.23 (<i>t</i>, <i>J</i> = 7.1 Hz, 3 H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Synthesis of <b>10a</b><sub><b>1</b></sub> to <b>10l</b><sub><b>2</b></sub> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Stage d)</h3><div class="NLM_p last">To cooled suspensions of the respective ethyl 2-(3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate hydrochloride salts <b>9a</b>â<b>l</b> (7 mmol) in DCM (20 mL) was added DIPEA at 0 Â°C (21 mmol), followed by the corresponding acyl chlorides (7.7 mmol). The resulting brown suspensions were allowed to stir at room temperature for 1 h. DCM was added, and the resulting organic phases were first washed with saturated aqueous NaHCO<sub>3</sub> solution, then with water and brine. The combined organic phases were dried over MgSO<sub>4</sub> and yielded brown solids after evaporation of the solvent in vacuo. The crude products were purified by flash chromatography on silica gel, using EtOAc/<i>n</i>-heptane as eluent. The various purification methods are mentioned within the corresponding sections.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Ethyl 2-(2-Benzoyl-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10a<sub>1</sub></b>)</h3><div class="NLM_p last">Acylation of <b>9a</b> with benzoyl chloride provided <b>10a</b><sub><b>1</b></sub> after preparative HPLC purification as a beige solid in 70% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.89 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 363.11. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´: 7.40â7.61 (m, 5 H), 7.02â7.32 (m, 3 H), 5.01 (bs, 1 H), 4.78 (s, 2 H), 4.70 (bs, 1 H), 4.24 (q, <i>J</i> = 7.1 Hz, 3 H), 4.22 (bs, 1H), 3.81 (bs, 1 H), 2.79â3.00 (m, 2 H), 1.30 (<i>t</i>, <i>J</i> = 7.1 Hz, 3 H).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ethyl 2-(2-(1-Naphthoyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10a</b><sub><b>3</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9a</b> with 1-naphthoyl chloride provided crude <b>10a</b><sub><b>3</b></sub> as yellow solid in 97% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 1.14 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 413.16. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 60:40 mixture of two rotamers, Î´: 8.02 (m, 2 H), 7.76 (m, 1 H), 7.64â7.40 (m, 5.4 H), 7.37 (d, <i>J</i> = 8.2 Hz, 0.4 H), 7.16 (m, 0.6 H), 7.10 (m, 0.6 H), 7.03 (m, 0.6 H), 6.84 (t, <i>J</i> = 7.4 Hz, 0.4 H), 5.10 (s, 0.8 H), 4.99 (m, 2.2 H), 4.36 (m, 1 H), 4.19 (m, <i>J</i> = 7.1 Hz, 0.8 H), 4.14 (q, <i>J</i> = 7.1 Hz, 1.2 H), 4.08 (m, 0.8 H), 3.51 (<i>t</i>, <i>J</i> = 5.6 Hz, 1 H), 2.97 (m, 1 H), 2.68 (m, 1 H), 2.55 (m, 1 H), 1.25 (t, <i>J</i> = 7.1 Hz, 1.2 H), 1.19 (t, <i>J</i> = 7.1 Hz, 1.8 H). The compound was used without further purification in the next step.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl 2-(2-(4â²-Ethyl-[1,1â²-biphenyl]-4-carbonyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10a</b><sub><b>4</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9a</b> with 4â²-ethyl-[1,1â²-biphenyl]-4-carbonyl chloride provided <b>10a</b><sub><b>4</b></sub> after column chromatography on silica gel, using EtOAc/<i>n</i>-heptane as eluent, as a white solid in 67% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 1.04 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 467.29. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 50:50 mixture of two rotamers, Î´: 7.64 (m, 2.5 H), 7.56 (m, 4 H), 7.30 (d, <i>J</i> = 7.5 Hz, 3 H), 7.00â7.25 (m, 2.5 H), 4.98 (bs, 1 H), 4.77 (m, 3 H), 4.22 (m, 3 H), 3.86 (m, 1 H), 2.89 (m, 2 H), 2.71 (q, <i>J</i> = 7.4 Hz, 2 H), 1.28 (m, 6 H).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Ethyl 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10b</b><sub><b>1</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9b</b> with 1-naphthoyl chloride provided <b>10b</b><sub><b>1</b></sub> after precipitation from <i>n</i>-heptane as a brown solid in 98% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.95 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 431.18. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 55:45 mixture of two rotamers, Î´: 7.88â7.98 (m, 2.55 H), 7.85 (d, <i>J</i> = 8.3 Hz, 0.45 H), 7.44â7.59 (m, 4 H), 7.25 (dd, <i>J</i><sub>HâF</sub> = 9.3 Hz, <i>J</i><sub>1</sub> = 2.4 Hz, 0.55 H), 7.17 (dd, <i>J</i><sub>1</sub> = 8.9 Hz, <i>J</i><sub>HâF</sub> = 4.2 Hz, 0.55 H), 7.12 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>HâF</sub> = 4.1 Hz, 0.45 H), 7.00 (ddd, <i>J</i><sub>HâF</sub> = 9.1 Hz, <i>J</i><sub>1</sub> = 8.9 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 0.55 H), 6.89 (ddd, <i>J</i><sub>HâF</sub> = 9.0 Hz, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 2.5 Hz, 0.45 H), 6.74 (dd, <i>J</i><sub>HâF</sub> = 9.3 Hz, <i>J</i><sub>2</sub> = 2.5 Hz, 0.45 H), 5.14 (m, 1.1 H), 4.78 (s, 0.9 H), 4.70 (s, 1.1 H), 4.30â4.48 (m, 1.8 H), 4.26 (q, <i>J</i> = 7.3 Hz, 0.9 H), 4.21 (q, <i>J</i> = 7.0 Hz, 1.1 H), 3.64 (<i>t</i>, <i>J</i> = 5.7 Hz, 1.1 H), 3.01 (m, 0.9 H), 2.65 (m, 1.1 H), 1.32 (<i>t</i>, <i>J</i> = 7.1 Hz, 1.35 H), 1.27 (m, 1.65 H).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl 2-(8-Fluoro-2-(thiophene-2-carbonyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10b</b><sub><b>3</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9b</b> with thiophene-2-carbonyl chloride provided <b>10b</b><sub><b>3</b></sub> after precipitation from acetonitrile/diethylether as a white solid in 69% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 1.09 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 386.96. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 7.81 (dd, <i>J</i><sub>1</sub> = 5.0 Hz, <i>J</i><sub>2</sub> = 1.0 Hz, 1 H), 7.56 (m, 1 H), 7.43 (dd, <i>J</i><sub>1</sub> = 8.9 Hz, <i>J</i><sub>2</sub> = 4.4 Hz, 1 H), 7.32 (m, 1 H), 7.19 (dd, <i>J</i><sub>1</sub> = 5.0 Hz, <i>J</i><sub>2</sub> = 3.7 Hz, 1 H), 6.95 (ddd, <i>J</i><sub>1</sub> = 9.3 Hz, <i>J</i><sub>2</sub> = 9.3 Hz, <i>J</i><sub>3</sub> = 2.5 Hz, 1 H), 5.08 (s, 2 H), 4.85 (m, 2 H), 3.99 (<i>t</i>, <i>J</i> = 5.7 Hz, 2 H), 2.90 (m, 2 H), 1.22 (<i>t</i>, <i>J</i> = 7.1 Hz, 3 H).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Ethyl 2-(2-(3-Chlorobenzoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10b</b><sub><b>4</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9b</b> with 3-chlorobenzoyl chloride provided <b>10b</b><sub><b>4</b></sub> after precipitation from acetonitrile/diisopropylether as a white solid in 70% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 1.04 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 415.11. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 53:47 mixture of two rotamers, Î´: 7.40â7.47 (m, 1 H), 7.28â7.40 (m, 3 H), 7.08â7.20 (m, 1.53 H), 6.86â6.99 (m, 1.47 H), 5.06 (m, 0.53 H), 4.92 (m, 0.53 H), 4.74 (s, 0.94 H), 4.69 (m, 1.06 H), 4.49 (m, 0.47 H), 4.32â4.46 (m, 1 H), 4.22 (m, 2 H), 4.03 (ddd, <i>J</i><sub>1</sub> = 12.7 Hz, <i>J</i><sub>2</sub> = 7.0 Hz, <i>J</i><sub>3</sub> = 5.4 Hz, 0.47 H), 3.66 (m, 1 H), 2.76â2.99 (m, 1.47 H), 2.70 (m, 0.53 H), 1.28 (<i>t</i>, <i>J</i> = 7.3 Hz, 1.41 Hz), 1.25 (<i>t</i>, <i>J</i> = 7.0 Hz, 1.59 Hz).</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Ethyl 2-(2-(2-(1<i>H</i>-Indol-3-yl)acetyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetate (<b>10b</b><sub><b>6</b></sub>)</h3><div class="NLM_p last">Acylation of <b>9b</b> with 2-(1<i>H</i>-indol-3-yl)acetyl chloride provided, after column chromatography on silica gel using EtOAc/<i>n</i>-heptane as eluent, <b>10b</b><sub><b>6</b></sub> as a colorless resin in 81% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.90 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 434.03. <sup>1</sup>H NMR (CDCl<sub>3</sub>), 55:45 mixture of two rotamers, Î´: 8.33 (m, 0.45 H), 8.12 (m, 0.55 H), 7.68 (m, 1 H), 7.37 (d, <i>J</i> = 7.9 Hz, 0.55 H), 7.05â7.28 (m, 4.45 H), 6.87â7.04 (m, 2 H), 4.84 (s, 0.9 H), 4.71 (s, 1.1 H), 4.68 (s, 1.1 H), 4.63 (s, 0.9 H), 4.21 (m, 2 H), 4.07 (<i>t</i>, <i>J</i> = 5.5 Hz, 1.1 H), 3.98 (s, 2 H), 3.83 (<i>t</i>, <i>J</i> = 5.3 Hz, 0.9 H), 2.79 (m, 1.1 H), 2.52 (s, 0.9 H), 1.27 (m, 3 H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure for the Synthesis of <b>5</b> and <b>11</b>â<b>36</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Stage e)</h3><div class="NLM_p last">To solutions of the respective esters <b>10a</b>â<b>l</b> (11 mmol) in THF (100 mL) was added 0.2 M aqueous NaOH solution (58 mL, 11.7 mmol). The resulting mixtures were allowed to stir at ambient temperature for 30 min. The reaction mixtures were extracted twice with diethyl ether. The pH of the aqueous phase was set to pH 2 by slow addition of concentrated aqueous HCl solution. The resulting acidic aqueous phases were extracted three times with DCM. The DCM phases were combined and dried over Na<sub>2</sub>SO<sub>4</sub>. The volatiles were removed under reduced pressure, and the obtained solids were recrystallized from acetonitrile or purified by preparative HPLC.</div></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(2-Benzoyl-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>5</b>)</h3><div class="NLM_p last">Saponification of <b>10a</b><sub><b>1</b></sub> provided pure <b>5</b> after recrystallization from acetonitrile as an orange solid in 73% yield, mp 225.8â226.9 Â°C (dec). LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.77 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 335.06. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 60:40 mixture of two rotamers, Î´: 13.04 (bs, 1 H), 7.44â7.57 (m, 5.6 H), 7.40 (m, 1 H), 7.27 (m, 0.4 H), 7.00â7.18 (m, 1.6 H), 6.97 (bs, 0.4 H), 4.94 (s, 2 H), 4.82 (bs, 1.2 H), 4.61 (bs, 0.8 H), 4.03 (bs, 0.8 H), 3.64 (bs, 1.2 H), 2.81 (s, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.9, 170.3 (bs), 137.2 (bs), 136.8 (bs), 134.2 (s), 130.1 (bs), 129.0, 127.5 (bs), 127.1 (bs), 121.5, 119.6, 118.0 (bs), 109.9, 106.4, 45.3 (bs), 45.1 (bs), 44.5, 22.9 (bs), 22.0 (bs). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 335.1395, found 335.1396.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(8-Fluoro-2-(thiophene-2-carbonyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>22</b>)</h3><div class="NLM_p last">Saponification of <b>10b</b><sub><b>3</b></sub> provided pure <b>22</b> after recrystallization from acetonitrile as a white solid in 82% yield, mp 239.4â241.9 Â°C (dec). LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.78 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 358.94. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 13.09 (m, 1 H), 7.81 (dd, <i>J</i><sub>1</sub> = 5.0 Hz, <i>J</i><sub>2</sub> = 0.7 Hz, 1 H), 7.57 (d, <i>J</i> = 0.3 Hz, 1 H), 7.43 (dd, <i>J</i><sub>1</sub> = 8.9 Hz, <i>J</i><sub>2</sub> = 4.4 Hz, 1 H), 7.31 (d, <i>J</i> = 8.8 Hz, 1 H), 7.19 (dd, <i>J</i><sub>1</sub> = 4.9 Hz, <i>J</i><sub>2</sub> = 3.8 Hz, 1 H), 6.95 (ddd, <i>J</i><sub>1</sub> = 9.3 Hz, <i>J</i><sub>2</sub> = 9.3 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1 H), 4.97 (s, 2 H), 4.85 (bs, 2 H), 4.00 (t, <i>J</i> = 5.6 Hz, 2 H), 2.87 (s, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.8, 163.5, 157.6 (d, <i>J</i><sub>CâF</sub> = 232 Hz), 138.0, 136.6, 133.9, 130.3 (bs), 129.6 (bs), 127.8, 125.4 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 110.9 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 109.2 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 106.7 (d, <i>J</i><sub>CâF</sub> = 4 Hz), 103.2 (d, <i>J</i><sub>CâF</sub> = 24 Hz), 44.7, 22.7 (bs). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>FS [M + H<sup>+</sup>] 359.0865, found 359.0863.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(2-(3-Chlorobenzoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2H)-yl)acetic Acid (<b>24</b>)</h3><div class="NLM_p last">Saponification of <b>10b</b><sub><b>4</b></sub> provided pure <b>24</b> after recrystallization from acetonitrile as a white solid in 89% yield, mp 251.8â256.2 Â°C (dec). LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.83 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 386.87. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 60:40 mixture of two rotamers, Î´: 7.57 (m, 1 H), 7.50 (m, 2 H), 7.41 (d, <i>J</i> = 7.5 Hz, 1 H), 7.25â7.38 (m, 1.6 H), 7.03â7.17 (m, 0.4 H), 6.79â6.95 (m, 1 H), 4.78 (s, 1.2 H), 4.63 (s, 2 H), 4.56 (s, 0.8 H), 3.99 (s, 0.8 H), 3.64 (s, 1.2 H), 2.81 (m, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.8, 168.7 (bs), 157.6 (d, <i>J</i><sub>CâF</sub> = 232 Hz), 138.9 (bs), 138.6 (m), 136.9 (bs), 136.3 (bs), 133.9, 133.8, 131.0, 130.3â129.9 (m), 127.3 (bs), 127.0 (bs), 126.1 (bs), 125.7â125.2 (m), 110.9 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 109.2 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 106.5 (bs), 103.2 (d, <i>J</i><sub>CâF</sub> = 24 Hz), 45.1 (bs), 44.9 (bs), 44.7, 23.0 (bs), 22.6 (bs). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub>ClF [M + H<sup>+</sup>] 387.0911, found 387.0910.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(2-(1-Naphthoyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>26</b>)</h3><div class="NLM_p last">Saponification of <b>10a</b><sub><b>3</b></sub> provided pure <b>26</b> after recrystallization from acetonitrile as a light yellow solid in 73% yield, mp 218.4â219.4 Â°C (dec). LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.82 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 385.03. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 65:35 mixture of two rotamers, Î´: 13.03 (m, 1 H), 8.02 (m, 2 H), 7.75 (m, 1 H), 7.39â7.63 (m, 5.35 H), 7.36 (d, <i>J</i> = 8.4 Hz, 0.35 H), 7.15 (<i>t</i>, <i>J</i> = 7.2 Hz, 0.65 H), 7.09 (m, 0.65 H), 7.03 (m, 0.65 H), 6.83 (<i>t</i>, <i>J</i> = 7.5 Hz, 0.35 H), 5.06 (d, <i>J</i> = 15.5 Hz, 0.65 H), 4.99 (m, 1.35 H), 4.90 (m, 1.35 H), 4.42 (m, 0.35 H), 4.31 (m, 0.65 H), 4.08 (m, 0.35 H), 3.51 (<i>t</i>, <i>J</i> = 5.4 Hz, 1.35 H), 2.96 (m, 0.70 H), 2.68 (m, 0.65 H), 2.56 (m, 0.65 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.9, 169.2, 137.3, 137.1, 135.2, 135.0, 134.1, 133.5, 133.5, 129.6, 129.5, 129.4, 129.3, 128.9, 128.9, 127.5, 127.0, 126.9, 126.0, 125.9, 125.5, 125.1, 125.0, 124.9, 124.1, 123.9, 121.6, 121.4, 119.7, 119.5, 118.0, 117.6, 109.9, 109.8, 106.5, 106.4, 44.6 (bs), 44.5, 39.3, 23.0, 22.2. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 385.1552, found 385.1551.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>28</b>)</h3><div class="NLM_p last">Saponification of <b>10b</b><sub><b>1</b></sub> provided pure <b>28</b> after recrystallization from acetonitrile as a beige solid in 93% yield, mp 224.0 Â°C. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.83 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 403.09. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 65:35 mixture of two rotamers, Î´: 8.02 (m, 2 H), 7.76 (d, <i>J</i> = 7.8 Hz, 0.65 H), 7.72 (m, 0.35 H), 7.49â7.64 (m, 3.35 H), 7.35â7.49 (m, 2.35 H), 6.98 (ddd, <i>J</i><sub>HâF</sub> = 9.3 Hz, <i>J</i><sub>1</sub> = 9.3 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 0.65 H), 6.88 (m, 0.65 H), 4.85â5.14 (m, 3.3 H), 4.42 (m, 0.35 H), 4.32 (m, 0.7 H), 4.06 (m, 0.35 H), 3.50 (<i>t</i>, <i>J</i> = 5.5 Hz, 1.3 H), 2.95 (m, 0.70 H), 2.68 (m, 0.65 H), 2.58 (m, 0.65 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.7, 169.2, 157.7 (d, <i>J</i><sub>CâF</sub> = 232 Hz), 157.4 (d, <i>J</i><sub>CâF</sub> = 233 Hz), 137.1, 136.2, 135.1, 134.9, 134.0, 133.8, 133.5, 129.6, 129.5, 129.4, 129.3, 128.9, 128.8, 127.5, 127.4, 127.0, 126.9, 126.0, 125.9, 125.7 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 125.2, 125.1, 125.0, 124.1, 123.9, 110.9 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 110.8 (m), 109.3 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 109.1 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 106.7 (m), 103.3 (d, <i>J</i><sub>CâF</sub> = 23 Hz), 103.0 (d, <i>J</i><sub>CâF</sub> = 23 Hz), 44.73, 44.70, 44.5, 44.4, 39.5, 39.3, 23.1, 22.3. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>F [M + H<sup>+</sup>] 403.1458, found 403.1458.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(2-(2-(1<i>H</i>-Indol-3-yl)acetyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>33</b>)</h3><div class="NLM_p last">Saponification of <b>10b</b><sub><b>6</b></sub> provided pure <b>33</b> after preparative HPLC as a beige foam in 88% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.79 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 406.11. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 60:40 mixture of two rotamers, Î´: 12.75 (m, 1 H), 10.92 (s, 0.6 H), 10.86 (s, 0.4 H), 7.61 (m, 1 H), 7.32â7.44 (m, 2 H), 7.24â7.32 (m, 2 H), 7.07 (m, 1 H), 6.95 (m, 2 H), 4.92 (s, 0.8 H), 4.90 (s, 1.2 H), 4.80 (s, 0.8 H), 4.65 (s, 1.2 H), 3.88 (m, 4 H), 2.69 (d, <i>J</i> = 5.1 Hz, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.8, 170.4, 170.3, 157.5 (d, <i>J</i><sub>CâF</sub> = 232 Hz), 157.5 (d, <i>J</i><sub>CâF</sub> = 231 Hz), 137.0, 136.6, 136.5, 136.4, 133.9, 133.8, 127.8, 127.7, 125.7 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 125.4 (d, <i>J</i><sub>CâF</sub> = 10 Hz), 124.0, 123.9, 121.5, 121.4, 119.3, 119.2, 118.9, 118.8, 111.8, 111.7, 110.8, 110.7, 109.0 (d, <i>J</i><sub>CâF</sub> = 26 Hz), 108.7, 108.6, 107.1 (d, <i>J</i><sub>CâF</sub> = 4 Hz), 107.0 (d, <i>J</i><sub>CâF</sub> = 4 Hz), 103.2 (d, <i>J</i><sub>CâF</sub> = 24 Hz), 103.1 (d, <i>J</i><sub>CâF</sub> = 24 Hz), 44.7, 43.4, 43.0, 39.1, 31.6, 31.5, 23.0, 22.1. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>F [M + H<sup>+</sup>] 406.1567, found 406.1564.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-(2-(4â²-Ethyl-[1,1â²-biphenyl]-4-carbonyl)-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (<b>35</b>)</h3><div class="NLM_p last">Saponification of <b>10a</b><sub><b>4</b></sub> provided pure <b>35</b> after precipitation from acetonitrile as a beige foam in 79% yield. LC(1)/ESI-MS <i>t</i><sub>R</sub> = 0.94 min; <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 439.00. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 60:40 mixture of two rotamers, Î´: 13.06 (m, 1 H), 7.76 (d, <i>J</i> = 7.9 Hz, 2 H), 7.64 (d, <i>J</i> = 8.1 Hz, 2 H), 7.55 (m, 2.5 H), 7.21â7.48 (m, 3.5 H), 6.83â7.20 (m, 2 H), 4.95 (bs, 2 H), 4.80 (bs, 1.2 H), 4.73 (bs, 0.8 H), 4.05 (bs, 0.8 H), 3.75 (bs, 1.2 H), 2.85 (bs, 2 H), 2.67 (q, <i>J</i> = 7.5 Hz, 2 H), 1.23 (<i>t</i>, <i>J</i> = 7.6 Hz, 3 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´: 170.9, 170.2 (bs), 144.1, 141.8, 137.2 (m), 135.4 (m), 134.3 (m), 129.0, 128.3â127.9 (m), 127.2, 127.0 (bs), 125.4 (bs), 121.5 (bs), 119.6 (bs), 117.7â118.0 (m), 109.9, 106.4 (bs), 45.2 (m, 2 C atoms), 44.6, 28.3, 23.0 (bs), 22.0 (bs), 16.0. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 439.2021, found 439.2021.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Solubility Measurements</h3><div class="NLM_p last">For each compound 40 Î¼L of 10 mM DMSO stock solution was dispensed into a Millipore MSHVN4510 Multiscreen 96-well filter plate for solubility by means of a BIOMEK NX<sup>P</sup> (Beckman Coulter) laboratory automated workstation. The solvents were evaporated under reduced pressure in a Hettich AG Combidancer. Each well was filled with 200 Î¼L of water, 60 mM citrate buffer, pH4, or 70 mM phosphate buffer, pH7. The mixture was stirred on a Eppendorf Thermomixer 5355 comfort at 300 rpm at 25 Â°C for 24 h. The resulting biphasic system was filtered under reduced pressure using a Millipore MAVM0960R vacuum manifold. The filtrates were collected into a 96-well Thermo Scientific AB0600PCR plate. Solubility was determined by measuring the concentration of the solutions using a high pressure mixing Shimadzu modular HPLC system with a Phenomenex column Synergi Polar-RP 4 Î¼m, 80 Ã, 2.0 cm Ã 50 mm warmed at 50 Â°C: eluent A, water containing 0.05% formic acid; eluent B, acetonitrile containing 0.05% formic acid; gradient, 5â100% A nonlinear gradient over 2.4 min; flow rate of 1.5 mL/min; injection volume, 5 Î¼L. UV detection occurred at 250 nm. Concentrations were determined by comparison of the peak area with the calibration curve.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>h</i>CRTh2 Radioligand Binding Assay</h3><div class="NLM_p">The CRTh2 binding assay was established based on previous reports.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> Membranes of HEK293 cells with recombinant expression of the human CRTH2 receptor were generated. Cells were detached from culture plates in 5 mL of buffer A (5 mM Tris, 1 mM MgCl<sub>2</sub>, 0.1 mM PMSF, 0.1 mM phenanthroline, pH 7.4) per plate using a rubber policeman, transferred into centrifugation tubes, and frozen at â80 Â°C. After thawing, the cells were fragmented by homogenization with a Polytron cell homogenizer for 30 s. The membrane fragments were collected by centrifugation at 30000<i>g</i> for 20 min and resuspended in buffer B (75 mM Tris, 25 mM MgCl<sub>2</sub>, 250 mM saccharose, pH 7.4). Aliquots were stored at â20 Â°C.</div><div class="NLM_p last">The binding assay was performed in a final assay volume of 250 Î¼L. In each well, an amount of 75 Î¼L of buffer C (50 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% protease free BSA, 0.01% NaN<sub>3</sub>) was mixed with 50 Î¼L of [<sup>3</sup>H]PGD<sub>2</sub> (2.5 nM, 220â000 dpm/well, Amersham Biosciences, TRK734) and 25 Î¼L of a solution of test compound in buffer C containing 10% DMSO. The binding assay was started by adding 100 Î¼L of a membrane suspension in buffer C, reaching a final concentration of 80 Î¼g of membrane protein per well. Nonspecific binding was determined in the presence of 10 Î¼M PGD<sub>2</sub>. This binding assay mix was incubated at room temperature for 90 min and then filtered through a GF/C filter 96-well plate which was presoaked in 0.5% PEI for 3 h. The filter wells were washed three times with ice cold binding buffer C. Then Microscint-40 (Packard, 40 Î¼L per well) was added and the receptor bound radioactivity was quantified by scintillation counting in a âTopCountâ benchtop microplate scintillation counter (Packard).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>h</i>CRTh2 Intracellular Calcium Liberation (FLIPR) Assay</h3><div class="NLM_p last">Human embryonic kidney cells (HEK-293, DSMZ) stably expressing the human CRTh2 receptor under the control of the CMV promoter were grown to near confluency in DMEM medium (1 g/L glucose, Gibco) supplemented with 10% fetal calf serum (Pan) containing penicillin and streptomycin (100 units/mL each, Gibco) under standard mammalian cell culture conditions at 37 Â°C in a humidified atmosphere of 5% CO<sub>2</sub>. Cells were detached from culture dishes with a cell dissociation buffer (0.02% EDTA in PBS, Gibco) for 1 min, washed off with DMEM without phenol red (Gibco), and collected by centrifugation with 200<i>g</i> at room temperature for 5 min. The cells were incubated with 4 Î¼M Fluo-4 AM ester (Teflabs) in DMEM (without phenol red) in 20 mM HEPES, pH 7.2 (Gibco), at 37 Â°C in a humidified atmosphere of 5% CO<sub>2</sub> for 40 min. Then they were washed with and resuspended in assay buffer (HBSS with 20 mM HEPES, pH 7.2). Resuspended cells, 100â000 in 60 Î¼L per well, were seeded onto a 384-well clear-bottom black assay plate (Greiner), sedimented by centrifugation, and incubated at room temperature for 15 min. Stock solutions of test compounds were made up at a concentration of 10 mM in DMSO and serially diluted in assay buffer to concentrations required for doseâresponse curves. PGD<sub>2</sub> (Biomol, Plymouth Meeting, PA) is used as an agonist. A FLIPRII instrument (Molecular Devices) was operated following the manufacturerâs instructions. Test compound (10 Î¼L) was added to each well and incubated for 5 min. Cells were activated by a final concentration of 50 nM PGD<sub>2</sub> (Biomol, Plymouth Meeting, PA) dissolved in the assay buffer supplemented with 0.05% bovine serum albumin (fatty acid content of <0.02%, Sigma). Fluorescence emission was recorded during test compound and PGD<sub>2</sub> addition, and emission peak values above base level after PGD<sub>2</sub> addition were exported. Values were normalized to high-level control (no antagonist added) after subtraction of baseline value control (no PGD<sub>2</sub> added). The IC<sub>50</sub> values were calculated by four-parameter doseâresponse curve fitting (XLfit, ISBS).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Intracellular cAMP Assay</h3><div class="NLM_p last">Cells were cultured in 96-well plates to reach about 80% confluency (10â000 cells seeded 3 days before experiment) using the same growth conditions as described above. The culture medium was removed and the stimulation started by addition of 100 Î¼L/well DMEM containing 50 Î¼M IBMX (3-isobutyl-1-methylxanthine), various concentrations of test compound, 100 nM PGD<sub>2</sub>, and 10 Î¼M forskolin. After a 20 min incubation time at 37 Â°C intracellular cAMP concentrations were quantified using the Tropix cAMP-screen chemiluminescent ELISA system (Applied Biosystems) following the instructions provided in the kit. Briefly, cells were solubilized by addition of 100 Î¼L of lysis buffer (provided in assay kit) and incubated for 30 min at 37 Â°C. Then an amount of 60 Î¼L per well of the cAMPâalkaline phosphatase conjugate, diluted 1:100, followed by 60 Î¼L of anti-cAMP antibody was added. After 1 h of incubation, the solution was removed and washed six times with washing buffer. Then 100 Î¼L/well CSPD/Sapphire-II RTU substrate enhancer solution was added and incubated for 30 min. The signal was quantified in the luminometer PHERAstar (BMG Labtech). Absolute cAMP concentrations were then determined using a standard cAMP curve that was generated in parallel.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Shape Change of Human Eosinophils</h3><div class="NLM_p">After healthy volunteers had given informed consent, blood samples were drawn by venipuncture according to the protocol approved by the ethics committee of Basel (Switzerland). Polymorphonuclear leukocytes (containing eosinophils, basophils, and neutrophils) were isolated using the Polymorphprep method according to the manufacturerâs protocol (Axis-Shield). In brief, anticoagulated whole blood was layered onto a Polymorphprep gradient (density, 1.113 g/mL) and centrifuged at 500<i>g</i> for 30 min. The polymorphonuclear fraction was harvested and depleted for erythrocytes by hypotonic saline lysis.</div><div class="NLM_p last">The polymorphonuclears (PMNs) were resuspended in assay buffer composed of PBS with Ca<sup>2+</sup>/Mg<sup>2+</sup> supplemented with 0.1% BSA, 10 mM Hepes, and 10 mM glucose, pH 7.4, with 10<sup>6</sup> cells/mL and stained with CD49d-APC (allophycocyanin conjugated mouse anti-human VLA-4) for 1 h at room temperature. Next, 45 Î¼L of human plasma was mixed with 10 Î¼L of assay buffer and 30 Î¼L of PMNs (1.3 Ã 10<sup>7</sup> cells/mL) were mixed. The PMNs were then activated by addition of 15 nM PGD<sub>2</sub> and incubated for 5 min at 37 Â°C. The activation was stopped by addition of 100 Î¼L of ice cold 1% paraformaldehyde. The samples were analyzed with a FACSAria flow cytometer (BD Biosciences). Eosinophils were identified based on the fluorescence signal (CD49d-APC (Allophycocyanin (APC)) and side scatter (SSC). The data recorded in our experiments were gated to detect the eosinophil cell population only. Eosinophil activation was quantified based on increase in forward scatter (FSC). Activation was expressed as the percent of cells with a forward scatter larger than that of nonactivated eosinophils.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/jm400122f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures and analytical data (Tables S1âS5) of synthesized compounds <b>11</b>â<b>21</b>, <b>23</b>, <b>25</b>, <b>27</b>, <b>29</b>â<b>32</b>, <b>34</b>, <b>36</b> and the respective precursors; method for the determination of the logÂ <i>D</i> values; experimental details for the biological assays used to assess the receptor selectivity, for the cytochrome P450 enzyme inhibition assays, and for the metabolic stability studies; and the detailed description of the pharmacokinetic studies in the rat and the dog. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400122f/suppl_file/jm400122f_si_001.pdf">jm400122f_si_001.pdf (790.57 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400122f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heinz Fretz</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e48c818d8a9eca829681909ea485879081888d8b8aca878b89"><span class="__cf_email__" data-cfemail="69010c000713470f1b0c1d1329080a1d0c05000607470a0604">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anja Valdenaire</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julien Pothier</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt Hilpert</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmela Gnerre</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Peter</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Leroy</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus A. Riederer</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d167e5099-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank S. Koch, D. Lotz, A. Jonuzi, P. Risch, B. Butscha, J. Giller, B. Lack, M. Baumann, and S. Brand for technical support; B. Capeleto for physicochemical and Francois Le Goff for stability measurements in different solution media; R. Bravo for formulation work; S. Delahaye and H. Kletzl for providing DMPK data; M. Holdener for supportive discussions; and J. Williams for proofreading the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> Abbreviations Used</h2><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">allophycocyanin</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">bs</td><td class="NLM_def"><p class="first last">broad singlet</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">chinese hamster ovary</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CRTh2</td><td class="NLM_def"><p class="first last">chemoattractant receptor-homologous molecule expressed on Th2 cells</p></td></tr><tr><td class="NLM_term">Da</td><td class="NLM_def"><p class="first last">dalton</p></td></tr><tr><td class="NLM_term">DAD</td><td class="NLM_def"><p class="first last">diode-array detector</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbeccoâs modified Eagle medium</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detector</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>HSA</sub></td><td class="NLM_def"><p class="first last">shift factor in human serum albumin</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorometric imaging plate reader</p></td></tr><tr><td class="NLM_term">FSC</td><td class="NLM_def"><p class="first last">forward scatter</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>Sel</sub></td><td class="NLM_def"><p class="first last">selectivity factor</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hankâs balanced salt solution</p></td></tr><tr><td class="NLM_term"><i>h</i>DP<sub>1</sub></td><td class="NLM_def"><p class="first last">human prostaglandin D<sub>2</sub> receptor subtype 1</p></td></tr><tr><td class="NLM_term"><i>h</i>EP<sub>1</sub></td><td class="NLM_def"><p class="first last">human prostaglandin E<sub>2</sub> receptor subtype 1</p></td></tr><tr><td class="NLM_term"><i>h</i>EP<sub>2</sub></td><td class="NLM_def"><p class="first last">human prostaglandin E<sub>2</sub> receptor subtype 2</p></td></tr><tr><td class="NLM_term"><i>h</i>EP<sub>3</sub></td><td class="NLM_def"><p class="first last">human prostaglandin E<sub>2</sub> receptor subtype 3</p></td></tr><tr><td class="NLM_term"><i>h</i>EP<sub>4</sub></td><td class="NLM_def"><p class="first last">human prostaglandin E<sub>2</sub> receptor subtype 4</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term"><i>h</i>ESC</td><td class="NLM_def"><p class="first last">human eosinophil shape change assay</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term"><i>h</i>TP</td><td class="NLM_def"><p class="first last">human thromboxane A<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">IBMX</td><td class="NLM_def"><p class="first last">3-isobutyl-1-methylxanthine</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">logÂ <i>D</i><sub>7.4</sub></td><td class="NLM_def"><p class="first last">measured logÂ <i>D</i> at pH 7.4</p></td></tr><tr><td class="NLM_term">mmol</td><td class="NLM_def"><p class="first last">millimole</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">PEI</td><td class="NLM_def"><p class="first last">polyethyleneimine</p></td></tr><tr><td class="NLM_term">PG</td><td class="NLM_def"><p class="first last">propylene glycol</p></td></tr><tr><td class="NLM_term">PGD<sub>2</sub></td><td class="NLM_def"><p class="first last">prostaglandin D<sub>2</sub></p></td></tr><tr><td class="NLM_term">PGDS</td><td class="NLM_def"><p class="first last">prostaglandin synthase</p></td></tr><tr><td class="NLM_term">PMSF</td><td class="NLM_def"><p class="first last">phenylmethanesulfonyl fluoride</p></td></tr><tr><td class="NLM_term">PMN</td><td class="NLM_def"><p class="first last">polymorphonuclear</p></td></tr><tr><td class="NLM_term">RHepa</td><td class="NLM_def"><p class="first last">rat hepatocyte</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">SSC</td><td class="NLM_def"><p class="first last">side scatter</p></td></tr><tr><td class="NLM_term">Th2</td><td class="NLM_def"><p class="first last">T-helper 2</p></td></tr><tr><td class="NLM_term">TL</td><td class="NLM_def"><p class="first last">traffic light</p></td></tr><tr><td class="NLM_term">TXA<sub>2</sub></td><td class="NLM_def"><p class="first last">thromboxane A<sub>2</sub></p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Papadopoulos, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agache, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavbek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braido, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardona, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demonchy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demoly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayraud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellings, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotvall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid-Grendelmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skevaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triggiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werfel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annesi-Maesano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolin-Amerigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apfelbacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogacka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonadonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butiene, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardell, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caubet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celenk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichocka-Jarosz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cingi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giacco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douladiris, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauquert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genuneit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Sommergruber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovhannisyan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hox, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnsen, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayci, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalpaklioglu, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleine-Tebbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstantinou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauener, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauerma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makrinioti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manole, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingomataj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niggemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâMahony, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitsios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raap, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf-Heimsoth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson-Ansley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roje, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudzeviciene, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rukhadze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackesen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergejeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seys, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siracusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skypala, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spertini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiewak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprikkelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreehorst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toskala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traidl-Hoffmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieg-Boerstra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xepapadaki, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdis, C. A.</span><span> </span><span class="NLM_article-title">Research needs in allergy: an EAACI position paper, in collaboration with EFA</span> <span class="citation_source-journal">Clin. Transl. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=1-23&issue=21&author=N.+G.+Papadopoulosauthor=I.+Agacheauthor=S.+Bavbekauthor=B.+M.+Biloauthor=F.+Braidoauthor=V.+Cardonaauthor=A.+Custovicauthor=J.+Demonchyauthor=P.+Demolyauthor=P.+Eigenmannauthor=J.+Gayraudauthor=C.+Grattanauthor=E.+Hefflerauthor=P.+W.+Hellingsauthor=M.+Jutelauthor=E.+Knolauthor=J.+Lotvallauthor=A.+Muraroauthor=L.+K.+Poulsenauthor=G.+Robertsauthor=P.+Schmid-Grendelmeierauthor=C.+Skevakiauthor=M.+Triggianiauthor=R.+Vanreeauthor=T.+Werfelauthor=B.+Floodauthor=S.+Palkonenauthor=R.+Savliauthor=P.+Allegriauthor=I.+Annesi-Maesanoauthor=F.+Annunziatoauthor=D.+Antolin-Amerigoauthor=C.+Apfelbacherauthor=M.+Blancaauthor=E.+Bogackaauthor=P.+Bonadonnaauthor=M.+Boniniauthor=O.+Boymanauthor=K.+Brockowauthor=P.+Burneyauthor=J.+Butersauthor=I.+Butieneauthor=M.+Calderonauthor=L.+O.+Cardellauthor=J.+C.+Caubetauthor=S.+Celenkauthor=E.+Cichocka-Jaroszauthor=C.+Cingiauthor=M.+Coutoauthor=N.+Dejongauthor=S.+Del+Giaccoauthor=N.+Douladirisauthor=F.+Fassioauthor=J.+L.+Fauquertauthor=J.+Fernandezauthor=M.+F.+Rivasauthor=M.+Ferrerauthor=C.+Flohrauthor=J.+Gardnerauthor=J.+Genuneitauthor=P.+Gevaertauthor=A.+Groblewskaauthor=E.+Hamelmannauthor=H.+J.+Hoffmannauthor=K.+Hoffmann-Sommergruberauthor=L.+Hovhannisyanauthor=V.+Hoxauthor=F.+L.+Jahnsenauthor=O.+Kalayciauthor=A.+F.+Kalpakliogluauthor=J.+Kleine-Tebbeauthor=G.+Konstantinouauthor=M.+Kurowskiauthor=S.+Lauauthor=R.+Lauenerauthor=A.+Lauermaauthor=K.+Loganauthor=A.+Magnanauthor=J.+Makowskaauthor=H.+Makriniotiauthor=P.+Manginaauthor=F.+Manoleauthor=A.+Mariauthor=A.+Mazonauthor=C.+Millsauthor=E.+Mingomatajauthor=B.+Niggemannauthor=G.+Nilssonauthor=M.+Ollertauthor=L.+O%E2%80%99Mahonyauthor=S.+O%E2%80%99Neilauthor=G.+Palaauthor=A.+Papiauthor=G.+Passalacquaauthor=M.+Perkinauthor=O.+Pfaarauthor=C.+Pitsiosauthor=S.+Quirceauthor=U.+Raapauthor=M.+Raulf-Heimsothauthor=C.+Rhynerauthor=P.+Robson-Ansleyauthor=R.+R.+Alvesauthor=Z.+Rojeauthor=C.+Rondonauthor=O.+Rudzevicieneauthor=F.+Rueffauthor=M.+Rukhadzeauthor=G.+Rumiauthor=C.+Sackesenauthor=A.+F.+Santosauthor=A.+Santucciauthor=C.+Scharfauthor=C.+Schmidt-Weberauthor=B.+Schnyderauthor=J.+Schwarzeauthor=G.+Sennaauthor=S.+Sergejevaauthor=S.+Seysauthor=A.+Siracusaauthor=I.+Skypalaauthor=M.+Sokolowskaauthor=F.+Spertiniauthor=R.+Spiewakauthor=A.+Sprikkelmanauthor=G.+Sturmauthor=I.+Swobodaauthor=I.+Terreehorstauthor=E.+Toskalaauthor=C.+Traidl-Hoffmannauthor=C.+Venterauthor=B.+Vlieg-Boerstraauthor=P.+Whitackerauthor=M.+Wormauthor=P.+Xepapadakiauthor=C.+A.+Akdis&title=Research+needs+in+allergy%3A+an+EAACI+position+paper%2C+in+collaboration+with+EFA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulos%26aufirst%3DN.%2BG.%26aulast%3DAgache%26aufirst%3DI.%26aulast%3DBavbek%26aufirst%3DS.%26aulast%3DBilo%26aufirst%3DB.%2BM.%26aulast%3DBraido%26aufirst%3DF.%26aulast%3DCardona%26aufirst%3DV.%26aulast%3DCustovic%26aufirst%3DA.%26aulast%3DDemonchy%26aufirst%3DJ.%26aulast%3DDemoly%26aufirst%3DP.%26aulast%3DEigenmann%26aufirst%3DP.%26aulast%3DGayraud%26aufirst%3DJ.%26aulast%3DGrattan%26aufirst%3DC.%26aulast%3DHeffler%26aufirst%3DE.%26aulast%3DHellings%26aufirst%3DP.%2BW.%26aulast%3DJutel%26aufirst%3DM.%26aulast%3DKnol%26aufirst%3DE.%26aulast%3DLotvall%26aufirst%3DJ.%26aulast%3DMuraro%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DL.%2BK.%26aulast%3DRoberts%26aufirst%3DG.%26aulast%3DSchmid-Grendelmeier%26aufirst%3DP.%26aulast%3DSkevaki%26aufirst%3DC.%26aulast%3DTriggiani%26aufirst%3DM.%26aulast%3DVanree%26aufirst%3DR.%26aulast%3DWerfel%26aufirst%3DT.%26aulast%3DFlood%26aufirst%3DB.%26aulast%3DPalkonen%26aufirst%3DS.%26aulast%3DSavli%26aufirst%3DR.%26aulast%3DAllegri%26aufirst%3DP.%26aulast%3DAnnesi-Maesano%26aufirst%3DI.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DAntolin-Amerigo%26aufirst%3DD.%26aulast%3DApfelbacher%26aufirst%3DC.%26aulast%3DBlanca%26aufirst%3DM.%26aulast%3DBogacka%26aufirst%3DE.%26aulast%3DBonadonna%26aufirst%3DP.%26aulast%3DBonini%26aufirst%3DM.%26aulast%3DBoyman%26aufirst%3DO.%26aulast%3DBrockow%26aufirst%3DK.%26aulast%3DBurney%26aufirst%3DP.%26aulast%3DButers%26aufirst%3DJ.%26aulast%3DButiene%26aufirst%3DI.%26aulast%3DCalderon%26aufirst%3DM.%26aulast%3DCardell%26aufirst%3DL.%2BO.%26aulast%3DCaubet%26aufirst%3DJ.%2BC.%26aulast%3DCelenk%26aufirst%3DS.%26aulast%3DCichocka-Jarosz%26aufirst%3DE.%26aulast%3DCingi%26aufirst%3DC.%26aulast%3DCouto%26aufirst%3DM.%26aulast%3DDejong%26aufirst%3DN.%26aulast%3DDel%2BGiacco%26aufirst%3DS.%26aulast%3DDouladiris%26aufirst%3DN.%26aulast%3DFassio%26aufirst%3DF.%26aulast%3DFauquert%26aufirst%3DJ.%2BL.%26aulast%3DFernandez%26aufirst%3DJ.%26aulast%3DRivas%26aufirst%3DM.%2BF.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DFlohr%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DGenuneit%26aufirst%3DJ.%26aulast%3DGevaert%26aufirst%3DP.%26aulast%3DGroblewska%26aufirst%3DA.%26aulast%3DHamelmann%26aufirst%3DE.%26aulast%3DHoffmann%26aufirst%3DH.%2BJ.%26aulast%3DHoffmann-Sommergruber%26aufirst%3DK.%26aulast%3DHovhannisyan%26aufirst%3DL.%26aulast%3DHox%26aufirst%3DV.%26aulast%3DJahnsen%26aufirst%3DF.%2BL.%26aulast%3DKalayci%26aufirst%3DO.%26aulast%3DKalpaklioglu%26aufirst%3DA.%2BF.%26aulast%3DKleine-Tebbe%26aufirst%3DJ.%26aulast%3DKonstantinou%26aufirst%3DG.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DLauener%26aufirst%3DR.%26aulast%3DLauerma%26aufirst%3DA.%26aulast%3DLogan%26aufirst%3DK.%26aulast%3DMagnan%26aufirst%3DA.%26aulast%3DMakowska%26aufirst%3DJ.%26aulast%3DMakrinioti%26aufirst%3DH.%26aulast%3DMangina%26aufirst%3DP.%26aulast%3DManole%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DA.%26aulast%3DMazon%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DMingomataj%26aufirst%3DE.%26aulast%3DNiggemann%26aufirst%3DB.%26aulast%3DNilsson%26aufirst%3DG.%26aulast%3DOllert%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%26aulast%3DPala%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DPassalacqua%26aufirst%3DG.%26aulast%3DPerkin%26aufirst%3DM.%26aulast%3DPfaar%26aufirst%3DO.%26aulast%3DPitsios%26aufirst%3DC.%26aulast%3DQuirce%26aufirst%3DS.%26aulast%3DRaap%26aufirst%3DU.%26aulast%3DRaulf-Heimsoth%26aufirst%3DM.%26aulast%3DRhyner%26aufirst%3DC.%26aulast%3DRobson-Ansley%26aufirst%3DP.%26aulast%3DAlves%26aufirst%3DR.%2BR.%26aulast%3DRoje%26aufirst%3DZ.%26aulast%3DRondon%26aufirst%3DC.%26aulast%3DRudzeviciene%26aufirst%3DO.%26aulast%3DRueff%26aufirst%3DF.%26aulast%3DRukhadze%26aufirst%3DM.%26aulast%3DRumi%26aufirst%3DG.%26aulast%3DSackesen%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DA.%2BF.%26aulast%3DSantucci%26aufirst%3DA.%26aulast%3DScharf%26aufirst%3DC.%26aulast%3DSchmidt-Weber%26aufirst%3DC.%26aulast%3DSchnyder%26aufirst%3DB.%26aulast%3DSchwarze%26aufirst%3DJ.%26aulast%3DSenna%26aufirst%3DG.%26aulast%3DSergejeva%26aufirst%3DS.%26aulast%3DSeys%26aufirst%3DS.%26aulast%3DSiracusa%26aufirst%3DA.%26aulast%3DSkypala%26aufirst%3DI.%26aulast%3DSokolowska%26aufirst%3DM.%26aulast%3DSpertini%26aufirst%3DF.%26aulast%3DSpiewak%26aufirst%3DR.%26aulast%3DSprikkelman%26aufirst%3DA.%26aulast%3DSturm%26aufirst%3DG.%26aulast%3DSwoboda%26aufirst%3DI.%26aulast%3DTerreehorst%26aufirst%3DI.%26aulast%3DToskala%26aufirst%3DE.%26aulast%3DTraidl-Hoffmann%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DC.%26aulast%3DVlieg-Boerstra%26aufirst%3DB.%26aulast%3DWhitacker%26aufirst%3DP.%26aulast%3DWorm%26aufirst%3DM.%26aulast%3DXepapadaki%26aufirst%3DP.%26aulast%3DAkdis%26aufirst%3DC.%2BA.%26atitle%3DResearch%2520needs%2520in%2520allergy%253A%2520an%2520EAACI%2520position%2520paper%252C%2520in%2520collaboration%2520with%2520EFA%26jtitle%3DClin.%2520Transl.%2520Allergy%26date%3D2012%26volume%3D2%26issue%3D21%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">New drugs for asthma</span> <span class="citation_source-journal">Semin. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">â</span> <span class="NLM_lpage">694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1055%2Fs-0032-1326958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=23047317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjsFOltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=685-694&author=P.+J.+Barnes&title=New+drugs+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New drugs for asthma</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Current therapy for asthma with inhaled corticosteroids and long-acting inhaled Î²(2)-agonists is highly effective, safe, and relatively inexpensive, but many patients remain poorly controlled.  Most advances have been through improving these drug classes and a major developmental hurdle is to improve existing drug classes.  Major unmet needs include better treatment of severe asthma (which has some similarity to chronic obstructive pulmonary disease), as well as curative therapies for mild to moderate asthma that do not result in the return of symptoms when the treatment is stopped.  Several new treatments are in development, but many are specific, targeting a single mediator or receptor, and are unlikely to have a major clinical impact, although they may be effective in specific asthma phenotypes (endotypes).  Drugs with more widespread effects, such as kinase inhibitors, may be more effective but have a greater risk of side effects so inhaled delivery may be needed.  Several new treatments target the underlying allergic/immune process and would treat concomitant allergic diseases.  Improved immunotherapy approaches have the potential for disease modification, although prospects for a cure are currently remote.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-S-3Mwh5Y95p6t8nS6Nc3fW6udTcc2eZEy9gr5MipiLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjsFOltA%253D%253D&md5=54b8285c9dbf669f0b9ec21d8154b4fd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1326958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1326958%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DNew%2520drugs%2520for%2520asthma%26jtitle%3DSemin.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D33%26spage%3D685%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Quirce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barranco, P.</span><span> </span><span class="NLM_article-title">Emerging drugs for asthma</span> <span class="citation_source-journal">Expert. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1517%2F14728214.2012.683410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=22607631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns12iurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=219-237&author=S.+Quirceauthor=I.+Boboleaauthor=P.+Barranco&title=Emerging+drugs+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for asthma</span></div><div class="casAuthors">Quirce, Santiago; Bobolea, Irina; Barranco, Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-237</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Current drug treatments for asthma relieve bronchospasm and airway inflammation but do not offer a cure, and symptoms return when treatment is stopped.  Asthma management guidelines emphasize the importance of effective asthma treatment to achieve and maintain asthma control.  However, despite widely available and effective treatments, achieving asthma control is still an unmet need for many patients.Areas covered: Remarkable efforts have been made to identify the characteristic features of difficult-to-control (usually severe) asthma that are different from those described for mild-to-moderate asthma, setting the stage for the development of new and even individualized therapies.  The most fascinating options of the new asthma treatments are biol. therapies, in particular monoclonal antibodies.  In addn., some novel once-daily combinations of long-acting Î²2-agonist and inhaled corticosteroids are under development.Expert opinion: Asthma is a complex syndrome made up of a no. of disease variants or asthma phenotypes, with different underlying pathophysiol.  As different drugs target different pathways, it is necessary to det. the individual profile of pathophysiol. abnormalities for each patient.  Several cytokines have been implicated in the inflammatory cascades leading to the different asthma phenotypes, and the most relevant ones are discussed.  The challenge in treating asthma resides precisely in its heterogeneity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAv_5eVsGq7LVg90H21EOLACvtfcHk0likhtP-2rYFbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns12iurc%253D&md5=c25fd64468c101628db23d7c7ea7916d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.2012.683410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2012.683410%26sid%3Dliteratum%253Aachs%26aulast%3DQuirce%26aufirst%3DS.%26aulast%3DBobolea%26aufirst%3DI.%26aulast%3DBarranco%26aufirst%3DP.%26atitle%3DEmerging%2520drugs%2520for%2520asthma%26jtitle%3DExpert.%2520Opin.%2520Emerging%2520Drugs%26date%3D2012%26volume%3D17%26spage%3D219%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Peters, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey-Sobotka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naclerio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGlashan, D. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, N. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, L. M.</span><span> </span><span class="NLM_article-title">The role of prostaglandin D2 in IgE-mediated reactions in man</span> <span class="citation_source-journal">Trans. Assoc. Am. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">â</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1982&pages=221-228&author=S.+P.+Petersauthor=R.+P.+Schleimerauthor=A.+Kagey-Sobotkaauthor=R.+M.+Naclerioauthor=D.+W.+MacGlashanauthor=E.+S.+Schulmanauthor=N.+F.+Adkinsonauthor=L.+M.+Lichtenstein&title=The+role+of+prostaglandin+D2+in+IgE-mediated+reactions+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DS.%2BP.%26aulast%3DSchleimer%26aufirst%3DR.%2BP.%26aulast%3DKagey-Sobotka%26aufirst%3DA.%26aulast%3DNaclerio%26aufirst%3DR.%2BM.%26aulast%3DMacGlashan%26aufirst%3DD.%2BW.%26aulast%3DSchulman%26aufirst%3DE.%2BS.%26aulast%3DAdkinson%26aufirst%3DN.%2BF.%26aulast%3DLichtenstein%26aufirst%3DL.%2BM.%26atitle%3DThe%2520role%2520of%2520prostaglandin%2520D2%2520in%2520IgE-mediated%2520reactions%2520in%2520man%26jtitle%3DTrans.%2520Assoc.%2520Am.%2520Physicians%26date%3D1982%26volume%3D95%26spage%3D221%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lewis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soter, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. J.,  2nd.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">â</span> <span class="NLM_lpage">1631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=6809826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaL38Xls1Sqt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=1982&pages=1627-1631&author=R.+A.+Lewisauthor=N.+A.+Soterauthor=P.+T.+Diamondauthor=K.+F.+Austenauthor=J.+A.+Oatesauthor=L.+J.+Roberts&title=Prostaglandin+D2+generation+after+activation+of+rat+and+human+mast+cells+with+anti-IgE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE</span></div><div class="casAuthors">Lewis, Robert A.; Soter, Nicholas A.; Diamond, Paul T.; Austen, K. Frank; Oates, John A.; Roberts, L. Jackson, II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">Anti-IgE-dependent activation of rat and human mast cells resulted in the preferential generation of the cyclooxygenase products PGD2 and PGI2 in the rat and PGD2 in the human.  The av. net generation of PGD2 was 13.1 ng/106 purified rat mast cells and 39.5 ng/106 dispersed, enriched human mast cells.  After IgE-dependent activation, there was a linear relation between the net quantities of PGD2 generated and histamine secreted from dispersed human pulmonary cells when the no. of mast cells was varied but the total no. of cells was held const., indicating that it is the no. of mast cells participating in IgE-dependent activation, rather than total mast cell no., that dets. PGD2 generation.  A linear relation was also shown between PGD2 generation and the release of the granule marker Î²-hexosaminidase from purified rat mast cells on the dose-response portion of the plot of their response to anti-IgE challenge.  With higher concns. of anti-IgE, PGD2 generation from rat mast cells plateaued, whereas net percent Î²-hexosaminidase release increased further.  In kinetic studies of rat mast cells activated with anti-IgE, the onset (1-2 min) and time of max. generation (5-10 min) for PGD2 were delayed relative to the onset (15-30 s) and completion (1-2 min) of Î²-hexosaminidase release.  Thus, the extracellular appearance of PGD2 during IgE-dependent mast cell activation represents a response addnl. to the secretion of granule-assocd. mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0ZhTYfyWvbVg90H21EOLACvtfcHk0likhtP-2rYFbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xls1Sqt7c%253D&md5=ed51cc5cc737b968cb30a21c9e339e2a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DR.%2BA.%26aulast%3DSoter%26aufirst%3DN.%2BA.%26aulast%3DDiamond%26aufirst%3DP.%2BT.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DL.%2BJ.%26atitle%3DProstaglandin%2520D2%2520generation%2520after%2520activation%2520of%2520rat%2520and%2520human%2520mast%2520cells%2520with%2520anti-IgE%26jtitle%3DJ.%2520Immunol.%26date%3D1982%26volume%3D129%26spage%3D1627%26epage%3D1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Crea, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakhosteen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span> </span><span class="NLM_article-title">Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=1348480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK383hslKkug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1992&pages=190-195&author=A.+E.+Creaauthor=J.+A.+Nakhosteenauthor=T.+H.+Lee&title=Mediator+concentrations+in+bronchoalveolar+lavage+fluid+of+patients+with+mild+asymptomatic+bronchial+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma</span></div><div class="casAuthors">Crea A E; Nakhosteen J A; Lee T H</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-5</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">Bronchoalveolar lavage (BAL) was performed on 11 atopic patients with mild asymptomatic bronchial asthma and 11 healthy nonasthmatic volunteers.  All asthmatic subjects had evidence of bronchial hyperresponsiveness to inhaled carbachol.  The concentrations of leukotriene (LT) C4, LTD4, LTE4, LTB4, prostaglandin D2 (PGD2), platelet-activating factor (PAF) and histamine in BAL fluid measured.  The leukotrienes were measured by radioimmunoassay following reverse phase high performance liquid chromatography.  PGD2 concentrations were determined by radio immunoassay after Amprep C2 extraction.  PAF was quantitated by means of in vitro aggregation of rabbit platelets and histamine content was measured using a single isotope radio-enzymatic assay.  There was an increase in the levels of PGD2 and a decrease in the concentration of LTB4 in asthmatic lavage samples.  There were no significant differences in the lavage concentrations of LTC4/D4/E4 and histamine between the two groups of individuals.  PAF was undetectable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCysiO0H3Xw8vLc4ARHEmzfW6udTcc2ebsUQomy4_t4bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383hslKkug%253D%253D&md5=4ff63cc26a6ea66f5703f6c3b0ebdc8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrea%26aufirst%3DA.%2BE.%26aulast%3DNakhosteen%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DT.%2BH.%26atitle%3DMediator%2520concentrations%2520in%2520bronchoalveolar%2520lavage%2520fluid%2520of%2520patients%2520with%2520mild%2520asymptomatic%2520bronchial%2520asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1992%26volume%3D5%26spage%3D190%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Liu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleecker, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey-Sobotka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niv, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLemore, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Permutt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, W. C.</span><span> </span><span class="NLM_article-title">Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1164%2Fajrccm%2F142.1.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=2368958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK3czhsVSksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1990&pages=126-132&author=M.+C.+Liuauthor=E.+R.+Bleeckerauthor=L.+M.+Lichtensteinauthor=A.+Kagey-Sobotkaauthor=Y.+Nivauthor=T.+L.+McLemoreauthor=S.+Permuttauthor=D.+Proudauthor=W.+C.+Hubbard&title=Evidence+for+elevated+levels+of+histamine%2C+prostaglandin+D2%2C+and+other+bronchoconstricting+prostaglandins+in+the+airways+of+subjects+with+mild+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma</span></div><div class="casAuthors">Liu M C; Bleecker E R; Lichtenstein L M; Kagey-Sobotka A; Niv Y; McLemore T L; Permutt S; Proud D; Hubbard W C</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-32</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">Histamine and certain cyclooxygenase products of arachidonic acid have been implicated as mediators of inflammation and are potent constrictors of human airways.  Because asthma may represent manifestations of chronic inflammation of the airways, the levels of histamine and six prostanoid mediators were measured in airway fluids obtained by bronchoalveolar lavage (BAL) of 12 normal, 11 allergic rhinitic, and 15 asymptomatic, allergic asthmatic subjects.  Simultaneous profiling of prostanoid mediators in individual samples was performed using gas chromatography-mass spectrometry.  Levels of PGD2, 9 alpha,11 beta-PGF2 and PGF2 alpha were 12 to 22 times higher in asthmatic than in normal subjects (p less than 0.01), with concentrations in airway fluids of asthmatic subjects after correction for dilution of 3.8, 0.5, and 1.4 nanomolar, respectively.  Levels of PGD2 and 9 alpha,11 beta-PGF2 were increased nearly tenfold in asthmatic subjects compared with those in rhinitic subjects (p less than 0.01), distinguishing the subjects with lower airway disease from those with another atopic condition.  Histamine levels were increased fourfold in asthmatic subjects compared with those in normal subjects (p less than 0.001); however, similar increases were found in rhinitic subjects.  We conclude that elevated levels of multiple mediators with potent bronchoconstricting activity are present in the airways of subjects with mild asthma, indicating that even mild disease is associated with evidence of airway inflammation.  The interactions of bronchoconstricting mediators and airway inflammation may play important roles in the pathogenesis of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjlx2PAsAQNySm0e6ZOaemfW6udTcc2ebsUQomy4_t4bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czhsVSksQ%253D%253D&md5=564fe9284acdcc1768f3a2a09c595b34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1164%2Fajrccm%2F142.1.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm%252F142.1.126%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%2BC.%26aulast%3DBleecker%26aufirst%3DE.%2BR.%26aulast%3DLichtenstein%26aufirst%3DL.%2BM.%26aulast%3DKagey-Sobotka%26aufirst%3DA.%26aulast%3DNiv%26aufirst%3DY.%26aulast%3DMcLemore%26aufirst%3DT.%2BL.%26aulast%3DPermutt%26aufirst%3DS.%26aulast%3DProud%26aufirst%3DD.%26aulast%3DHubbard%26aufirst%3DW.%2BC.%26atitle%3DEvidence%2520for%2520elevated%2520levels%2520of%2520histamine%252C%2520prostaglandin%2520D2%252C%2520and%2520other%2520bronchoconstricting%2520prostaglandins%2520in%2520the%2520airways%2520of%2520subjects%2520with%2520mild%2520asthma%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1990%26volume%3D142%26spage%3D126%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenmotsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1084%2Fjem.193.2.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=11208866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=255-261&author=H.+Hiraiauthor=K.+Tanakaauthor=O.+Yoshieauthor=K.+Ogawaauthor=K.+Kenmotsuauthor=Y.+Takamoriauthor=M.+Ichimasaauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takanoauthor=K.+Nagata&title=Prostaglandin+D2+selectively+induces+chemotaxis+in+T+helper+type+2+cells%2C+eosinophils%2C+and+basophils+via+seven-transmembrane+receptor+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span></div><div class="casAuthors">Hirai, Hiroyuki; Tanaka, Kazuya; Yoshie, Osamu; Ogawa, Kazuyuki; Kenmotsu, Kazumi; Takamori, Yasushi; Ichimasa, Michiko; Sugamura, Kazuo; Nakamura, Masataka; Takano, Shoichi; Nagata, Kinya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prostaglandin (PG)D2, which has long been implicated in allergic diseases, is currently considered to elicit its biol. actions through the DP receptor (DP).  Involvement of DP in the formation of allergic asthma was recently demonstrated with DP-deficient mice.  However, proinflammatory functions of PGD2 cannot be explained by DP alone.  The authors show here that a 7-transmembrane receptor, CRTH2, which is preferentially expressed in T helper type 2 (Th2) cells, eosinophils, and basophils in humans, serves as the novel receptor for PGD2.  In response to PGD2, CRTH2 induces intracellular Ca2+ mobilization and chemotaxis in Th2 cells in a GÎ±i-dependent manner.  In addn., CRTH2, but not DP, mediates PGD2-dependent cell migration of blood eosinophils and basophils.  Thus, PGD2 is likely involved in multiple aspects of allergic inflammation through its dual receptor systems, DP and CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrVzvfWtBArVg90H21EOLACvtfcHk0lgOT21DIvzOGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D&md5=be2c6671805c587029df75738463ccd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1084%2Fjem.193.2.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.193.2.255%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKenmotsu%26aufirst%3DK.%26aulast%3DTakamori%26aufirst%3DY.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DProstaglandin%2520D2%2520selectively%2520induces%2520chemotaxis%2520in%2520T%2520helper%2520type%25202%2520cells%252C%2520eosinophils%252C%2520and%2520basophils%2520via%2520seven-transmembrane%2520receptor%2520CRTH2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D193%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mjosberg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crellin, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drunen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokkens, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupedo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span> </span><span class="NLM_article-title">Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">â</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1038%2Fni.2104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=21909091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BC3MbisVCmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1055-1062&author=J.+M.+Mjosbergauthor=S.+Trifariauthor=N.+K.+Crellinauthor=C.+P.+Petersauthor=C.+M.+van+Drunenauthor=B.+Pietauthor=W.+J.+Fokkensauthor=T.+Cupedoauthor=H.+Spits&title=Human+IL-25-+and+IL-33-responsive+type+2+innate+lymphoid+cells+are+defined+by+expression+of+CRTH2+and+CD161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161</span></div><div class="casAuthors">Mjosberg Jenny M; Trifari Sara; Crellin Natasha K; Peters Charlotte P; van Drunen Cornelis M; Piet Berber; Fokkens Wytske J; Cupedo Tom; Spits Hergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1055-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Innate lymphoid cells (ILCs) are emerging as a family of effectors and regulators of innate immunity and tissue remodeling.  Interleukin 22 (IL-22)- and IL-17-producing ILCs, which depend on the transcription factor RORÎ³t, express CD127 (IL-7 receptor Î±-chain) and the natural killer cell marker CD161.  Here we describe another lineage-negative CD127(+)CD161(+) ILC population found in humans that expressed the chemoattractant receptor CRTH2.  These cells responded in vitro to IL-2 plus IL-25 and IL-33 by producing IL-13.  CRTH2(+) ILCs were present in fetal and adult lung and gut.  In fetal gut, these cells expressed IL-13 but not IL-17 or IL-22.  There was enrichment for CRTH2(+) ILCs in nasal polyps of chronic rhinosinusitis, a typical type 2 inflammatory disease.  Our data identify a unique type of human ILC that provides an innate source of T helper type 2 (T(H)2) cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJE3sDc42Er0ewzGPswiWOfW6udTcc2eZUBAWCFqOp8bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbisVCmtA%253D%253D&md5=d64523177599d66477eaed09292cea27</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fni.2104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2104%26sid%3Dliteratum%253Aachs%26aulast%3DMjosberg%26aufirst%3DJ.%2BM.%26aulast%3DTrifari%26aufirst%3DS.%26aulast%3DCrellin%26aufirst%3DN.%2BK.%26aulast%3DPeters%26aufirst%3DC.%2BP.%26aulast%3Dvan%2BDrunen%26aufirst%3DC.%2BM.%26aulast%3DPiet%26aufirst%3DB.%26aulast%3DFokkens%26aufirst%3DW.%2BJ.%26aulast%3DCupedo%26aufirst%3DT.%26aulast%3DSpits%26aufirst%3DH.%26atitle%3DHuman%2520IL-25-%2520and%2520IL-33-responsive%2520type%25202%2520innate%2520lymphoid%2520cells%2520are%2520defined%2520by%2520expression%2520of%2520CRTH2%2520and%2520CD161%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D1055%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyles, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettey, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, R.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">6531</span><span class="NLM_x">â</span> <span class="NLM_lpage">6536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=6531-6536&author=L.+Xueauthor=S.+L.+Gylesauthor=F.+R.+Wetteyauthor=L.+Gaziauthor=E.+Townsendauthor=M.+G.+Hunterauthor=R.+Pettipher&title=Prostaglandin+D2+causes+preferential+induction+of+proinflammatory+Th2+cytokine+production+through+an+action+on+chemoattractant+receptor-like+molecule+expressed+on+Th2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DL.%26aulast%3DGyles%26aufirst%3DS.%2BL.%26aulast%3DWettey%26aufirst%3DF.%2BR.%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DE.%26aulast%3DHunter%26aufirst%3DM.%2BG.%26aulast%3DPettipher%26aufirst%3DR.%26atitle%3DProstaglandin%2520D2%2520causes%2520preferential%2520induction%2520of%2520proinflammatory%2520Th2%2520cytokine%2520production%2520through%2520an%2520action%2520on%2520chemoattractant%2520receptor-like%2520molecule%2520expressed%2520on%2520Th2%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D6531%26epage%3D6536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yoshimura-Uchiyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span> </span><span class="NLM_article-title">Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">â</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1111%2Fj.1365-2222.2004.02027.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=15298571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Gntbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=1283-1290&author=C.+Yoshimura-Uchiyamaauthor=M.+Iikuraauthor=M.+Yamaguchiauthor=H.+Nagaseauthor=A.+Ishiiauthor=K.+Matsushimaauthor=K.+Yamamotoauthor=M.+Shichijoauthor=K.+B.+Baconauthor=K.+Hirai&title=Differential+modulation+of+human+basophil+functions+through+prostaglandin+D2+receptors+DP+and+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+cells%2FDP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2</span></div><div class="casAuthors">Yoshimura-Uchiyama, C.; Iikura, M.; Yamaguchi, M.; Nagase, H.; Ishii, A.; Matsushima, K.; Yamamoto, K.; Shichijo, M.; Bacon, K. B.; Hirai, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1283-1290</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Both prostaglandin (PG) D receptor (DP) and CRTH2 (chemoattractant receptor-homologous mol. expressed on Th2 cells)/DP2 are high-affinity receptors for PGD2.  Previous studies have demonstrated that PGD2 enhances releasability and induces CRTH2/DP2-mediated migration in human basophils, but the precise effects of PGD2 on basophils as well as receptor usage have not been fully clarified.  Objective: We comprehensively explored the roles of DP and CRTH2/DP2 in basophil functions by using selective agonists and antagonists for each receptor.  Methods: DP and CRTH2/DP2 transcripts were quantified by real-time PCR.  We studied the effects of selective agonists (DP: BW 245C; CRTH2/DP2: 13,14-dihydro-15-keto (DK)-PGD2) and/or antagonists (DP; BWA 868C; CRTH2/DP2: ramatroban) on Ca2+ mobilization, migration, degranulation, CD116 expression and survival of human basophils.  Results: Basophils expressed transcripts of both DP and CRTH2/DP2, but the levels of CRTH2/DP2 transcripts were â¼100-fold higher compared with DP transcripts.  Ca2+ influx was induced in basophils by either PGD2 or DK-PGD2/CRTH2 agonist but not by BW 245C/DP agonist.  Basophils treated with PGD2 were completely desensitized to subsequent stimulation with DK-PGD2, but not vice versa.  DK-PGD2 as well as PGD2 up-regulated CD11b expression, induced migration and enhanced degranulation, and those effects were completely antagonized by ramatroban/CRTH2 antagonist.  In contrast, BW 245C/DP agonist exhibited an inhibitory effect on basophil migration and IgE-mediated degranulation, and the migration inhibitory effect was effectively antagonized by BWA 969C/DP antagonist.  On the other hand, while PGD2 significantly shortened the basophil lifespan, neither DK-PGD2/CRTH2 agonist nor BW 245C/DP agonist did.  Conclusion: CRTH2/DP2 is primarily responsible for the pro-inflammatory effects of PGD2 on human basophils, while DP introduces neg. signals capable of antagonizing the effects of CRTH2/DP2 in these cells.  The effects of PGD2 on longevity imply a mechanism(s) other than via DP or CRTH2/DP2.  CRTH2/DP2 on basophils may afford opportunities for therapeutic targeting in allergic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQL-50aQNsTLVg90H21EOLACvtfcHk0lgPPpNXZx9wYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Gntbs%253D&md5=53216933edbc7eea8e0960dd78c07e83</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2222.2004.02027.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2222.2004.02027.x%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura-Uchiyama%26aufirst%3DC.%26aulast%3DIikura%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DDifferential%2520modulation%2520of%2520human%2520basophil%2520functions%2520through%2520prostaglandin%2520D2%2520receptors%2520DP%2520and%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520cells%252FDP2%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2004%26volume%3D34%26spage%3D1283%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Effects of prostaglandin D2 on helper T cell functions</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">â</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2004&pages=1009-1014&author=K.+Tanakaauthor=H.+Hiraiauthor=S.+Takanoauthor=M.+Nakamuraauthor=K.+Nagata&title=Effects+of+prostaglandin+D2+on+helper+T+cell+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520prostaglandin%2520D2%2520on%2520helper%2520T%2520cell%2520functions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D316%26spage%3D1009%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wills-Karp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyimbazi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neben, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, D. D.</span><span> </span><span class="NLM_article-title">Interleukin-13: central mediator of allergic asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">â</span> <span class="NLM_lpage">2261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2258-2261&author=M.+Wills-Karpauthor=J.+Luyimbaziauthor=X.+Xuauthor=B.+Schofieldauthor=T.+Y.+Nebenauthor=C.+L.+Karpauthor=D.+D.+Donaldson&title=Interleukin-13%3A+central+mediator+of+allergic+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills-Karp%26aufirst%3DM.%26aulast%3DLuyimbazi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSchofield%26aufirst%3DB.%26aulast%3DNeben%26aufirst%3DT.%2BY.%26aulast%3DKarp%26aufirst%3DC.%2BL.%26aulast%3DDonaldson%26aufirst%3DD.%2BD.%26atitle%3DInterleukin-13%253A%2520central%2520mediator%2520of%2520allergic%2520asthma%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2258%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Grunig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakil, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkayya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brombacher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennick, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locksley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corry, D. B.</span><span> </span><span class="NLM_article-title">Requirement for IL-13 independently of IL-4 in experimental asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">â</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2261-2263&author=G.+Grunigauthor=M.+Warnockauthor=A.+E.+Wakilauthor=R.+Venkayyaauthor=F.+Brombacherauthor=D.+M.+Rennickauthor=D.+Sheppardauthor=M.+Mohrsauthor=D.+D.+Donaldsonauthor=R.+M.+Locksleyauthor=D.+B.+Corry&title=Requirement+for+IL-13+independently+of+IL-4+in+experimental+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrunig%26aufirst%3DG.%26aulast%3DWarnock%26aufirst%3DM.%26aulast%3DWakil%26aufirst%3DA.%2BE.%26aulast%3DVenkayya%26aufirst%3DR.%26aulast%3DBrombacher%26aufirst%3DF.%26aulast%3DRennick%26aufirst%3DD.%2BM.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DMohrs%26aufirst%3DM.%26aulast%3DDonaldson%26aufirst%3DD.%2BD.%26aulast%3DLocksley%26aufirst%3DR.%2BM.%26aulast%3DCorry%26aufirst%3DD.%2BB.%26atitle%3DRequirement%2520for%2520IL-13%2520independently%2520of%2520IL-4%2520in%2520experimental%2520asthma%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2261%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Matsuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aze, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 as a mediator of allergic asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">â</span> <span class="NLM_lpage">2017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=2013-2017&author=T.+Matsuokaauthor=M.+Hirataauthor=H.+Tanakaauthor=Y.+Takahashiauthor=T.+Murataauthor=K.+Kabashimaauthor=Y.+Sugimotoauthor=T.+Kobayashiauthor=F.+Ushikubiauthor=Y.+Azeauthor=N.+Eguchiauthor=Y.+Uradeauthor=N.+Yoshidaauthor=K.+Kimuraauthor=A.+Mizoguchiauthor=Y.+Hondaauthor=H.+Nagaiauthor=S.+Narumiya&title=Prostaglandin+D2+as+a+mediator+of+allergic+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DKabashima%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DAze%26aufirst%3DY.%26aulast%3DEguchi%26aufirst%3DN.%26aulast%3DUrade%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMizoguchi%26aufirst%3DA.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520D2%2520as%2520a%2520mediator%2520of%2520allergic%2520asthma%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D2013%26epage%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Emerging roles of DP and CRTH2 in allergic inflammation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=148-158&author=E.+Kostenisauthor=T.+Ulven&title=Emerging+roles+of+DP+and+CRTH2+in+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DEmerging%2520roles%2520of%2520DP%2520and%2520CRTH2%2520in%2520allergic%2520inflammation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hart, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boardman, P. L.</span><span> </span><span class="NLM_article-title">Indomethacin: a new non-steroid anti-inflammatory agent</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">â</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1136%2Fbmj.2.5363.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=14056924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaF2c%252FhsVGnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1963&pages=965-970&author=F.+D.+Hartauthor=P.+L.+Boardman&title=Indomethacin%3A+a+new+non-steroid+anti-inflammatory+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT</span></div><div class="casAuthors">HART F D; BOARDMAN P L</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5363</span>),
    <span class="NLM_cas:pages">965-70</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCVfn3XDOnikNHe_gFldTbfW6udTcc2eaP63OHLPn6Obntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252FhsVGnuw%253D%253D&md5=fc49e274294e4425dddec48f657ff356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fbmj.2.5363.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.2.5363.965%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DF.%2BD.%26aulast%3DBoardman%26aufirst%3DP.%2BL.%26atitle%3DIndomethacin%253A%2520a%2520new%2520non-steroid%2520anti-inflammatory%2520agent%26jtitle%3DBr.%2520Med.%2520J.%26date%3D1963%26volume%3D2%26spage%3D965%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=981-985&author=H.+Hiraiauthor=K.+Tanakaauthor=S.+Takanoauthor=M.+Ichimasaauthor=M.+Nakamuraauthor=K.+Nagata&title=Cutting+edge%3A+agonistic+effect+of+indomethacin+on+a+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DCutting%2520edge%253A%2520agonistic%2520effect%2520of%2520indomethacin%2520on%2520a%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D981%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rosentreter, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshagen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perzborn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, V. B.</span><span> </span><span class="NLM_article-title">Synthesis and absolute configuration of the new thromboxane antagonist (3<i>R</i>)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">â</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=2624597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyjt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1989&pages=1519-1521&author=U.+Rosentreterauthor=H.+Boshagenauthor=F.+Seuterauthor=E.+Perzbornauthor=V.+B.+Fiedler&title=Synthesis+and+absolute+configuration+of+the+new+thromboxane+antagonist+%283R%29-3-%284-fluorophenylsulfonamido%29-1%2C2%2C3%2C4-tetrahydro-9-carbazolepropan+oic+acid+and+comparison+with+its+enantiomer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid and comparison with its enantiomer</span></div><div class="casAuthors">Rosentreter, U.; Boeshagen, H.; Seuter, F.; Perzborn, E.; Fiedler, V. B.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1519-21</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The title compd, (+)-I (Bay u 3405), was synthesized as an enantiomerically pure thromboxan A2 antagonist.  (+)-I was a more potent blood platelet-aggregation inhibitor than (-)-I (Bay u 3406); both enantiomers showed in vitro activity as vasoconstrictors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp95v6fXC1Xz7Vg90H21EOLACvtfcHk0liqq2BLB3Rsgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyjt7Y%253D&md5=8782109d96e10f0f6b604601c9d892ea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosentreter%26aufirst%3DU.%26aulast%3DBoshagen%26aufirst%3DH.%26aulast%3DSeuter%26aufirst%3DF.%26aulast%3DPerzborn%26aufirst%3DE.%26aulast%3DFiedler%26aufirst%3DV.%2BB.%26atitle%3DSynthesis%2520and%2520absolute%2520configuration%2520of%2520the%2520new%2520thromboxane%2520antagonist%2520%25283R%2529-3-%25284-fluorophenylsulfonamido%2529-1%252C2%252C3%252C4-tetrahydro-9-carbazolepropan%2520oic%2520acid%2520and%2520comparison%2520with%2520its%2520enantiomer%26jtitle%3DArzneim.%2520Forsch.%26date%3D1989%26volume%3D39%26spage%3D1519%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Aizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, N.</span><span> </span><span class="NLM_article-title">BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">â</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1996&pages=338-342&author=H.+Aizawaauthor=M.+Shigyoauthor=H.+Nogamiauthor=T.+Hiroseauthor=N.+Hara&title=BAY+u3405%2C+a+thromboxane+A2+antagonist%2C+reduces+bronchial+hyperresponsiveness+in+asthmatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAizawa%26aufirst%3DH.%26aulast%3DShigyo%26aufirst%3DM.%26aulast%3DNogami%26aufirst%3DH.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DN.%26atitle%3DBAY%2520u3405%252C%2520a%2520thromboxane%2520A2%2520antagonist%252C%2520reduces%2520bronchial%2520hyperresponsiveness%2520in%2520asthmatics%26jtitle%3DChest%26date%3D1996%26volume%3D109%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Terada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maesako, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, A.</span><span> </span><span class="NLM_article-title">The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis</span> <span class="citation_source-journal">Acta Otolaryngol. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1080%2F00016489850182323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=9870646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK1M%252Fos1WqsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=1998&pages=32-37&author=N.+Teradaauthor=T.+Yamakoshiauthor=M.+Hasegawaauthor=H.+Tanikawaauthor=K.+Maesakoauthor=K.+Ishikawaauthor=A.+Konno&title=The+effect+of+ramatroban+%28BAY+u+3405%29%2C+a+thromboxane+A2+receptor+antagonist%2C+on+nasal+cavity+volume+and+minimum+cross-sectional+area+and+nasal+mucosal+hemodynamics+after+nasal+mucosal+allergen+challenge+in+patients+with+perennial+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis</span></div><div class="casAuthors">Terada N; Yamakoshi T; Hasegawa M; Tanikawa H; Maesako K; Ishikawa K; Konno A</div><div class="citationInfo"><span class="NLM_cas:title">Acta oto-laryngologica. Supplementum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-7</span>
        ISSN:<span class="NLM_cas:issn">0365-5237</span>.
    </div><div class="casAbstract">The thromboxane A2 receptor antagonist, ramatroban (BAY u 3405), was orally administered for 4 weeks at a daily dose of 150 mg (b.i.d.) to 10 patients with perennial allergic rhinitis who had a positive reaction to house dust challenge on nasal mucosa.  Nasal cavity volume and minimum cross-sectional area were measured, and changes in nasal mucosal swelling were determined following allergen challenge with house dust.  The influence on nasal mucosal hemodynamics was also investigated.  Nasal cavity volume and minimum cross-sectional area were measured by acoustic rhinometry, and blood flow in the nasal mucosa was measured by laser Doppler flowmetry.  Percent changes in values from baseline nasal cavity volume were significantly decreased by allergen challenge before ramatroban administration, but no significant decrease was noted after ramatroban administration.  Similarly, percent changes in values from baseline nasal cavity minimum cross-sectional area were significantly decreased by allergen challenge before administration of ramatroban, but not after administration.  Percent changes in values from baseline nasal mucosal hemodynamics were significantly increased by allergen challenge both before and after ramatroban administration, which thus had no effect on mucosal hemodynamics.  These findings suggest that ramatroban might inhibit the increase in nasal mucosal swelling but has no effect on nasal mucosal hemodynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCzbCKf6pyciEJCPKhJPuqfW6udTcc2eaTYVCBb72Vebntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252Fos1WqsQ%253D%253D&md5=32abe5902be3f0e64719f74c3528f1ce</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F00016489850182323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00016489850182323%26sid%3Dliteratum%253Aachs%26aulast%3DTerada%26aufirst%3DN.%26aulast%3DYamakoshi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTanikawa%26aufirst%3DH.%26aulast%3DMaesako%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DKonno%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520ramatroban%2520%2528BAY%2520u%25203405%2529%252C%2520a%2520thromboxane%2520A2%2520receptor%2520antagonist%252C%2520on%2520nasal%2520cavity%2520volume%2520and%2520minimum%2520cross-sectional%2520area%2520and%2520nasal%2520mucosal%2520hemodynamics%2520after%2520nasal%2520mucosal%2520allergen%2520challenge%2520in%2520patients%2520with%2520perennial%2520allergic%2520rhinitis%26jtitle%3DActa%2520Otolaryngol.%2520Suppl.%26date%3D1998%26volume%3D537%26spage%3D32%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span> </span><span class="NLM_article-title">An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1124%2Fjpet.102.046748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=12649388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1amsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=347-352&author=H.+Sugimotoauthor=M.+Shichijoauthor=T.+Iinoauthor=Y.+Manabeauthor=A.+Watanabeauthor=M.+Shimazakiauthor=F.+Gantnerauthor=K.+B.+Bacon&title=An+orally+bioavailable+small+molecule+antagonist+of+CRTH2%2C+ramatroban+%28BAY+u3405%29%2C+inhibits+prostaglandin+D2-induced+eosinophil+migration+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro</span></div><div class="casAuthors">Sugimoto, Hiromi; Shichijo, Michitaka; Iino, Takashi; Manabe, Yoshihisa; Watanabe, Akihiko; Shimazaki, Makoto; Gantner, Florian; Bacon, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">347-352</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ramatroban (Baynas, BAY u3405), a thromboxane A2 (TxA2) antagonist marketed for allergic rhinitis, has been shown to partially attenuate prostaglandin (PG)D2-induced bronchial hyperresponsiveness in humans, as well as reduce antigen-induced early- and late-phase inflammatory responses in mice, guinea pigs, and rats.  PGD2 is known to induce eosinophilia following intranasal administration, and to induce eosinophil activation in vitro.  In addn. to the TxA2 receptor, PGD2 is known as a ligand for the PGD2 receptor, and the newly identified G-protein-coupled chemoattractant receptor-homologous mol. expressed on Th2 cells (CRTH2).  To fully characterize PGD2-mediated inflammatory responses relevant to eosinophil activation, further anal. of the mechanism of action of ramatroban has now been performed.  PGD2-stimulated human eosinophil migration was shown to be mediated exclusively through activation of CRTH2, and surprisingly, these effects were completely inhibited by ramatroban.  This is also the first report detailing an orally bioavailable small mol. CRTH2 antagonist.  Our findings suggest that clin. efficacy of ramatroban may be in part mediated through its action on this Th2-, eosinophil-, and basophil-specific chemoattractant receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0W109cRJrbLVg90H21EOLACvtfcHk0lj2i6sU5XgKAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1amsro%253D&md5=0b7a96b4a8e0fc0b40b6c4c2888b8721</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.046748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.046748%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DIino%26aufirst%3DT.%26aulast%3DManabe%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DShimazaki%26aufirst%3DM.%26aulast%3DGantner%26aufirst%3DF.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26atitle%3DAn%2520orally%2520bioavailable%2520small%2520molecule%2520antagonist%2520of%2520CRTH2%252C%2520ramatroban%2520%2528BAY%2520u3405%2529%252C%2520inhibits%2520prostaglandin%2520D2-induced%2520eosinophil%2520migration%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D347%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Pettipher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span> </span><span class="NLM_article-title">Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2915</span><span class="NLM_x">â</span> <span class="NLM_lpage">2931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKhtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2915-2931&author=R.+Pettipherauthor=M.+Whittaker&title=Update+on+the+development+of+antagonists+of+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+cells+%28CRTH2%29.+From+lead+optimization+to+clinical+proof-of-concept+in+asthma+and+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis</span></div><div class="casAuthors">Pettipher, Roy; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2915-2931</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the discovery of PGD2 as the ligand for CRTH2 in 2001 there has been significant progress in defining the role of this receptor in allergic response and the identification of small mol. wt. antagonists with drug-like properties.  With ramatroban, indomethacin and various high throughput screening hits as starting points for medicinal chem. programs, a no. of companies have identified lipophilic carboxylic acids as highly potent and selective CRTH2 antagonists.  Early proof-of-concept clin. studies indicate that CRTH2 antagonists are effective in treating the signs and symptoms of both asthma and allergic rhinitis and possess features that are differentiated from existing therapies for these indications.  It seems likely that CRTH2 antagonists will ultimately find utility as novel anti-allergic drugs, the challenge is to identify compds. that are effective when dosed once a day and prove to have an acceptable safety profile in long term studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8a9ruvvaF0LVg90H21EOLACvtfcHk0lj2i6sU5XgKAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKhtA%253D%253D&md5=98caa4a80dab99aee72aafd5cd94ffc4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm2013997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013997%26sid%3Dliteratum%253Aachs%26aulast%3DPettipher%26aufirst%3DR.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520the%2520development%2520of%2520antagonists%2520of%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520cells%2520%2528CRTH2%2529.%2520From%2520lead%2520optimization%2520to%2520clinical%2520proof-of-concept%2520in%2520asthma%2520and%2520allergic%2520rhinitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2915%26epage%3D2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renneberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H. .</span><span> </span><span class="NLM_article-title">Evolution of novel tricyclic CRTh2 receptor antagonists from a (<i>E</i>)-2-cyano-3-(1<i>H</i>-indol-3-yl)acrylamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">â</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=944-948&author=A.+Valdenaireauthor=J.+Pothierauthor=D.+Rennebergauthor=M.+A.+Riedererauthor=O.+Peterauthor=X.+Leroyauthor=C.+Gnerreauthor=H.+.+Fretz&title=Evolution+of+novel+tricyclic+CRTh2+receptor+antagonists+from+a+%28E%29-2-cyano-3-%281H-indol-3-yl%29acrylamide+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DRenneberg%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DFretz%26aufirst%3DH.%2B.%26atitle%3DEvolution%2520of%2520novel%2520tricyclic%2520CRTh2%2520receptor%2520antagonists%2520from%2520a%2520%2528E%2529-2-cyano-3-%25281H-indol-3-yl%2529acrylamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D944%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Boie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slipetz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of the human prostanoid DP receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">18910</span><span class="NLM_x">â</span> <span class="NLM_lpage">18916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=18910-18916&author=Y.+Boieauthor=N.+Sawyerauthor=D.+M.+Slipetzauthor=K.+M.+Mettersauthor=M.+Abramovitz&title=Molecular+cloning+and+characterization+of+the+human+prostanoid+DP+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoie%26aufirst%3DY.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DSlipetz%26aufirst%3DD.%2BM.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DAbramovitz%26aufirst%3DM.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520the%2520human%2520prostanoid%2520DP%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D18910%26epage%3D18916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Stubbs, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schratl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskar, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabroe, I.</span><span> </span><span class="NLM_article-title">Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">26012</span><span class="NLM_x">â</span> <span class="NLM_lpage">26020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=26012-26020&author=V.+E.+Stubbsauthor=P.+Schratlauthor=A.+Hartnellauthor=T.+J.+Williamsauthor=B.+A.+Peskarauthor=A.+Heinemannauthor=I.+Sabroe&title=Indomethacin+causes+prostaglandin+D%282%29-like+and+eotaxin-like+selective+responses+in+eosinophils+and+basophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStubbs%26aufirst%3DV.%2BE.%26aulast%3DSchratl%26aufirst%3DP.%26aulast%3DHartnell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DPeskar%26aufirst%3DB.%2BA.%26aulast%3DHeinemann%26aufirst%3DA.%26aulast%3DSabroe%26aufirst%3DI.%26atitle%3DIndomethacin%2520causes%2520prostaglandin%2520D%25282%2529-like%2520and%2520eotaxin-like%2520selective%2520responses%2520in%2520eosinophils%2520and%2520basophils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D26012%26epage%3D26020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sabroe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jopling, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span> </span><span class="NLM_article-title">Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">2946</span><span class="NLM_x">â</span> <span class="NLM_lpage">2955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=10072545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlyis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=2946-2955&author=I.+Sabroeauthor=A.+Hartnellauthor=L.+A.+Joplingauthor=S.+Belauthor=P.+D.+Ponathauthor=J.+E.+Peaseauthor=P.+D.+Collinsauthor=T.+J.+Williams&title=Differential+regulation+of+eosinophil+chemokine+signaling+via+CCR3+and+non-CCR3+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways</span></div><div class="casAuthors">Sabroe, Ian; Hartnell, Adele; Jopling, Louise A.; Bel, Sandra; Ponath, Paul D.; Pease, James E.; Collins, Paul D.; Williams, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2946-2955</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To investigate eosinophil stimulation by chemokines we developed a sensitive assay of leukocyte shape change, the gated autofluorescence/forward scatter assay.  Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation.  We examd. the actions of the chemokines eotaxin, eotaxin-2, monocyte chemoattractant protein-1 (MCP-1), MCP-3, MCP-4, RANTES, macrophage inflammatory protein-1Î± (MIP-1Î±), and IL-8 on leukocytes in mixed cell suspensions and focused on the responses of eosinophils to C-C chemokines.  Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.  Responses to MCP-4 were qual. different, showing marked reversal of shape change responses with agonist concn. and duration of treatment.  In contrast, MIP-1Î± induced a potent response in eosinophils from a small and previously undescribed subgroup of donors via a non-CCR3 pathway likely to be CCR1 mediated.  Incubation of leukocytes at 370C for 90 min in the absence of extracellular calcium up-regulated responses to MCP-4 and MIP-1Î± in the majority of donors, and there was a small increase in responses to eotaxin.  MIP-1Î± responsiveness in vivo may therefore be a function of both CCR1 expression levels and the regulated efficiency of coupling to intracellular signaling pathways.  The obsd. up-regulation of MIP-1Î± signaling via non-CCR3 pathways may play a role in eosinophil recruitment in inflammatory states such as occurs in the asthmatic lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCFIVxPlaQZ7Vg90H21EOLACvtfcHk0lgcTZc514pnSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlyis7w%253D&md5=5e51bfd041b76a8c8a761a07ee829342</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabroe%26aufirst%3DI.%26aulast%3DHartnell%26aufirst%3DA.%26aulast%3DJopling%26aufirst%3DL.%2BA.%26aulast%3DBel%26aufirst%3DS.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26aulast%3DCollins%26aufirst%3DP.%2BD.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26atitle%3DDifferential%2520regulation%2520of%2520eosinophil%2520chemokine%2520signaling%2520via%2520CCR3%2520and%2520non-CCR3%2520pathways%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D2946%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fretz, H.; Fecher, A.; Hilpert, K.; Riederer, M. A.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydropyridoindole Derivatives as CRTH2 Receptor Antagonists for the Treatment of Prostaglandin-Mediated Diseases</span> PCT Int. Appl. WO 2005095397 A1 20051013,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=H.+Fretz&author=A.+Fecher&author=K.+Hilpert&author=M.+A.+Riederer&title=Preparation+of+Tetrahydropyridoindole+Derivatives+as+CRTH2+Receptor+Antagonists+for+the+Treatment+of+Prostaglandin-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520Tetrahydropyridoindole%2520Derivatives%2520as%2520CRTH2%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Prostaglandin-Mediated%2520Diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eabhNbALj2O6bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eabhNbALj2O6bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Asafu-Adjaye, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faustino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawakkul, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, D. A.</span><span> </span><span class="NLM_article-title">Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">â</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2Fj.jpba.2006.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=17300896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVGgtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=1854-1859&author=E.+B.+Asafu-Adjayeauthor=P.+J.+Faustinoauthor=M.+A.+Tawakkulauthor=L.+W.+Andersonauthor=L.+X.+Yuauthor=H.+Kwonauthor=D.+A.+Volpe&title=Validation+and+application+of+a+stability-indicating+HPLC+method+for+the+in+vitro+determination+of+gastric+and+intestinal+stability+of+venlafaxine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine</span></div><div class="casAuthors">Asafu-Adjaye, Ebenezer B.; Faustino, Patrick J.; Tawakkul, Mobin A.; Anderson, Lawrence W.; Yu, Lawrence X.; Kwon, Hyojong; Volpe, Donna A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1854-1859</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gastrointestinal stability of venlafaxine was evaluated in vitro in simulated gastric (SGF) and intestinal (SIF) fluids using a stability indicating HPLC method.  The method was validated using a 5 Î¼m Ascentis C18 column (150 mm Ã 4.6 mm) and mobile phase consisting of 30% acetonitrile in 20 mM potassium phosphate buffer (pH 6.5) delivered isocratically at a flow rate of 1 mL/min with UV detection at 228 nm.  Venlafaxine in USP simulated gastric and intestinal fluids (0.4 mg/mL) was incubated at 37Â° in a shaking water bath.  The gastric stability study samples were assayed at 0, 15, 30, and 60 min intervals while sampling for the intestinal stability study was at 0, 1, 2, and 3 h.  System suitability detns. gave R.S.D.s of 0.68, 0.5 and 3.9% for retention factor (k'), peak area and tailing factor, resp.  The method was shown to be accurate, precise, specific, and linear over the anal. range.  Intra- and inter-day precision was <5.3%.  Forced degrdn. studies of drug substance in basic media at 70Â° as well as in H2O2 for 1 h and ultra-violet photostability studies at 255 and 365 nm for 24 h did not produce any detectable degrdn. products.  Forced degrdn. studies of drug substance in acidic media at 70Â° for 1 h produced the dehydro-venlafaxine degradant.  Venlafaxine was stable in SGF (pH â¼1.2) for the 1-h incubation period and in SIF (pH 6.8) up to 3 h with <1.5% relative difference (RD) between the amt. of drug added and that found for all time points.  This stability expt. in simulated gastric and intestinal fluids suggests that drug loss in the gastrointestinal tract takes place by membrane permeation rather than a degrdn. process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1gAxjbfWNRbVg90H21EOLACvtfcHk0lg9foaoN_CzQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVGgtbc%253D&md5=a2e3002ae107886c0a5e7c546ad12084</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DAsafu-Adjaye%26aufirst%3DE.%2BB.%26aulast%3DFaustino%26aufirst%3DP.%2BJ.%26aulast%3DTawakkul%26aufirst%3DM.%2BA.%26aulast%3DAnderson%26aufirst%3DL.%2BW.%26aulast%3DYu%26aufirst%3DL.%2BX.%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26atitle%3DValidation%2520and%2520application%2520of%2520a%2520stability-indicating%2520HPLC%2520method%2520for%2520the%2520in%2520vitro%2520determination%2520of%2520gastric%2520and%2520intestinal%2520stability%2520of%2520venlafaxine%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2007%26volume%3D43%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keldenich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schohe-Loop, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">In silico ADMET traffic lights as a tool for the prioritization of HTS hits</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">â</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1002%2Fcmdc.200600168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=16991174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVClsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1229-1236&author=M.+Lobellauthor=M.+Hendrixauthor=B.+Hinzenauthor=J.+Keldenichauthor=H.+Meierauthor=C.+Schmeckauthor=R.+Schohe-Loopauthor=T.+Wunbergauthor=A.+Hillisch&title=In+silico+ADMET+traffic+lights+as+a+tool+for+the+prioritization+of+HTS+hits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">In silico ADMET traffic lights as a tool for the prioritization of HTS hits</span></div><div class="casAuthors">Lobell, Mario; Hendrix, Martin; Hinzen, Berthold; Keldenich, Joerg; Meier, Heinrich; Schmeck, Carsten; Schohe-Loop, Rudolf; Wunberg, Tobias; Hillisch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1229-1236</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The need for in silico characterization of HTS hit structures as part of a data-driven hit-selection process is demonstrated.  A soln. is described in the form of an in silicon ADMET traffic light and PhysChem scoring system.  This has been extensively validated with inhouse data at Bayer, published data, and a collection of launched small-mol. oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrg56R2ER5WrVg90H21EOLACvtfcHk0lg9foaoN_CzQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVClsb8%253D&md5=00d7c6b4d215d12873caa2809a4dbe56</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600168%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DHinzen%26aufirst%3DB.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DH.%26aulast%3DSchmeck%26aufirst%3DC.%26aulast%3DSchohe-Loop%26aufirst%3DR.%26aulast%3DWunberg%26aufirst%3DT.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DIn%2520silico%2520ADMET%2520traffic%2520lights%2520as%2520a%2520tool%2520for%2520the%2520prioritization%2520of%2520HTS%2520hits%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D1229%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tanimoto, N.; Hiramatsu, Y.; Mitsumori, S.; Inagaki, M.</span>, <span> </span><span class="NLM_article-title">Preparation of Indole Derivatives as PGD2 Receptor Antagonists</span>. PCT Int. Appl. WO 2003097598 A1 20031127,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=N.+Tanimoto&author=Y.+Hiramatsu&author=S.+Mitsumori&author=M.+Inagaki&title=Preparation+of+Indole+Derivatives+as+PGD2+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTanimoto%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Indole%2520Derivatives%2520as%2520PGD2%2520Receptor%2520Antagonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ruediger, E. H.; Deon, D., H.; Kadow, J. F.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydrocarbolines for Treatment of HIV Infection and AIDS</span>. U.S. Pat. Appl. Publ. US 20050267130 A1 20051201,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+H.+Ruediger&author=D.%2C+H.+Deon&author=J.+F.+Kadow&title=Preparation+of+Tetrahydrocarbolines+for+Treatment+of+HIV+Infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuediger%26aufirst%3DE.%2BH.%26atitle%3DPreparation%2520of%2520Tetrahydrocarbolines%2520for%2520Treatment%2520of%2520HIV%2520Infection%2520and%2520AIDS%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Bonjoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaba, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, C.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4299</span><span class="NLM_x">â</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4299-4302&author=J.+Bonjochauthor=F.+Diabaauthor=L.+Pagesauthor=D.+Perezauthor=L.+Socaauthor=M.+Miralpeixauthor=D.+Vilellaauthor=P.+Antonauthor=C.+Puig&title=Synthesis+and+structure%E2%80%93activity+relationships+of+gamma-carboline+derivatives+as+potent+and+selective+cysLT%281%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonjoch%26aufirst%3DJ.%26aulast%3DDiaba%26aufirst%3DF.%26aulast%3DPages%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DSoca%26aufirst%3DL.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DAnton%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520gamma-carboline%2520derivatives%2520as%2520potent%2520and%2520selective%2520cysLT%25281%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4299%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ivashchenko, A. A.; Ivashchenko, A. V.; Tkachenko, S. Y.; Okun, I. M.; Savchuk, N. F.; Mitkin, O. D.; Kravchenko, D. V.</span><span> </span><span class="NLM_article-title">Substituted 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as Novel Antihistaminic Agents and Processes for Preparation Thereof</span>. PCT Int. Appl. WO 2008115098 A2 20080925,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+A.+Ivashchenko&author=A.+V.+Ivashchenko&author=S.+Y.+Tkachenko&author=I.+M.+Okun&author=N.+F.+Savchuk&author=O.+D.+Mitkin&author=D.+V.+Kravchenko&title=Substituted+2%2C3%2C4%2C5-Tetrahydro-1H-pyrido%5B4%2C3-b%5Dindoles+as+Novel+Antihistaminic+Agents+and+Processes+for+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIvashchenko%26aufirst%3DA.%2BA.%26atitle%3DSubstituted%25202%252C3%252C4%252C5-Tetrahydro-1H-pyrido%255B4%252C3-b%255Dindoles%2520as%2520Novel%2520Antihistaminic%2520Agents%2520and%2520Processes%2520for%2520Preparation%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ivashchenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitâkin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisil, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolov, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachenko, S. E.</span> <span class="citation_source-journal">Izv. Vyssh. Uchebn. Zaved., Khim. Khim. Tekhnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ivashchenko%2C+A.+V.%3B+Mit%E2%80%99kin%2C+O.+D.%3B+Kisil%2C+V.+M.%3B+Frolov%2C+E.+B.%3B+Tkachenko%2C+S.+E.Izv.+Vyssh.+Uchebn.+Zaved.%2C+Khim.+Khim.+Tekhnol.+2009%2C+52%2C+78%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIvashchenko%26aufirst%3DA.%2BV.%26aulast%3DMit%25E2%2580%2599kin%26aufirst%3DO.%2BD.%26aulast%3DKisil%26aufirst%3DV.%2BM.%26aulast%3DFrolov%26aufirst%3DE.%2BB.%26aulast%3DTkachenko%26aufirst%3DS.%2BE.%26jtitle%3DIzv.%2520Vyssh.%2520Uchebn.%2520Zaved.%252C%2520Khim.%2520Khim.%2520Tekhnol.%26date%3D2009%26volume%3D52%26spage%3D78%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayaishi, O.</span><span> </span><span class="NLM_article-title">Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">13570</span><span class="NLM_x">â</span> <span class="NLM_lpage">13575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=13570-13575&author=T.+Shimizuauthor=A.+Yamashitaauthor=O.+Hayaishi&title=Specific+binding+of+prostaglandin+D2+to+rat+brain+synaptic+membrane.+Occurrence%2C+properties%2C+and+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DSpecific%2520binding%2520of%2520prostaglandin%2520D2%2520to%2520rat%2520brain%2520synaptic%2520membrane.%2520Occurrence%252C%2520properties%252C%2520and%2520distribution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D13570%26epage%3D13575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Fortini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modesti, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gensini, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri Serneri, G. G.</span><span> </span><span class="NLM_article-title">Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">â</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2F0049-3848%2885%2990267-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=3001968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaL28XivVKgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1985&pages=319-328&author=A.+Fortiniauthor=P.+A.+Modestiauthor=R.+Abbateauthor=G.+F.+Gensiniauthor=G.+G.+Neri+Serneri&title=Heparin+does+not+interfere+with+prostacyclin+and+prostaglandin+D2+binding+to+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets</span></div><div class="casAuthors">Fortini, A.; Modesti, P. A.; Abbate, R.; Gensini, G. F.; Serneri, G. G. Neri</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-28</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">The no. and the affinity of binding sites for PGI2  [35121-78-9] and PGD2  [41598-07-6] were detd. in healthy subjects in the absence and in the presence of heparin  [9005-49-6].  Preliminary aggregation tests indicated that the heparin concn. tested (2 IU/mL) reduced the antiaggregating activity of PGI2 and PGD2.  Heparin, when preincubated with platelet suspension, did not induce any significant change in the no. per platelet or affinity (Kd) of PGI2 and PGD2 binding sites in comparison to control values.  Also, no significant binding modification was obsd. when heparin was preincubated with [3H]-PGI2 and [3H]-PGD2.  Apparently, heparin reduces the antiaggregating effects of PGI2 and PGD2 by directly potentiating platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi_QMvysJYibVg90H21EOLACvtfcHk0lhYxodoa8fLwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XivVKgtA%253D%253D&md5=93bb24a3955d66f6ddb6acfa5dceac16</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0049-3848%2885%2990267-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0049-3848%252885%252990267-1%26sid%3Dliteratum%253Aachs%26aulast%3DFortini%26aufirst%3DA.%26aulast%3DModesti%26aufirst%3DP.%2BA.%26aulast%3DAbbate%26aufirst%3DR.%26aulast%3DGensini%26aufirst%3DG.%2BF.%26aulast%3DNeri%2BSerneri%26aufirst%3DG.%2BG.%26atitle%3DHeparin%2520does%2520not%2520interfere%2520with%2520prostacyclin%2520and%2520prostaglandin%2520D2%2520binding%2520to%2520platelets%26jtitle%3DThromb.%2520Res.%26date%3D1985%26volume%3D40%26spage%3D319%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervais, F. G.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1038%2Fsj.bjp.0704973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=12466225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlSj" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=1163-1172&author=N.+Sawyerauthor=E.+Cauchonauthor=A.+Chateauneufauthor=R.+P.+Cruzauthor=D.+W.+Nicholsonauthor=K.+M.+Mettersauthor=G.+P.+O%E2%80%99Neillauthor=F.+G.+Gervais&title=Molecular+pharmacology+of+the+human+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2</span></div><div class="casAuthors">Sawyer, Nicole; Cauchon, Elizabeth; Chateauneuf, Anne; Cruz, Rani P. G.; Nicholson, Donald W.; Metters, Kathleen M.; O'Neill, Gary P.; Gervais, Francois G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1163-1172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The recombinant human prostaglandin D2 (PGD2) receptor, hCRTH2, has been expressed in HEK293(EBNA) and characterized with respect to radioligand binding and signal transduction properties.  High and low affinity binding sites for PGD2 were identified in the CRTH2 receptor population by satn. anal. with resp. equil. dissocn. consts. (KD) of 2.5 and 109 nM.  This revealed that the affinity of PGD2 for CRTH2 is eight times less than its affinity for the DP receptor.  Equil. competition binding assays revealed that of the compds. tested, only PGD2 and several related metabolites bound with high affinity to CRTH2 (Ki values ranging from 2.4 to 34.0 nM) with the following rank order of potency: PGD2 > 13,14-dihydro-15-keto PGD2 > 15-deoxy-Î12,14-PGJ2 > PGJ2 > Î12-PGJ2 > 15(S)-15-methyl-PGD2.  This is in sharp contrast with the rank order of potency obtained at DP: PGD2 > PGJ2 > Î12-PGJ2 > 15-deoxy-Î12,14-PGJ2 >>> 13,14-dihydro-15-keto-PGD2.  Functional studies demonstrated that PGD2 activation of recombinant CRTH2 results in decrease of intracellular cAMP in a pertussis toxin-sensitive manner.  Therefore, the authors showed that CRTH2 can functionally couple to the G-protein GÎ±i/o.  PGD2 and related metabolites were tested and their rank order of potency followed the results of the membrane binding assay.  By Northern blot anal., the authors showed that, besides hemopoietic cells, CRTH2 is expressed in many other tissues such as brain, heart, thymus, spleen and various tissues of the digestive system.  In addn., in situ hybridization studies revealed that CRTH2 mRNA is expressed in human eosinophils.  Finally, radioligand binding studies demonstrated that two eosinophilic cell lines, butyric acid-differentiated HL-60 and AML 14.3D10, also endogenously express CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV1pbS5yK7J7Vg90H21EOLACvtfcHk0lhSob3rHAsCNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlSj&md5=592b7cf5a686d37df38a4f5a19fb0255</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704973%26sid%3Dliteratum%253Aachs%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DCauchon%26aufirst%3DE.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DCruz%26aufirst%3DR.%2BP.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DGervais%26aufirst%3DF.%2BG.%26atitle%3DMolecular%2520pharmacology%2520of%2520the%2520human%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D1163%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Fan Xiao, Shi-Ming Xu, Xiu-Qin Dong, <span class="NLM_string-name hlFld-ContribAuthor">Chun-Jiang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Ir-Catalyzed Asymmetric Tandem Allylation/Iso-PictetâSpengler Cyclization Reaction for the Enantioselective Construction of Tetrahydro-Î³-carbolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 706-710. <a href="https://doi.org/10.1021/acs.orglett.0c03909" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03909%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIr-Catalyzed%252BAsymmetric%252BTandem%252BAllylation%25252FIso-Pictet%2525E2%252580%252593Spengler%252BCyclization%252BReaction%252Bfor%252Bthe%252BEnantioselective%252BConstruction%252Bof%252BTetrahydro-%2525CE%2525B3-carbolines%26aulast%3DXiao%26aufirst%3DFan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D11012021%26volume%3D23%26issue%3D3%26spage%3D706%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Karuppu Selvaraj, <span class="NLM_string-name hlFld-ContribAuthor">K. C. Kumara Swamy</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free, BrÃ¸nsted Acid-Mediated Cascade Sequence in the Reaction of Propargyl Alcohols with Sulfonamido-indoles/-indolines: Highly Substituted Î´- and Î±-Carbolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (24)
                                     , 15043-15056. <a href="https://doi.org/10.1021/acs.joc.8b02293" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02293%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition-Metal-Free%25252C%252BBr%2525C3%2525B8nsted%252BAcid-Mediated%252BCascade%252BSequence%252Bin%252Bthe%252BReaction%252Bof%252BPropargyl%252BAlcohols%252Bwith%252BSulfonamido-indoles%25252F-indolines%25253A%252BHighly%252BSubstituted%252B%2525CE%2525B4-%252Band%252B%2525CE%2525B1-Carbolines%26aulast%3DSelvaraj%26aufirst%3DKaruppu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05092018%26date%3D04122018%26date%3D19112018%26volume%3D83%26issue%3D24%26spage%3D15043%26epage%3D15056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wu-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Jing  Qin</span>, <span class="hlFld-ContribAuthor ">Fei-Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Xingxin  Yu</span>, and <span class="hlFld-ContribAuthor ">Wei-Ping  Deng</span>  . </span><span class="cited-content_cbyCitation_article-title">Cu(I)-Catalyzed Chemoselective and Stereoselective [3 + 3] Cycloaddition of Azomethine Ylides with 2-Indolylnitroethylenes: Facile Access to Highly Substituted Tetrahydro-Î³-Carbolines. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , 5685-5690. <a href="https://doi.org/10.1021/acscatal.6b01596" title="DOI URL">https://doi.org/10.1021/acscatal.6b01596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b01596%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCu%252528I%252529-Catalyzed%252BChemoselective%252Band%252BStereoselective%252B%25255B3%252B%25252B%252B3%25255D%252BCycloaddition%252Bof%252BAzomethine%252BYlides%252Bwith%252B2-Indolylnitroethylenes%25253A%252BFacile%252BAccess%252Bto%252BHighly%252BSubstituted%252BTetrahydro-%2525CE%2525B3-Carbolines%26aulast%3DYang%26aufirst%3DWu-Lin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07062016%26date%3D26072016%26date%3D01082016%26date%3D02092016%26date%3D27072016%26volume%3D6%26issue%3D9%26spage%3D5685%26epage%3D5690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">JosÃ© Luis  AceÃ±a</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase IIâIII Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Risch</span>, <span class="hlFld-ContribAuthor ">Thomas  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Jerome  Segrestaa</span>, <span class="hlFld-ContribAuthor ">Heinz  Fretz</span>, and <span class="hlFld-ContribAuthor ">Julien  Pothier</span>  . </span><span class="cited-content_cbyCitation_article-title">Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8011-8035. <a href="https://doi.org/10.1021/acs.jmedchem.5b00824" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00824</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00824%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVerification%252Bof%252Bthe%252BMajor%252BMetabolic%252BOxidation%252BPath%252Bfor%252Bthe%252BNaphthoyl%252BGroup%252Bin%252BChemoattractant%252BReceptor-Homologous%252BMolecule%252BExpressed%252Bon%252BTh2%252BCells%252B%252528CRTh2%252529%252BAntagonist%252B2-%2525282-%2525281-Naphthoyl%252529-8-fluoro-3%25252C4-dihydro-1H-pyrido%25255B4%25252C3-b%25255Dindol-5%2525282H%252529-yl%252529acetic%252BAcid%252B%252528Setipiprant%25252FACT-129968%252529%26aulast%3DRisch%26aufirst%3DPhilippe%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29052015%26date%3D02102015%26date%3D22102015%26date%3D23092015%26volume%3D58%26issue%3D20%26spage%3D8011%26epage%3D8035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Bruce  Follows</span>, <span class="hlFld-ContribAuthor ">Louis  Leung</span>, <span class="hlFld-ContribAuthor ">Jennifer  Thomason</span>, <span class="hlFld-ContribAuthor ">Adrian  Huang</span>, <span class="hlFld-ContribAuthor ">Alessandro  Moretto</span>, <span class="hlFld-ContribAuthor ">Kristin  Janz</span>, <span class="hlFld-ContribAuthor ">Michael  Lowe</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Cedric  Hubeau</span>, <span class="hlFld-ContribAuthor ">Karen  Page</span>, <span class="hlFld-ContribAuthor ">Paul  Morgan</span>, <span class="hlFld-ContribAuthor ">Susan  Fish</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Cara  Williams</span>, and <span class="hlFld-ContribAuthor ">Eddine  Saiah</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1299-1322. <a href="https://doi.org/10.1021/jm401509e" title="DOI URL">https://doi.org/10.1021/jm401509e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401509e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401509e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIsoquinolinone%252BIndole%252BAcetic%252BAcids%252Bas%252BAntagonists%252Bof%252BChemoattractant%252BReceptor%252BHomologous%252BMolecule%252BExpressed%252Bon%252BTh2%252BCells%252B%252528CRTH2%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAllergic%252BInflammatory%252BDiseases%26aulast%3DKaila%26aufirst%3DNeelu%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27092013%26date%3D10022014%26date%3D27022014%26volume%3D57%26issue%3D4%26spage%3D1299%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liudmila L.  Mazaleuskaya</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ricciotti</span>. </span><span class="cited-content_cbyCitation_article-title">Eicosanoid Pathway Modulators: Prostaglandins, Prostacyclin, and Thromboxane. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-54. <a href="https://doi.org/10.1002/0471266949.bmc284" title="DOI URL">https://doi.org/10.1002/0471266949.bmc284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc284%26sid%3Dliteratum%253Aachs%26atitle%3DEicosanoid%252BPathway%252BModulators%25253A%252BProstaglandins%25252C%252BProstacyclin%25252C%252Band%252BThromboxane%26aulast%3DMazaleuskaya%26aufirst%3DLiudmila%2BL.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D54%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristofer  Pezzetta</span>, <span class="hlFld-ContribAuthor ">Andrea  Folli</span>, <span class="hlFld-ContribAuthor ">Oliwia  Matuszewska</span>, <span class="hlFld-ContribAuthor ">Damien  Murphy</span>, <span class="hlFld-ContribAuthor ">Robert W. M.  Davidson</span>, <span class="hlFld-ContribAuthor ">Davide  Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">peri
              âXanthenoxanthene (PXX): a Versatile Organic Photocatalyst in Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>77 </em><a href="https://doi.org/10.1002/adsc.202100030" title="DOI URL">https://doi.org/10.1002/adsc.202100030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100030%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3Dperi%252B%2525E2%252580%252590Xanthenoxanthene%252B%252528PXX%252529%25253A%252Ba%252BVersatile%252BOrganic%252BPhotocatalyst%252Bin%252BOrganic%252BSynthesis%26aulast%3DPezzetta%26aufirst%3DCristofer%26date%3D2021%26date%3D2021%26volume%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina A.  Huang</span>, <span class="hlFld-ContribAuthor ">Kelly X.  Huang</span>, <span class="hlFld-ContribAuthor ">Jui  Tu</span>, <span class="hlFld-ContribAuthor ">Fouad  Kandeel</span>, <span class="hlFld-ContribAuthor ">Junfeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Ramatroban-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1433. <a href="https://doi.org/10.3390/molecules26051433" title="DOI URL">https://doi.org/10.3390/molecules26051433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051433%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRamatroban-Based%252BAnalogues%252BContaining%252BFluorine%252BGroup%252Bas%252BPotential%252B18F-Labeled%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BG-Protein%252BCoupled%252BReceptor%252B44%252B%252528GPR44%252529%252BTracers%26aulast%3DHuang%26aufirst%3DLina%2BA.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepa S.  Mandlik</span>, <span class="hlFld-ContribAuthor ">Satish K.  Mandlik</span>. </span><span class="cited-content_cbyCitation_article-title">New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. </span><span class="cited-content_cbyCitation_journal-name">Immunopharmacology and Immunotoxicology</span><span> <strong>2020,</strong> <em>42 </em>
                                    (6)
                                     , 521-544. <a href="https://doi.org/10.1080/08923973.2020.1824238" title="DOI URL">https://doi.org/10.1080/08923973.2020.1824238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08923973.2020.1824238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08923973.2020.1824238%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunopharmacology%2520and%2520Immunotoxicology%26atitle%3DNew%252Bperspectives%252Bin%252Bbronchial%252Basthma%25253A%252Bpathological%25252C%252Bimmunological%252Balterations%25252C%252Bbiological%252Btargets%25252C%252Band%252Bpharmacotherapy%26aulast%3DMandlik%26aufirst%3DDeepa%2BS.%26date%3D2020%26date%3D2020%26volume%3D42%26issue%3D6%26spage%3D521%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liudmila L.  Mazaleuskaya</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ricciotti</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Prostanoid Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 29-54. <a href="https://doi.org/10.1007/978-3-030-50621-6_3" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_3%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BProstanoid%252BPathway%26aulast%3DMazaleuskaya%26aufirst%3DLiudmila%2BL.%26date%3D2020%26date%3D2020%26spage%3D29%26epage%3D54%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stacy Gelhaus  Wendell</span>, <span class="hlFld-ContribAuthor ">Hao  Fan</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhang</span>, . </span><span class="cited-content_cbyCitation_article-title">G ProteinâCoupled Receptors in Asthma Therapy: Pharmacology and Drug Action. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2020,</strong> <em>72 </em>
                                    (1)
                                     , 1-49. <a href="https://doi.org/10.1124/pr.118.016899" title="DOI URL">https://doi.org/10.1124/pr.118.016899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.016899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.016899%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DG%252BProtein%2525E2%252580%252593Coupled%252BReceptors%252Bin%252BAsthma%252BTherapy%25253A%252BPharmacology%252Band%252BDrug%252BAction%26aulast%3DWendell%26aufirst%3DStacy%2BGelhaus%26date%3D2020%26date%3D2019%26volume%3D72%26issue%3D1%26spage%3D1%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Liang  Wei</span>, <span class="hlFld-ContribAuthor ">Chong  Shen</span>, <span class="hlFld-ContribAuthor ">Lu  Xiao</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Tao</span>, <span class="hlFld-ContribAuthor ">Chun-Jiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Stereodivergent assembly of tetrahydro-Î³-carbolines via synergistic catalytic asymmetric cascade reaction. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-13529-z" title="DOI URL">https://doi.org/10.1038/s41467-019-13529-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-13529-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-13529-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStereodivergent%252Bassembly%252Bof%252Btetrahydro-%2525CE%2525B3-carbolines%252Bvia%252Bsynergistic%252Bcatalytic%252Basymmetric%252Bcascade%252Breaction%26aulast%3DXu%26aufirst%3DShi-Ming%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Zi  Liu</span>, <span class="hlFld-ContribAuthor ">Shao-Jing  Shang</span>, <span class="hlFld-ContribAuthor ">Jing-Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Wu-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective and Stereoselective [3+3] Annulation of Ketones Derived Azomethine Ylides with 2-Indolylethylenes: Direct Access to Highly Substituted Tetrahydro-Î³-Carbolines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (11)
                                     , 2191-2203. <a href="https://doi.org/10.1002/adsc.201800274" title="DOI URL">https://doi.org/10.1002/adsc.201800274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800274%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRegioselective%252Band%252BStereoselective%252B%25255B3%25252B3%25255D%252BAnnulation%252Bof%252BKetones%252BDerived%252BAzomethine%252BYlides%252Bwith%252B2-Indolylethylenes%25253A%252BDirect%252BAccess%252Bto%252BHighly%252BSubstituted%252BTetrahydro-%2525CE%2525B3-Carbolines%26aulast%3DLiu%26aufirst%3DYang-Zi%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D11%26spage%3D2191%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Jana  Ballekova</span>, <span class="hlFld-ContribAuthor ">Marta  Prnova</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6353-6360. <a href="https://doi.org/10.1016/j.bmc.2017.10.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Boptimization%252Bof%252Btetrahydropyridoindole-based%252Baldose%252Breductase%252Binhibitors%252Bimproved%252Btheir%252Befficacy%252Band%252Bselectivity%26aulast%3DMajekova%26aufirst%3DMagdalena%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6353%26epage%3D6360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Ratner</span>, <span class="hlFld-ContribAuthor ">Charles P.  Andrews</span>, <span class="hlFld-ContribAuthor ">Frank C.  Hampel</span>, <span class="hlFld-ContribAuthor ">Bruce  Martin</span>, <span class="hlFld-ContribAuthor ">Dale E.  Mohar</span>, <span class="hlFld-ContribAuthor ">Denis  Bourrelly</span>, <span class="hlFld-ContribAuthor ">Parisa  Danaietash</span>, <span class="hlFld-ContribAuthor ">Sara  Mangialaio</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Abdel  Hmissi</span>, <span class="hlFld-ContribAuthor ">Jay  van Bavel</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. </span><span class="cited-content_cbyCitation_journal-name">Allergy, Asthma & Clinical Immunology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13223-017-0183-z" title="DOI URL">https://doi.org/10.1186/s13223-017-0183-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13223-017-0183-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13223-017-0183-z%26sid%3Dliteratum%253Aachs%26jtitle%3DAllergy%252C%2520Asthma%2520%2526%2520Clinical%2520Immunology%26atitle%3DEfficacy%252Band%252Bsafety%252Bof%252Bsetipiprant%252Bin%252Bseasonal%252Ballergic%252Brhinitis%25253A%252Bresults%252Bfrom%252BPhase%252B2%252Band%252BPhase%252B3%252Brandomized%25252C%252Bdouble-blind%25252C%252Bplacebo-%252Band%252Bactive-referenced%252Bstudies%26aulast%3DRatner%26aufirst%3DPaul%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  BALLEKOVA</span>, <span class="hlFld-ContribAuthor ">M.  SOLTESOVA-PRNOVA</span>, <span class="hlFld-ContribAuthor ">M.  MAJEKOVA</span>, <span class="hlFld-ContribAuthor ">M.  STEFEK</span>. </span><span class="cited-content_cbyCitation_article-title">Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?. </span><span class="cited-content_cbyCitation_journal-name">Physiological Research</span><span> <strong>2017,</strong> <em> </em>, 687-693. <a href="https://doi.org/10.33549/physiolres.933516" title="DOI URL">https://doi.org/10.33549/physiolres.933516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.33549/physiolres.933516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.33549%2Fphysiolres.933516%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Research%26atitle%3DDoes%252BInhibition%252Bof%252BAldose%252BReductase%252BContribute%252Bto%252Bthe%252BAnti-Inflammatory%252BAction%252Bof%252BSetipiprant%25253F%26aulast%3DBALLEKOVA%26aufirst%3DJ.%26date%3D2017%26date%3D2017%26spage%3D687%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tang-Hao  Yang</span>, <span class="hlFld-ContribAuthor ">Chun-Wei  Kuo</span>, <span class="hlFld-ContribAuthor ">Veerababurao  Kavala</span>, <span class="hlFld-ContribAuthor ">Ashok  Konala</span>, <span class="hlFld-ContribAuthor ">Chia-Yu  Huang</span>, <span class="hlFld-ContribAuthor ">Ching-Fa  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective switching approach for the synthesis of Î± and Î´ carboline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (10)
                                     , 1676-1679. <a href="https://doi.org/10.1039/C6CC09468F" title="DOI URL">https://doi.org/10.1039/C6CC09468F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC09468F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC09468F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRegioselective%252Bswitching%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252B%2525CE%2525B1%252Band%252B%2525CE%2525B4%252Bcarboline%252Bderivatives%26aulast%3DYang%26aufirst%3DTang-Hao%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D10%26spage%3D1676%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jatinder  Singh</span>, <span class="hlFld-ContribAuthor ">Ramanpreet  Shah</span>, <span class="hlFld-ContribAuthor ">Dhandeep  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2016,</strong> <em>40 </em>, 362-384. <a href="https://doi.org/10.1016/j.intimp.2016.09.019" title="DOI URL">https://doi.org/10.1016/j.intimp.2016.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2016.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2016.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DTargeting%252Bmast%252Bcells%25253A%252BUncovering%252Bprolific%252Btherapeutic%252Brole%252Bin%252Bmyriad%252Bdiseases%26aulast%3DSingh%26aufirst%3DJatinder%26date%3D2016%26volume%3D40%26spage%3D362%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Santini</span>, <span class="hlFld-ContribAuthor ">Nadia  Mores</span>, <span class="hlFld-ContribAuthor ">Mario  Malerba</span>, <span class="hlFld-ContribAuthor ">Chiara  Mondino</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Macis</span>, <span class="hlFld-ContribAuthor ">Paolo  Montuschi</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational prostaglandin D
              2
              receptor antagonists for airway inflammation. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (6)
                                     , 639-652. <a href="https://doi.org/10.1080/13543784.2016.1175434" title="DOI URL">https://doi.org/10.1080/13543784.2016.1175434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2016.1175434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2016.1175434%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bprostaglandin%252BD%252B2%252Breceptor%252Bantagonists%252Bfor%252Bairway%252Binflammation%26aulast%3DSantini%26aufirst%3DGiuseppe%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D6%26spage%3D639%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Boumediene</span>, <span class="hlFld-ContribAuthor ">RaphaÃ«l F.  Guignard</span>, <span class="hlFld-ContribAuthor ">Samir Z.  Zard</span>. </span><span class="cited-content_cbyCitation_article-title">Methoxycarbonyl migration in 3-methylene-1,4-cyclohexadienes. An extension of the von Auwers rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (26)
                                     , 3678-3686. <a href="https://doi.org/10.1016/j.tet.2016.03.032" title="DOI URL">https://doi.org/10.1016/j.tet.2016.03.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.03.032%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMethoxycarbonyl%252Bmigration%252Bin%252B3-methylene-1%25252C4-cyclohexadienes.%252BAn%252Bextension%252Bof%252Bthe%252Bvon%252BAuwers%252Brearrangement%26aulast%3DBoumediene%26aufirst%3DMehdi%26date%3D2016%26volume%3D72%26issue%3D26%26spage%3D3678%26epage%3D3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Santhosh Kumar  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Sung Haeng  Lee</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Structural characterization of human CRTh2: a combined homology modeling, molecular docking and 3D-QSAR-based in silico approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (4)
                                     , 653-671. <a href="https://doi.org/10.1007/s00044-016-1516-z" title="DOI URL">https://doi.org/10.1007/s00044-016-1516-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1516-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1516-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructural%252Bcharacterization%252Bof%252Bhuman%252BCRTh2%25253A%252Ba%252Bcombined%252Bhomology%252Bmodeling%25252C%252Bmolecular%252Bdocking%252Band%252B3D-QSAR-based%252Bin%252Bsilico%252Bapproach%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D4%26spage%3D653%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonu  Kumar</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Saunthwal</span>, <span class="hlFld-ContribAuthor ">Trapti  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Siva K. Reddy  Kotla</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium meets copper: one-pot tandem synthesis of pyrido fused heterocycles via Sonogashira conjoined electrophilic cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (38)
                                     , 9063-9071. <a href="https://doi.org/10.1039/C6OB01539E" title="DOI URL">https://doi.org/10.1039/C6OB01539E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01539E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01539E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium%252Bmeets%252Bcopper%25253A%252Bone-pot%252Btandem%252Bsynthesis%252Bof%252Bpyrido%252Bfused%252Bheterocycles%252Bvia%252BSonogashira%252Bconjoined%252Belectrophilic%252Bcyclization%26aulast%3DKumar%26aufirst%3DSonu%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D38%26spage%3D9063%26epage%3D9071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Seema A.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Honglae  Sohn</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of leads through in silico approaches utilizing benzylthio-1H-benzo[d]imidazol-1-yl acetic acid derivatives: A potent CRTh2 antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2015,</strong> <em>1102 </em>, 25-41. <a href="https://doi.org/10.1016/j.molstruc.2015.08.031" title="DOI URL">https://doi.org/10.1016/j.molstruc.2015.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2015.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIdentification%252Bof%252Bleads%252Bthrough%252Bin%252Bsilico%252Bapproaches%252Butilizing%252Bbenzylthio-1H-benzo%25255Bd%25255Dimidazol-1-yl%252Bacetic%252Bacid%252Bderivatives%25253A%252BA%252Bpotent%252BCRTh2%252Bantagonist%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2015%26volume%3D1102%26spage%3D25%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martine  Gehin</span>, <span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">Carmela  Gnerre</span>, <span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Atef  Halabi</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Clinical Pharmacology</span><span> <strong>2015,</strong> <em>71 </em>
                                    (1)
                                     , 15-23. <a href="https://doi.org/10.1007/s00228-014-1767-x" title="DOI URL">https://doi.org/10.1007/s00228-014-1767-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00228-014-1767-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00228-014-1767-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DPharmacokinetic%252Binteractions%252Bbetween%252Bsimvastatin%252Band%252Bsetipiprant%25252C%252Ba%252BCRTH2%252Bantagonist%26aulast%3DGehin%26aufirst%3DMartine%26date%3D2015%26date%3D2014%26volume%3D71%26issue%3D1%26spage%3D15%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">Zuzana  Diamant</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects. </span><span class="cited-content_cbyCitation_journal-name">Fundamental & Clinical Pharmacology</span><span> <strong>2014,</strong> <em>28 </em>
                                    (6)
                                     , 690-699. <a href="https://doi.org/10.1111/fcp.12079" title="DOI URL">https://doi.org/10.1111/fcp.12079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/fcp.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffcp.12079%26sid%3Dliteratum%253Aachs%26jtitle%3DFundamental%2520%2526%2520Clinical%2520Pharmacology%26atitle%3DSingle-%252Band%252Bmultiple-dose%252Btolerability%252Band%252Bpharmacokinetics%252Bof%252Bthe%252BCRTH2%252Bantagonist%252Bsetipiprant%252Bin%252Bhealthy%252Bmale%252Bsubjects%26aulast%3DSidharta%26aufirst%3DPatricia%2BN.%26date%3D2014%26date%3D2014%26volume%3D28%26issue%3D6%26spage%3D690%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Diamant</span>, <span class="hlFld-ContribAuthor ">P. N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">D.  Singh</span>, <span class="hlFld-ContribAuthor ">B. J.  O'Connor</span>, <span class="hlFld-ContribAuthor ">R.  Zuiker</span>, <span class="hlFld-ContribAuthor ">B. R.  Leaker</span>, <span class="hlFld-ContribAuthor ">M.  Silkey</span>, <span class="hlFld-ContribAuthor ">J.  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics. </span><span class="cited-content_cbyCitation_journal-name">Clinical & Experimental Allergy</span><span> <strong>2014,</strong> <em>44 </em>
                                    (8)
                                     , 1044-1052. <a href="https://doi.org/10.1111/cea.12357" title="DOI URL">https://doi.org/10.1111/cea.12357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cea.12357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcea.12357%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520%2526%2520Experimental%2520Allergy%26atitle%3DSetipiprant%25252C%252Ba%252Bselective%252BCRTH2%252Bantagonist%25252C%252Breduces%252Ballergen-induced%252Bairway%252Bresponses%252Bin%252Ballergic%252Basthmatics%26aulast%3DDiamant%26aufirst%3DZ.%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D8%26spage%3D1044%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamee  Castillo</span>, <span class="hlFld-ContribAuthor ">Vesselin  Dimov</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs for the treatment of allergic rhinitis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (6)
                                     , 823-836. <a href="https://doi.org/10.1517/13543784.2014.907271" title="DOI URL">https://doi.org/10.1517/13543784.2014.907271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.907271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.907271%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Ballergic%252Brhinitis%26aulast%3DCastillo%26aufirst%3DJamee%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D6%26spage%3D823%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuya  Yokosaka</span>, <span class="hlFld-ContribAuthor ">Tomoya  Kanehira</span>, <span class="hlFld-ContribAuthor ">Hiroki  Nakayama</span>, <span class="hlFld-ContribAuthor ">Tetsuhiro  Nemoto</span>, <span class="hlFld-ContribAuthor ">Yasumasa  Hamada</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of fused-tricyclic indole derivatives through an acid-promoted skeletal rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (12)
                                     , 2151-2160. <a href="https://doi.org/10.1016/j.tet.2014.01.074" title="DOI URL">https://doi.org/10.1016/j.tet.2014.01.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.01.074%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bfused-tricyclic%252Bindole%252Bderivatives%252Bthrough%252Ban%252Bacid-promoted%252Bskeletal%252Brearrangement%26aulast%3DYokosaka%26aufirst%3DTakuya%26date%3D2014%26volume%3D70%26issue%3D12%26spage%3D2151%26epage%3D2160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (1)
                                     , 55-66. <a href="https://doi.org/10.1517/13543784.2013.839658" title="DOI URL">https://doi.org/10.1517/13543784.2013.839658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.839658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.839658%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DUpdate%252Bon%252Bthe%252Bstatus%252Bof%252BDP2%252Breceptor%252Bantagonists%25253B%252Bfrom%252Bproof%252Bof%252Bconcept%252Bthrough%252Bclinical%252Bfailures%252Bto%252Bpromising%252Bnew%252Bdrugs%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D1%26spage%3D55%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structure of Endogenous CRTh2 Agonist PGD<sub>2</sub> (<b>1</b>), Partial Agonist Indomethacin (<b>2</b>), Antagonist Ramatroban (<b>3</b>), Primary Screening Hit <b>4</b>, Lead Compound <b>5</b>, and Clinical Development Candidate Setipiprant/ACT-129968 (<b>28</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/medium/jm-2013-00122f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme for the Preparation of 2-(3,4-Dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid Derivatives <b>5</b> and <b>11</b>â<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400122f/production/images/large/jm-2013-00122f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400122f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Boc<sub>2</sub>O, DIPEA or Et<sub>3</sub>N, DCM or THF, room temperature, 53â100%; (b) BrCH<sub>2</sub>CO<sub>2</sub>Et, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C or acetone, room temperature, 41â88% yield; (c) 4 N HCl in 1,4-dioxane, DCM, room temperature, 16â99% yield; (d) R-COCl, DIPEA, DCM, 0 Â°C to room temperature, 28â98% yield; (e) 0.2 N aqueous NaOH, THF, room temperature, 18â93% yield.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Papadopoulos, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agache, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavbek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braido, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardona, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demonchy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demoly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayraud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellings, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotvall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid-Grendelmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skevaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triggiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werfel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annesi-Maesano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolin-Amerigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apfelbacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogacka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonadonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butiene, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardell, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caubet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celenk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichocka-Jarosz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cingi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giacco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douladiris, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauquert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genuneit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Sommergruber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovhannisyan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hox, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnsen, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayci, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalpaklioglu, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleine-Tebbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstantinou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauener, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauerma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makrinioti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manole, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingomataj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niggemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâMahony, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitsios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raap, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf-Heimsoth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson-Ansley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roje, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudzeviciene, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rukhadze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackesen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergejeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seys, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siracusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skypala, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spertini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiewak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprikkelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreehorst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toskala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traidl-Hoffmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieg-Boerstra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xepapadaki, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdis, C. A.</span><span> </span><span class="NLM_article-title">Research needs in allergy: an EAACI position paper, in collaboration with EFA</span> <span class="citation_source-journal">Clin. Transl. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=1-23&issue=21&author=N.+G.+Papadopoulosauthor=I.+Agacheauthor=S.+Bavbekauthor=B.+M.+Biloauthor=F.+Braidoauthor=V.+Cardonaauthor=A.+Custovicauthor=J.+Demonchyauthor=P.+Demolyauthor=P.+Eigenmannauthor=J.+Gayraudauthor=C.+Grattanauthor=E.+Hefflerauthor=P.+W.+Hellingsauthor=M.+Jutelauthor=E.+Knolauthor=J.+Lotvallauthor=A.+Muraroauthor=L.+K.+Poulsenauthor=G.+Robertsauthor=P.+Schmid-Grendelmeierauthor=C.+Skevakiauthor=M.+Triggianiauthor=R.+Vanreeauthor=T.+Werfelauthor=B.+Floodauthor=S.+Palkonenauthor=R.+Savliauthor=P.+Allegriauthor=I.+Annesi-Maesanoauthor=F.+Annunziatoauthor=D.+Antolin-Amerigoauthor=C.+Apfelbacherauthor=M.+Blancaauthor=E.+Bogackaauthor=P.+Bonadonnaauthor=M.+Boniniauthor=O.+Boymanauthor=K.+Brockowauthor=P.+Burneyauthor=J.+Butersauthor=I.+Butieneauthor=M.+Calderonauthor=L.+O.+Cardellauthor=J.+C.+Caubetauthor=S.+Celenkauthor=E.+Cichocka-Jaroszauthor=C.+Cingiauthor=M.+Coutoauthor=N.+Dejongauthor=S.+Del+Giaccoauthor=N.+Douladirisauthor=F.+Fassioauthor=J.+L.+Fauquertauthor=J.+Fernandezauthor=M.+F.+Rivasauthor=M.+Ferrerauthor=C.+Flohrauthor=J.+Gardnerauthor=J.+Genuneitauthor=P.+Gevaertauthor=A.+Groblewskaauthor=E.+Hamelmannauthor=H.+J.+Hoffmannauthor=K.+Hoffmann-Sommergruberauthor=L.+Hovhannisyanauthor=V.+Hoxauthor=F.+L.+Jahnsenauthor=O.+Kalayciauthor=A.+F.+Kalpakliogluauthor=J.+Kleine-Tebbeauthor=G.+Konstantinouauthor=M.+Kurowskiauthor=S.+Lauauthor=R.+Lauenerauthor=A.+Lauermaauthor=K.+Loganauthor=A.+Magnanauthor=J.+Makowskaauthor=H.+Makriniotiauthor=P.+Manginaauthor=F.+Manoleauthor=A.+Mariauthor=A.+Mazonauthor=C.+Millsauthor=E.+Mingomatajauthor=B.+Niggemannauthor=G.+Nilssonauthor=M.+Ollertauthor=L.+O%E2%80%99Mahonyauthor=S.+O%E2%80%99Neilauthor=G.+Palaauthor=A.+Papiauthor=G.+Passalacquaauthor=M.+Perkinauthor=O.+Pfaarauthor=C.+Pitsiosauthor=S.+Quirceauthor=U.+Raapauthor=M.+Raulf-Heimsothauthor=C.+Rhynerauthor=P.+Robson-Ansleyauthor=R.+R.+Alvesauthor=Z.+Rojeauthor=C.+Rondonauthor=O.+Rudzevicieneauthor=F.+Rueffauthor=M.+Rukhadzeauthor=G.+Rumiauthor=C.+Sackesenauthor=A.+F.+Santosauthor=A.+Santucciauthor=C.+Scharfauthor=C.+Schmidt-Weberauthor=B.+Schnyderauthor=J.+Schwarzeauthor=G.+Sennaauthor=S.+Sergejevaauthor=S.+Seysauthor=A.+Siracusaauthor=I.+Skypalaauthor=M.+Sokolowskaauthor=F.+Spertiniauthor=R.+Spiewakauthor=A.+Sprikkelmanauthor=G.+Sturmauthor=I.+Swobodaauthor=I.+Terreehorstauthor=E.+Toskalaauthor=C.+Traidl-Hoffmannauthor=C.+Venterauthor=B.+Vlieg-Boerstraauthor=P.+Whitackerauthor=M.+Wormauthor=P.+Xepapadakiauthor=C.+A.+Akdis&title=Research+needs+in+allergy%3A+an+EAACI+position+paper%2C+in+collaboration+with+EFA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulos%26aufirst%3DN.%2BG.%26aulast%3DAgache%26aufirst%3DI.%26aulast%3DBavbek%26aufirst%3DS.%26aulast%3DBilo%26aufirst%3DB.%2BM.%26aulast%3DBraido%26aufirst%3DF.%26aulast%3DCardona%26aufirst%3DV.%26aulast%3DCustovic%26aufirst%3DA.%26aulast%3DDemonchy%26aufirst%3DJ.%26aulast%3DDemoly%26aufirst%3DP.%26aulast%3DEigenmann%26aufirst%3DP.%26aulast%3DGayraud%26aufirst%3DJ.%26aulast%3DGrattan%26aufirst%3DC.%26aulast%3DHeffler%26aufirst%3DE.%26aulast%3DHellings%26aufirst%3DP.%2BW.%26aulast%3DJutel%26aufirst%3DM.%26aulast%3DKnol%26aufirst%3DE.%26aulast%3DLotvall%26aufirst%3DJ.%26aulast%3DMuraro%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DL.%2BK.%26aulast%3DRoberts%26aufirst%3DG.%26aulast%3DSchmid-Grendelmeier%26aufirst%3DP.%26aulast%3DSkevaki%26aufirst%3DC.%26aulast%3DTriggiani%26aufirst%3DM.%26aulast%3DVanree%26aufirst%3DR.%26aulast%3DWerfel%26aufirst%3DT.%26aulast%3DFlood%26aufirst%3DB.%26aulast%3DPalkonen%26aufirst%3DS.%26aulast%3DSavli%26aufirst%3DR.%26aulast%3DAllegri%26aufirst%3DP.%26aulast%3DAnnesi-Maesano%26aufirst%3DI.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DAntolin-Amerigo%26aufirst%3DD.%26aulast%3DApfelbacher%26aufirst%3DC.%26aulast%3DBlanca%26aufirst%3DM.%26aulast%3DBogacka%26aufirst%3DE.%26aulast%3DBonadonna%26aufirst%3DP.%26aulast%3DBonini%26aufirst%3DM.%26aulast%3DBoyman%26aufirst%3DO.%26aulast%3DBrockow%26aufirst%3DK.%26aulast%3DBurney%26aufirst%3DP.%26aulast%3DButers%26aufirst%3DJ.%26aulast%3DButiene%26aufirst%3DI.%26aulast%3DCalderon%26aufirst%3DM.%26aulast%3DCardell%26aufirst%3DL.%2BO.%26aulast%3DCaubet%26aufirst%3DJ.%2BC.%26aulast%3DCelenk%26aufirst%3DS.%26aulast%3DCichocka-Jarosz%26aufirst%3DE.%26aulast%3DCingi%26aufirst%3DC.%26aulast%3DCouto%26aufirst%3DM.%26aulast%3DDejong%26aufirst%3DN.%26aulast%3DDel%2BGiacco%26aufirst%3DS.%26aulast%3DDouladiris%26aufirst%3DN.%26aulast%3DFassio%26aufirst%3DF.%26aulast%3DFauquert%26aufirst%3DJ.%2BL.%26aulast%3DFernandez%26aufirst%3DJ.%26aulast%3DRivas%26aufirst%3DM.%2BF.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DFlohr%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DJ.%26aulast%3DGenuneit%26aufirst%3DJ.%26aulast%3DGevaert%26aufirst%3DP.%26aulast%3DGroblewska%26aufirst%3DA.%26aulast%3DHamelmann%26aufirst%3DE.%26aulast%3DHoffmann%26aufirst%3DH.%2BJ.%26aulast%3DHoffmann-Sommergruber%26aufirst%3DK.%26aulast%3DHovhannisyan%26aufirst%3DL.%26aulast%3DHox%26aufirst%3DV.%26aulast%3DJahnsen%26aufirst%3DF.%2BL.%26aulast%3DKalayci%26aufirst%3DO.%26aulast%3DKalpaklioglu%26aufirst%3DA.%2BF.%26aulast%3DKleine-Tebbe%26aufirst%3DJ.%26aulast%3DKonstantinou%26aufirst%3DG.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DLauener%26aufirst%3DR.%26aulast%3DLauerma%26aufirst%3DA.%26aulast%3DLogan%26aufirst%3DK.%26aulast%3DMagnan%26aufirst%3DA.%26aulast%3DMakowska%26aufirst%3DJ.%26aulast%3DMakrinioti%26aufirst%3DH.%26aulast%3DMangina%26aufirst%3DP.%26aulast%3DManole%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DA.%26aulast%3DMazon%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DMingomataj%26aufirst%3DE.%26aulast%3DNiggemann%26aufirst%3DB.%26aulast%3DNilsson%26aufirst%3DG.%26aulast%3DOllert%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%26aulast%3DPala%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DPassalacqua%26aufirst%3DG.%26aulast%3DPerkin%26aufirst%3DM.%26aulast%3DPfaar%26aufirst%3DO.%26aulast%3DPitsios%26aufirst%3DC.%26aulast%3DQuirce%26aufirst%3DS.%26aulast%3DRaap%26aufirst%3DU.%26aulast%3DRaulf-Heimsoth%26aufirst%3DM.%26aulast%3DRhyner%26aufirst%3DC.%26aulast%3DRobson-Ansley%26aufirst%3DP.%26aulast%3DAlves%26aufirst%3DR.%2BR.%26aulast%3DRoje%26aufirst%3DZ.%26aulast%3DRondon%26aufirst%3DC.%26aulast%3DRudzeviciene%26aufirst%3DO.%26aulast%3DRueff%26aufirst%3DF.%26aulast%3DRukhadze%26aufirst%3DM.%26aulast%3DRumi%26aufirst%3DG.%26aulast%3DSackesen%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DA.%2BF.%26aulast%3DSantucci%26aufirst%3DA.%26aulast%3DScharf%26aufirst%3DC.%26aulast%3DSchmidt-Weber%26aufirst%3DC.%26aulast%3DSchnyder%26aufirst%3DB.%26aulast%3DSchwarze%26aufirst%3DJ.%26aulast%3DSenna%26aufirst%3DG.%26aulast%3DSergejeva%26aufirst%3DS.%26aulast%3DSeys%26aufirst%3DS.%26aulast%3DSiracusa%26aufirst%3DA.%26aulast%3DSkypala%26aufirst%3DI.%26aulast%3DSokolowska%26aufirst%3DM.%26aulast%3DSpertini%26aufirst%3DF.%26aulast%3DSpiewak%26aufirst%3DR.%26aulast%3DSprikkelman%26aufirst%3DA.%26aulast%3DSturm%26aufirst%3DG.%26aulast%3DSwoboda%26aufirst%3DI.%26aulast%3DTerreehorst%26aufirst%3DI.%26aulast%3DToskala%26aufirst%3DE.%26aulast%3DTraidl-Hoffmann%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DC.%26aulast%3DVlieg-Boerstra%26aufirst%3DB.%26aulast%3DWhitacker%26aufirst%3DP.%26aulast%3DWorm%26aufirst%3DM.%26aulast%3DXepapadaki%26aufirst%3DP.%26aulast%3DAkdis%26aufirst%3DC.%2BA.%26atitle%3DResearch%2520needs%2520in%2520allergy%253A%2520an%2520EAACI%2520position%2520paper%252C%2520in%2520collaboration%2520with%2520EFA%26jtitle%3DClin.%2520Transl.%2520Allergy%26date%3D2012%26volume%3D2%26issue%3D21%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">New drugs for asthma</span> <span class="citation_source-journal">Semin. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">â</span> <span class="NLM_lpage">694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1055%2Fs-0032-1326958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=23047317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjsFOltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=685-694&author=P.+J.+Barnes&title=New+drugs+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New drugs for asthma</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Current therapy for asthma with inhaled corticosteroids and long-acting inhaled Î²(2)-agonists is highly effective, safe, and relatively inexpensive, but many patients remain poorly controlled.  Most advances have been through improving these drug classes and a major developmental hurdle is to improve existing drug classes.  Major unmet needs include better treatment of severe asthma (which has some similarity to chronic obstructive pulmonary disease), as well as curative therapies for mild to moderate asthma that do not result in the return of symptoms when the treatment is stopped.  Several new treatments are in development, but many are specific, targeting a single mediator or receptor, and are unlikely to have a major clinical impact, although they may be effective in specific asthma phenotypes (endotypes).  Drugs with more widespread effects, such as kinase inhibitors, may be more effective but have a greater risk of side effects so inhaled delivery may be needed.  Several new treatments target the underlying allergic/immune process and would treat concomitant allergic diseases.  Improved immunotherapy approaches have the potential for disease modification, although prospects for a cure are currently remote.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-S-3Mwh5Y95p6t8nS6Nc3fW6udTcc2eaLe4zbkWwrcrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjsFOltA%253D%253D&md5=54b8285c9dbf669f0b9ec21d8154b4fd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1326958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1326958%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DNew%2520drugs%2520for%2520asthma%26jtitle%3DSemin.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D33%26spage%3D685%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Quirce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barranco, P.</span><span> </span><span class="NLM_article-title">Emerging drugs for asthma</span> <span class="citation_source-journal">Expert. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1517%2F14728214.2012.683410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=22607631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns12iurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=219-237&author=S.+Quirceauthor=I.+Boboleaauthor=P.+Barranco&title=Emerging+drugs+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for asthma</span></div><div class="casAuthors">Quirce, Santiago; Bobolea, Irina; Barranco, Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-237</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Current drug treatments for asthma relieve bronchospasm and airway inflammation but do not offer a cure, and symptoms return when treatment is stopped.  Asthma management guidelines emphasize the importance of effective asthma treatment to achieve and maintain asthma control.  However, despite widely available and effective treatments, achieving asthma control is still an unmet need for many patients.Areas covered: Remarkable efforts have been made to identify the characteristic features of difficult-to-control (usually severe) asthma that are different from those described for mild-to-moderate asthma, setting the stage for the development of new and even individualized therapies.  The most fascinating options of the new asthma treatments are biol. therapies, in particular monoclonal antibodies.  In addn., some novel once-daily combinations of long-acting Î²2-agonist and inhaled corticosteroids are under development.Expert opinion: Asthma is a complex syndrome made up of a no. of disease variants or asthma phenotypes, with different underlying pathophysiol.  As different drugs target different pathways, it is necessary to det. the individual profile of pathophysiol. abnormalities for each patient.  Several cytokines have been implicated in the inflammatory cascades leading to the different asthma phenotypes, and the most relevant ones are discussed.  The challenge in treating asthma resides precisely in its heterogeneity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAv_5eVsGq7LVg90H21EOLACvtfcHk0liZa4hX4pxD5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns12iurc%253D&md5=c25fd64468c101628db23d7c7ea7916d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.2012.683410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2012.683410%26sid%3Dliteratum%253Aachs%26aulast%3DQuirce%26aufirst%3DS.%26aulast%3DBobolea%26aufirst%3DI.%26aulast%3DBarranco%26aufirst%3DP.%26atitle%3DEmerging%2520drugs%2520for%2520asthma%26jtitle%3DExpert.%2520Opin.%2520Emerging%2520Drugs%26date%3D2012%26volume%3D17%26spage%3D219%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Peters, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey-Sobotka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naclerio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGlashan, D. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, N. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, L. M.</span><span> </span><span class="NLM_article-title">The role of prostaglandin D2 in IgE-mediated reactions in man</span> <span class="citation_source-journal">Trans. Assoc. Am. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">â</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1982&pages=221-228&author=S.+P.+Petersauthor=R.+P.+Schleimerauthor=A.+Kagey-Sobotkaauthor=R.+M.+Naclerioauthor=D.+W.+MacGlashanauthor=E.+S.+Schulmanauthor=N.+F.+Adkinsonauthor=L.+M.+Lichtenstein&title=The+role+of+prostaglandin+D2+in+IgE-mediated+reactions+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DS.%2BP.%26aulast%3DSchleimer%26aufirst%3DR.%2BP.%26aulast%3DKagey-Sobotka%26aufirst%3DA.%26aulast%3DNaclerio%26aufirst%3DR.%2BM.%26aulast%3DMacGlashan%26aufirst%3DD.%2BW.%26aulast%3DSchulman%26aufirst%3DE.%2BS.%26aulast%3DAdkinson%26aufirst%3DN.%2BF.%26aulast%3DLichtenstein%26aufirst%3DL.%2BM.%26atitle%3DThe%2520role%2520of%2520prostaglandin%2520D2%2520in%2520IgE-mediated%2520reactions%2520in%2520man%26jtitle%3DTrans.%2520Assoc.%2520Am.%2520Physicians%26date%3D1982%26volume%3D95%26spage%3D221%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lewis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soter, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. J.,  2nd.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">â</span> <span class="NLM_lpage">1631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=6809826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaL38Xls1Sqt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=1982&pages=1627-1631&author=R.+A.+Lewisauthor=N.+A.+Soterauthor=P.+T.+Diamondauthor=K.+F.+Austenauthor=J.+A.+Oatesauthor=L.+J.+Roberts&title=Prostaglandin+D2+generation+after+activation+of+rat+and+human+mast+cells+with+anti-IgE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE</span></div><div class="casAuthors">Lewis, Robert A.; Soter, Nicholas A.; Diamond, Paul T.; Austen, K. Frank; Oates, John A.; Roberts, L. Jackson, II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">Anti-IgE-dependent activation of rat and human mast cells resulted in the preferential generation of the cyclooxygenase products PGD2 and PGI2 in the rat and PGD2 in the human.  The av. net generation of PGD2 was 13.1 ng/106 purified rat mast cells and 39.5 ng/106 dispersed, enriched human mast cells.  After IgE-dependent activation, there was a linear relation between the net quantities of PGD2 generated and histamine secreted from dispersed human pulmonary cells when the no. of mast cells was varied but the total no. of cells was held const., indicating that it is the no. of mast cells participating in IgE-dependent activation, rather than total mast cell no., that dets. PGD2 generation.  A linear relation was also shown between PGD2 generation and the release of the granule marker Î²-hexosaminidase from purified rat mast cells on the dose-response portion of the plot of their response to anti-IgE challenge.  With higher concns. of anti-IgE, PGD2 generation from rat mast cells plateaued, whereas net percent Î²-hexosaminidase release increased further.  In kinetic studies of rat mast cells activated with anti-IgE, the onset (1-2 min) and time of max. generation (5-10 min) for PGD2 were delayed relative to the onset (15-30 s) and completion (1-2 min) of Î²-hexosaminidase release.  Thus, the extracellular appearance of PGD2 during IgE-dependent mast cell activation represents a response addnl. to the secretion of granule-assocd. mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0ZhTYfyWvbVg90H21EOLACvtfcHk0liZa4hX4pxD5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xls1Sqt7c%253D&md5=ed51cc5cc737b968cb30a21c9e339e2a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DR.%2BA.%26aulast%3DSoter%26aufirst%3DN.%2BA.%26aulast%3DDiamond%26aufirst%3DP.%2BT.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DL.%2BJ.%26atitle%3DProstaglandin%2520D2%2520generation%2520after%2520activation%2520of%2520rat%2520and%2520human%2520mast%2520cells%2520with%2520anti-IgE%26jtitle%3DJ.%2520Immunol.%26date%3D1982%26volume%3D129%26spage%3D1627%26epage%3D1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Crea, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakhosteen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span> </span><span class="NLM_article-title">Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=1348480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK383hslKkug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1992&pages=190-195&author=A.+E.+Creaauthor=J.+A.+Nakhosteenauthor=T.+H.+Lee&title=Mediator+concentrations+in+bronchoalveolar+lavage+fluid+of+patients+with+mild+asymptomatic+bronchial+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma</span></div><div class="casAuthors">Crea A E; Nakhosteen J A; Lee T H</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-5</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">Bronchoalveolar lavage (BAL) was performed on 11 atopic patients with mild asymptomatic bronchial asthma and 11 healthy nonasthmatic volunteers.  All asthmatic subjects had evidence of bronchial hyperresponsiveness to inhaled carbachol.  The concentrations of leukotriene (LT) C4, LTD4, LTE4, LTB4, prostaglandin D2 (PGD2), platelet-activating factor (PAF) and histamine in BAL fluid measured.  The leukotrienes were measured by radioimmunoassay following reverse phase high performance liquid chromatography.  PGD2 concentrations were determined by radio immunoassay after Amprep C2 extraction.  PAF was quantitated by means of in vitro aggregation of rabbit platelets and histamine content was measured using a single isotope radio-enzymatic assay.  There was an increase in the levels of PGD2 and a decrease in the concentration of LTB4 in asthmatic lavage samples.  There were no significant differences in the lavage concentrations of LTC4/D4/E4 and histamine between the two groups of individuals.  PAF was undetectable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCysiO0H3Xw8vLc4ARHEmzfW6udTcc2eaOqmcDE1wwvLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383hslKkug%253D%253D&md5=4ff63cc26a6ea66f5703f6c3b0ebdc8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrea%26aufirst%3DA.%2BE.%26aulast%3DNakhosteen%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DT.%2BH.%26atitle%3DMediator%2520concentrations%2520in%2520bronchoalveolar%2520lavage%2520fluid%2520of%2520patients%2520with%2520mild%2520asymptomatic%2520bronchial%2520asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1992%26volume%3D5%26spage%3D190%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Liu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleecker, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey-Sobotka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niv, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLemore, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Permutt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, W. C.</span><span> </span><span class="NLM_article-title">Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1164%2Fajrccm%2F142.1.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=2368958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK3czhsVSksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1990&pages=126-132&author=M.+C.+Liuauthor=E.+R.+Bleeckerauthor=L.+M.+Lichtensteinauthor=A.+Kagey-Sobotkaauthor=Y.+Nivauthor=T.+L.+McLemoreauthor=S.+Permuttauthor=D.+Proudauthor=W.+C.+Hubbard&title=Evidence+for+elevated+levels+of+histamine%2C+prostaglandin+D2%2C+and+other+bronchoconstricting+prostaglandins+in+the+airways+of+subjects+with+mild+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma</span></div><div class="casAuthors">Liu M C; Bleecker E R; Lichtenstein L M; Kagey-Sobotka A; Niv Y; McLemore T L; Permutt S; Proud D; Hubbard W C</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-32</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">Histamine and certain cyclooxygenase products of arachidonic acid have been implicated as mediators of inflammation and are potent constrictors of human airways.  Because asthma may represent manifestations of chronic inflammation of the airways, the levels of histamine and six prostanoid mediators were measured in airway fluids obtained by bronchoalveolar lavage (BAL) of 12 normal, 11 allergic rhinitic, and 15 asymptomatic, allergic asthmatic subjects.  Simultaneous profiling of prostanoid mediators in individual samples was performed using gas chromatography-mass spectrometry.  Levels of PGD2, 9 alpha,11 beta-PGF2 and PGF2 alpha were 12 to 22 times higher in asthmatic than in normal subjects (p less than 0.01), with concentrations in airway fluids of asthmatic subjects after correction for dilution of 3.8, 0.5, and 1.4 nanomolar, respectively.  Levels of PGD2 and 9 alpha,11 beta-PGF2 were increased nearly tenfold in asthmatic subjects compared with those in rhinitic subjects (p less than 0.01), distinguishing the subjects with lower airway disease from those with another atopic condition.  Histamine levels were increased fourfold in asthmatic subjects compared with those in normal subjects (p less than 0.001); however, similar increases were found in rhinitic subjects.  We conclude that elevated levels of multiple mediators with potent bronchoconstricting activity are present in the airways of subjects with mild asthma, indicating that even mild disease is associated with evidence of airway inflammation.  The interactions of bronchoconstricting mediators and airway inflammation may play important roles in the pathogenesis of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjlx2PAsAQNySm0e6ZOaemfW6udTcc2eaOqmcDE1wwvLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3czhsVSksQ%253D%253D&md5=564fe9284acdcc1768f3a2a09c595b34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1164%2Fajrccm%2F142.1.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm%252F142.1.126%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%2BC.%26aulast%3DBleecker%26aufirst%3DE.%2BR.%26aulast%3DLichtenstein%26aufirst%3DL.%2BM.%26aulast%3DKagey-Sobotka%26aufirst%3DA.%26aulast%3DNiv%26aufirst%3DY.%26aulast%3DMcLemore%26aufirst%3DT.%2BL.%26aulast%3DPermutt%26aufirst%3DS.%26aulast%3DProud%26aufirst%3DD.%26aulast%3DHubbard%26aufirst%3DW.%2BC.%26atitle%3DEvidence%2520for%2520elevated%2520levels%2520of%2520histamine%252C%2520prostaglandin%2520D2%252C%2520and%2520other%2520bronchoconstricting%2520prostaglandins%2520in%2520the%2520airways%2520of%2520subjects%2520with%2520mild%2520asthma%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1990%26volume%3D142%26spage%3D126%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenmotsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1084%2Fjem.193.2.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=11208866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=255-261&author=H.+Hiraiauthor=K.+Tanakaauthor=O.+Yoshieauthor=K.+Ogawaauthor=K.+Kenmotsuauthor=Y.+Takamoriauthor=M.+Ichimasaauthor=K.+Sugamuraauthor=M.+Nakamuraauthor=S.+Takanoauthor=K.+Nagata&title=Prostaglandin+D2+selectively+induces+chemotaxis+in+T+helper+type+2+cells%2C+eosinophils%2C+and+basophils+via+seven-transmembrane+receptor+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2</span></div><div class="casAuthors">Hirai, Hiroyuki; Tanaka, Kazuya; Yoshie, Osamu; Ogawa, Kazuyuki; Kenmotsu, Kazumi; Takamori, Yasushi; Ichimasa, Michiko; Sugamura, Kazuo; Nakamura, Masataka; Takano, Shoichi; Nagata, Kinya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Prostaglandin (PG)D2, which has long been implicated in allergic diseases, is currently considered to elicit its biol. actions through the DP receptor (DP).  Involvement of DP in the formation of allergic asthma was recently demonstrated with DP-deficient mice.  However, proinflammatory functions of PGD2 cannot be explained by DP alone.  The authors show here that a 7-transmembrane receptor, CRTH2, which is preferentially expressed in T helper type 2 (Th2) cells, eosinophils, and basophils in humans, serves as the novel receptor for PGD2.  In response to PGD2, CRTH2 induces intracellular Ca2+ mobilization and chemotaxis in Th2 cells in a GÎ±i-dependent manner.  In addn., CRTH2, but not DP, mediates PGD2-dependent cell migration of blood eosinophils and basophils.  Thus, PGD2 is likely involved in multiple aspects of allergic inflammation through its dual receptor systems, DP and CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrVzvfWtBArVg90H21EOLACvtfcHk0lhILNuekjCxJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksl2msg%253D%253D&md5=be2c6671805c587029df75738463ccd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1084%2Fjem.193.2.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.193.2.255%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKenmotsu%26aufirst%3DK.%26aulast%3DTakamori%26aufirst%3DY.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DProstaglandin%2520D2%2520selectively%2520induces%2520chemotaxis%2520in%2520T%2520helper%2520type%25202%2520cells%252C%2520eosinophils%252C%2520and%2520basophils%2520via%2520seven-transmembrane%2520receptor%2520CRTH2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D193%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mjosberg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crellin, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drunen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokkens, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupedo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span> </span><span class="NLM_article-title">Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">â</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1038%2Fni.2104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=21909091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BC3MbisVCmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1055-1062&author=J.+M.+Mjosbergauthor=S.+Trifariauthor=N.+K.+Crellinauthor=C.+P.+Petersauthor=C.+M.+van+Drunenauthor=B.+Pietauthor=W.+J.+Fokkensauthor=T.+Cupedoauthor=H.+Spits&title=Human+IL-25-+and+IL-33-responsive+type+2+innate+lymphoid+cells+are+defined+by+expression+of+CRTH2+and+CD161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161</span></div><div class="casAuthors">Mjosberg Jenny M; Trifari Sara; Crellin Natasha K; Peters Charlotte P; van Drunen Cornelis M; Piet Berber; Fokkens Wytske J; Cupedo Tom; Spits Hergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1055-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Innate lymphoid cells (ILCs) are emerging as a family of effectors and regulators of innate immunity and tissue remodeling.  Interleukin 22 (IL-22)- and IL-17-producing ILCs, which depend on the transcription factor RORÎ³t, express CD127 (IL-7 receptor Î±-chain) and the natural killer cell marker CD161.  Here we describe another lineage-negative CD127(+)CD161(+) ILC population found in humans that expressed the chemoattractant receptor CRTH2.  These cells responded in vitro to IL-2 plus IL-25 and IL-33 by producing IL-13.  CRTH2(+) ILCs were present in fetal and adult lung and gut.  In fetal gut, these cells expressed IL-13 but not IL-17 or IL-22.  There was enrichment for CRTH2(+) ILCs in nasal polyps of chronic rhinosinusitis, a typical type 2 inflammatory disease.  Our data identify a unique type of human ILC that provides an innate source of T helper type 2 (T(H)2) cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJE3sDc42Er0ewzGPswiWOfW6udTcc2eafE1M74UP5F7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbisVCmtA%253D%253D&md5=d64523177599d66477eaed09292cea27</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fni.2104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2104%26sid%3Dliteratum%253Aachs%26aulast%3DMjosberg%26aufirst%3DJ.%2BM.%26aulast%3DTrifari%26aufirst%3DS.%26aulast%3DCrellin%26aufirst%3DN.%2BK.%26aulast%3DPeters%26aufirst%3DC.%2BP.%26aulast%3Dvan%2BDrunen%26aufirst%3DC.%2BM.%26aulast%3DPiet%26aufirst%3DB.%26aulast%3DFokkens%26aufirst%3DW.%2BJ.%26aulast%3DCupedo%26aufirst%3DT.%26aulast%3DSpits%26aufirst%3DH.%26atitle%3DHuman%2520IL-25-%2520and%2520IL-33-responsive%2520type%25202%2520innate%2520lymphoid%2520cells%2520are%2520defined%2520by%2520expression%2520of%2520CRTH2%2520and%2520CD161%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D1055%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyles, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettey, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettipher, R.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">6531</span><span class="NLM_x">â</span> <span class="NLM_lpage">6536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=6531-6536&author=L.+Xueauthor=S.+L.+Gylesauthor=F.+R.+Wetteyauthor=L.+Gaziauthor=E.+Townsendauthor=M.+G.+Hunterauthor=R.+Pettipher&title=Prostaglandin+D2+causes+preferential+induction+of+proinflammatory+Th2+cytokine+production+through+an+action+on+chemoattractant+receptor-like+molecule+expressed+on+Th2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DL.%26aulast%3DGyles%26aufirst%3DS.%2BL.%26aulast%3DWettey%26aufirst%3DF.%2BR.%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DE.%26aulast%3DHunter%26aufirst%3DM.%2BG.%26aulast%3DPettipher%26aufirst%3DR.%26atitle%3DProstaglandin%2520D2%2520causes%2520preferential%2520induction%2520of%2520proinflammatory%2520Th2%2520cytokine%2520production%2520through%2520an%2520action%2520on%2520chemoattractant%2520receptor-like%2520molecule%2520expressed%2520on%2520Th2%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D6531%26epage%3D6536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yoshimura-Uchiyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span> </span><span class="NLM_article-title">Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">â</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1111%2Fj.1365-2222.2004.02027.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=15298571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Gntbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=1283-1290&author=C.+Yoshimura-Uchiyamaauthor=M.+Iikuraauthor=M.+Yamaguchiauthor=H.+Nagaseauthor=A.+Ishiiauthor=K.+Matsushimaauthor=K.+Yamamotoauthor=M.+Shichijoauthor=K.+B.+Baconauthor=K.+Hirai&title=Differential+modulation+of+human+basophil+functions+through+prostaglandin+D2+receptors+DP+and+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+cells%2FDP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2</span></div><div class="casAuthors">Yoshimura-Uchiyama, C.; Iikura, M.; Yamaguchi, M.; Nagase, H.; Ishii, A.; Matsushima, K.; Yamamoto, K.; Shichijo, M.; Bacon, K. B.; Hirai, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1283-1290</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Both prostaglandin (PG) D receptor (DP) and CRTH2 (chemoattractant receptor-homologous mol. expressed on Th2 cells)/DP2 are high-affinity receptors for PGD2.  Previous studies have demonstrated that PGD2 enhances releasability and induces CRTH2/DP2-mediated migration in human basophils, but the precise effects of PGD2 on basophils as well as receptor usage have not been fully clarified.  Objective: We comprehensively explored the roles of DP and CRTH2/DP2 in basophil functions by using selective agonists and antagonists for each receptor.  Methods: DP and CRTH2/DP2 transcripts were quantified by real-time PCR.  We studied the effects of selective agonists (DP: BW 245C; CRTH2/DP2: 13,14-dihydro-15-keto (DK)-PGD2) and/or antagonists (DP; BWA 868C; CRTH2/DP2: ramatroban) on Ca2+ mobilization, migration, degranulation, CD116 expression and survival of human basophils.  Results: Basophils expressed transcripts of both DP and CRTH2/DP2, but the levels of CRTH2/DP2 transcripts were â¼100-fold higher compared with DP transcripts.  Ca2+ influx was induced in basophils by either PGD2 or DK-PGD2/CRTH2 agonist but not by BW 245C/DP agonist.  Basophils treated with PGD2 were completely desensitized to subsequent stimulation with DK-PGD2, but not vice versa.  DK-PGD2 as well as PGD2 up-regulated CD11b expression, induced migration and enhanced degranulation, and those effects were completely antagonized by ramatroban/CRTH2 antagonist.  In contrast, BW 245C/DP agonist exhibited an inhibitory effect on basophil migration and IgE-mediated degranulation, and the migration inhibitory effect was effectively antagonized by BWA 969C/DP antagonist.  On the other hand, while PGD2 significantly shortened the basophil lifespan, neither DK-PGD2/CRTH2 agonist nor BW 245C/DP agonist did.  Conclusion: CRTH2/DP2 is primarily responsible for the pro-inflammatory effects of PGD2 on human basophils, while DP introduces neg. signals capable of antagonizing the effects of CRTH2/DP2 in these cells.  The effects of PGD2 on longevity imply a mechanism(s) other than via DP or CRTH2/DP2.  CRTH2/DP2 on basophils may afford opportunities for therapeutic targeting in allergic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQL-50aQNsTLVg90H21EOLACvtfcHk0liITqcow6R7gw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Gntbs%253D&md5=53216933edbc7eea8e0960dd78c07e83</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2222.2004.02027.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2222.2004.02027.x%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura-Uchiyama%26aufirst%3DC.%26aulast%3DIikura%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DDifferential%2520modulation%2520of%2520human%2520basophil%2520functions%2520through%2520prostaglandin%2520D2%2520receptors%2520DP%2520and%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520cells%252FDP2%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2004%26volume%3D34%26spage%3D1283%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Effects of prostaglandin D2 on helper T cell functions</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">â</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2004&pages=1009-1014&author=K.+Tanakaauthor=H.+Hiraiauthor=S.+Takanoauthor=M.+Nakamuraauthor=K.+Nagata&title=Effects+of+prostaglandin+D2+on+helper+T+cell+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520prostaglandin%2520D2%2520on%2520helper%2520T%2520cell%2520functions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D316%26spage%3D1009%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wills-Karp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyimbazi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neben, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, D. D.</span><span> </span><span class="NLM_article-title">Interleukin-13: central mediator of allergic asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">â</span> <span class="NLM_lpage">2261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2258-2261&author=M.+Wills-Karpauthor=J.+Luyimbaziauthor=X.+Xuauthor=B.+Schofieldauthor=T.+Y.+Nebenauthor=C.+L.+Karpauthor=D.+D.+Donaldson&title=Interleukin-13%3A+central+mediator+of+allergic+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills-Karp%26aufirst%3DM.%26aulast%3DLuyimbazi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSchofield%26aufirst%3DB.%26aulast%3DNeben%26aufirst%3DT.%2BY.%26aulast%3DKarp%26aufirst%3DC.%2BL.%26aulast%3DDonaldson%26aufirst%3DD.%2BD.%26atitle%3DInterleukin-13%253A%2520central%2520mediator%2520of%2520allergic%2520asthma%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2258%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Grunig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakil, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkayya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brombacher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennick, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locksley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corry, D. B.</span><span> </span><span class="NLM_article-title">Requirement for IL-13 independently of IL-4 in experimental asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">â</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2261-2263&author=G.+Grunigauthor=M.+Warnockauthor=A.+E.+Wakilauthor=R.+Venkayyaauthor=F.+Brombacherauthor=D.+M.+Rennickauthor=D.+Sheppardauthor=M.+Mohrsauthor=D.+D.+Donaldsonauthor=R.+M.+Locksleyauthor=D.+B.+Corry&title=Requirement+for+IL-13+independently+of+IL-4+in+experimental+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrunig%26aufirst%3DG.%26aulast%3DWarnock%26aufirst%3DM.%26aulast%3DWakil%26aufirst%3DA.%2BE.%26aulast%3DVenkayya%26aufirst%3DR.%26aulast%3DBrombacher%26aufirst%3DF.%26aulast%3DRennick%26aufirst%3DD.%2BM.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DMohrs%26aufirst%3DM.%26aulast%3DDonaldson%26aufirst%3DD.%2BD.%26aulast%3DLocksley%26aufirst%3DR.%2BM.%26aulast%3DCorry%26aufirst%3DD.%2BB.%26atitle%3DRequirement%2520for%2520IL-13%2520independently%2520of%2520IL-4%2520in%2520experimental%2520asthma%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2261%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Matsuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aze, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin D2 as a mediator of allergic asthma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">â</span> <span class="NLM_lpage">2017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=2013-2017&author=T.+Matsuokaauthor=M.+Hirataauthor=H.+Tanakaauthor=Y.+Takahashiauthor=T.+Murataauthor=K.+Kabashimaauthor=Y.+Sugimotoauthor=T.+Kobayashiauthor=F.+Ushikubiauthor=Y.+Azeauthor=N.+Eguchiauthor=Y.+Uradeauthor=N.+Yoshidaauthor=K.+Kimuraauthor=A.+Mizoguchiauthor=Y.+Hondaauthor=H.+Nagaiauthor=S.+Narumiya&title=Prostaglandin+D2+as+a+mediator+of+allergic+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DKabashima%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DAze%26aufirst%3DY.%26aulast%3DEguchi%26aufirst%3DN.%26aulast%3DUrade%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMizoguchi%26aufirst%3DA.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520D2%2520as%2520a%2520mediator%2520of%2520allergic%2520asthma%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D2013%26epage%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Emerging roles of DP and CRTH2 in allergic inflammation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=148-158&author=E.+Kostenisauthor=T.+Ulven&title=Emerging+roles+of+DP+and+CRTH2+in+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DEmerging%2520roles%2520of%2520DP%2520and%2520CRTH2%2520in%2520allergic%2520inflammation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D148%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hart, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boardman, P. L.</span><span> </span><span class="NLM_article-title">Indomethacin: a new non-steroid anti-inflammatory agent</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">â</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1136%2Fbmj.2.5363.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=14056924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaF2c%252FhsVGnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1963&pages=965-970&author=F.+D.+Hartauthor=P.+L.+Boardman&title=Indomethacin%3A+a+new+non-steroid+anti-inflammatory+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT</span></div><div class="casAuthors">HART F D; BOARDMAN P L</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5363</span>),
    <span class="NLM_cas:pages">965-70</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCVfn3XDOnikNHe_gFldTbfW6udTcc2ebVFwraJcysTbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252FhsVGnuw%253D%253D&md5=fc49e274294e4425dddec48f657ff356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fbmj.2.5363.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.2.5363.965%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DF.%2BD.%26aulast%3DBoardman%26aufirst%3DP.%2BL.%26atitle%3DIndomethacin%253A%2520a%2520new%2520non-steroid%2520anti-inflammatory%2520agent%26jtitle%3DBr.%2520Med.%2520J.%26date%3D1963%26volume%3D2%26spage%3D965%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span> </span><span class="NLM_article-title">Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=981-985&author=H.+Hiraiauthor=K.+Tanakaauthor=S.+Takanoauthor=M.+Ichimasaauthor=M.+Nakamuraauthor=K.+Nagata&title=Cutting+edge%3A+agonistic+effect+of+indomethacin+on+a+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DS.%26aulast%3DIchimasa%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26atitle%3DCutting%2520edge%253A%2520agonistic%2520effect%2520of%2520indomethacin%2520on%2520a%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D981%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rosentreter, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshagen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perzborn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, V. B.</span><span> </span><span class="NLM_article-title">Synthesis and absolute configuration of the new thromboxane antagonist (3<i>R</i>)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">â</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=2624597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyjt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1989&pages=1519-1521&author=U.+Rosentreterauthor=H.+Boshagenauthor=F.+Seuterauthor=E.+Perzbornauthor=V.+B.+Fiedler&title=Synthesis+and+absolute+configuration+of+the+new+thromboxane+antagonist+%283R%29-3-%284-fluorophenylsulfonamido%29-1%2C2%2C3%2C4-tetrahydro-9-carbazolepropan+oic+acid+and+comparison+with+its+enantiomer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid and comparison with its enantiomer</span></div><div class="casAuthors">Rosentreter, U.; Boeshagen, H.; Seuter, F.; Perzborn, E.; Fiedler, V. B.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1519-21</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The title compd, (+)-I (Bay u 3405), was synthesized as an enantiomerically pure thromboxan A2 antagonist.  (+)-I was a more potent blood platelet-aggregation inhibitor than (-)-I (Bay u 3406); both enantiomers showed in vitro activity as vasoconstrictors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp95v6fXC1Xz7Vg90H21EOLACvtfcHk0lhj4JfwQBKQdw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyjt7Y%253D&md5=8782109d96e10f0f6b604601c9d892ea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosentreter%26aufirst%3DU.%26aulast%3DBoshagen%26aufirst%3DH.%26aulast%3DSeuter%26aufirst%3DF.%26aulast%3DPerzborn%26aufirst%3DE.%26aulast%3DFiedler%26aufirst%3DV.%2BB.%26atitle%3DSynthesis%2520and%2520absolute%2520configuration%2520of%2520the%2520new%2520thromboxane%2520antagonist%2520%25283R%2529-3-%25284-fluorophenylsulfonamido%2529-1%252C2%252C3%252C4-tetrahydro-9-carbazolepropan%2520oic%2520acid%2520and%2520comparison%2520with%2520its%2520enantiomer%26jtitle%3DArzneim.%2520Forsch.%26date%3D1989%26volume%3D39%26spage%3D1519%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Aizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, N.</span><span> </span><span class="NLM_article-title">BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">â</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1996&pages=338-342&author=H.+Aizawaauthor=M.+Shigyoauthor=H.+Nogamiauthor=T.+Hiroseauthor=N.+Hara&title=BAY+u3405%2C+a+thromboxane+A2+antagonist%2C+reduces+bronchial+hyperresponsiveness+in+asthmatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAizawa%26aufirst%3DH.%26aulast%3DShigyo%26aufirst%3DM.%26aulast%3DNogami%26aufirst%3DH.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DN.%26atitle%3DBAY%2520u3405%252C%2520a%2520thromboxane%2520A2%2520antagonist%252C%2520reduces%2520bronchial%2520hyperresponsiveness%2520in%2520asthmatics%26jtitle%3DChest%26date%3D1996%26volume%3D109%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Terada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maesako, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, A.</span><span> </span><span class="NLM_article-title">The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis</span> <span class="citation_source-journal">Acta Otolaryngol. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1080%2F00016489850182323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=9870646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADyaK1M%252Fos1WqsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=1998&pages=32-37&author=N.+Teradaauthor=T.+Yamakoshiauthor=M.+Hasegawaauthor=H.+Tanikawaauthor=K.+Maesakoauthor=K.+Ishikawaauthor=A.+Konno&title=The+effect+of+ramatroban+%28BAY+u+3405%29%2C+a+thromboxane+A2+receptor+antagonist%2C+on+nasal+cavity+volume+and+minimum+cross-sectional+area+and+nasal+mucosal+hemodynamics+after+nasal+mucosal+allergen+challenge+in+patients+with+perennial+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis</span></div><div class="casAuthors">Terada N; Yamakoshi T; Hasegawa M; Tanikawa H; Maesako K; Ishikawa K; Konno A</div><div class="citationInfo"><span class="NLM_cas:title">Acta oto-laryngologica. Supplementum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-7</span>
        ISSN:<span class="NLM_cas:issn">0365-5237</span>.
    </div><div class="casAbstract">The thromboxane A2 receptor antagonist, ramatroban (BAY u 3405), was orally administered for 4 weeks at a daily dose of 150 mg (b.i.d.) to 10 patients with perennial allergic rhinitis who had a positive reaction to house dust challenge on nasal mucosa.  Nasal cavity volume and minimum cross-sectional area were measured, and changes in nasal mucosal swelling were determined following allergen challenge with house dust.  The influence on nasal mucosal hemodynamics was also investigated.  Nasal cavity volume and minimum cross-sectional area were measured by acoustic rhinometry, and blood flow in the nasal mucosa was measured by laser Doppler flowmetry.  Percent changes in values from baseline nasal cavity volume were significantly decreased by allergen challenge before ramatroban administration, but no significant decrease was noted after ramatroban administration.  Similarly, percent changes in values from baseline nasal cavity minimum cross-sectional area were significantly decreased by allergen challenge before administration of ramatroban, but not after administration.  Percent changes in values from baseline nasal mucosal hemodynamics were significantly increased by allergen challenge both before and after ramatroban administration, which thus had no effect on mucosal hemodynamics.  These findings suggest that ramatroban might inhibit the increase in nasal mucosal swelling but has no effect on nasal mucosal hemodynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCzbCKf6pyciEJCPKhJPuqfW6udTcc2eb8YXlB4XQ-9Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252Fos1WqsQ%253D%253D&md5=32abe5902be3f0e64719f74c3528f1ce</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F00016489850182323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00016489850182323%26sid%3Dliteratum%253Aachs%26aulast%3DTerada%26aufirst%3DN.%26aulast%3DYamakoshi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTanikawa%26aufirst%3DH.%26aulast%3DMaesako%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DKonno%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520ramatroban%2520%2528BAY%2520u%25203405%2529%252C%2520a%2520thromboxane%2520A2%2520receptor%2520antagonist%252C%2520on%2520nasal%2520cavity%2520volume%2520and%2520minimum%2520cross-sectional%2520area%2520and%2520nasal%2520mucosal%2520hemodynamics%2520after%2520nasal%2520mucosal%2520allergen%2520challenge%2520in%2520patients%2520with%2520perennial%2520allergic%2520rhinitis%26jtitle%3DActa%2520Otolaryngol.%2520Suppl.%26date%3D1998%26volume%3D537%26spage%3D32%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span> </span><span class="NLM_article-title">An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1124%2Fjpet.102.046748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=12649388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1amsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=347-352&author=H.+Sugimotoauthor=M.+Shichijoauthor=T.+Iinoauthor=Y.+Manabeauthor=A.+Watanabeauthor=M.+Shimazakiauthor=F.+Gantnerauthor=K.+B.+Bacon&title=An+orally+bioavailable+small+molecule+antagonist+of+CRTH2%2C+ramatroban+%28BAY+u3405%29%2C+inhibits+prostaglandin+D2-induced+eosinophil+migration+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro</span></div><div class="casAuthors">Sugimoto, Hiromi; Shichijo, Michitaka; Iino, Takashi; Manabe, Yoshihisa; Watanabe, Akihiko; Shimazaki, Makoto; Gantner, Florian; Bacon, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">347-352</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ramatroban (Baynas, BAY u3405), a thromboxane A2 (TxA2) antagonist marketed for allergic rhinitis, has been shown to partially attenuate prostaglandin (PG)D2-induced bronchial hyperresponsiveness in humans, as well as reduce antigen-induced early- and late-phase inflammatory responses in mice, guinea pigs, and rats.  PGD2 is known to induce eosinophilia following intranasal administration, and to induce eosinophil activation in vitro.  In addn. to the TxA2 receptor, PGD2 is known as a ligand for the PGD2 receptor, and the newly identified G-protein-coupled chemoattractant receptor-homologous mol. expressed on Th2 cells (CRTH2).  To fully characterize PGD2-mediated inflammatory responses relevant to eosinophil activation, further anal. of the mechanism of action of ramatroban has now been performed.  PGD2-stimulated human eosinophil migration was shown to be mediated exclusively through activation of CRTH2, and surprisingly, these effects were completely inhibited by ramatroban.  This is also the first report detailing an orally bioavailable small mol. CRTH2 antagonist.  Our findings suggest that clin. efficacy of ramatroban may be in part mediated through its action on this Th2-, eosinophil-, and basophil-specific chemoattractant receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0W109cRJrbLVg90H21EOLACvtfcHk0lir5CDaL-M0vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1amsro%253D&md5=0b7a96b4a8e0fc0b40b6c4c2888b8721</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.046748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.046748%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DIino%26aufirst%3DT.%26aulast%3DManabe%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DShimazaki%26aufirst%3DM.%26aulast%3DGantner%26aufirst%3DF.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26atitle%3DAn%2520orally%2520bioavailable%2520small%2520molecule%2520antagonist%2520of%2520CRTH2%252C%2520ramatroban%2520%2528BAY%2520u3405%2529%252C%2520inhibits%2520prostaglandin%2520D2-induced%2520eosinophil%2520migration%2520in%2520vitro%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D347%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Pettipher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span> </span><span class="NLM_article-title">Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2915</span><span class="NLM_x">â</span> <span class="NLM_lpage">2931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKhtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2915-2931&author=R.+Pettipherauthor=M.+Whittaker&title=Update+on+the+development+of+antagonists+of+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+cells+%28CRTH2%29.+From+lead+optimization+to+clinical+proof-of-concept+in+asthma+and+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis</span></div><div class="casAuthors">Pettipher, Roy; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2915-2931</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the discovery of PGD2 as the ligand for CRTH2 in 2001 there has been significant progress in defining the role of this receptor in allergic response and the identification of small mol. wt. antagonists with drug-like properties.  With ramatroban, indomethacin and various high throughput screening hits as starting points for medicinal chem. programs, a no. of companies have identified lipophilic carboxylic acids as highly potent and selective CRTH2 antagonists.  Early proof-of-concept clin. studies indicate that CRTH2 antagonists are effective in treating the signs and symptoms of both asthma and allergic rhinitis and possess features that are differentiated from existing therapies for these indications.  It seems likely that CRTH2 antagonists will ultimately find utility as novel anti-allergic drugs, the challenge is to identify compds. that are effective when dosed once a day and prove to have an acceptable safety profile in long term studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8a9ruvvaF0LVg90H21EOLACvtfcHk0li62Il9lN2RaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKhtA%253D%253D&md5=98caa4a80dab99aee72aafd5cd94ffc4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm2013997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013997%26sid%3Dliteratum%253Aachs%26aulast%3DPettipher%26aufirst%3DR.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520the%2520development%2520of%2520antagonists%2520of%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520cells%2520%2528CRTH2%2529.%2520From%2520lead%2520optimization%2520to%2520clinical%2520proof-of-concept%2520in%2520asthma%2520and%2520allergic%2520rhinitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2915%26epage%3D2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Valdenaire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renneberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H. .</span><span> </span><span class="NLM_article-title">Evolution of novel tricyclic CRTh2 receptor antagonists from a (<i>E</i>)-2-cyano-3-(1<i>H</i>-indol-3-yl)acrylamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">â</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=944-948&author=A.+Valdenaireauthor=J.+Pothierauthor=D.+Rennebergauthor=M.+A.+Riedererauthor=O.+Peterauthor=X.+Leroyauthor=C.+Gnerreauthor=H.+.+Fretz&title=Evolution+of+novel+tricyclic+CRTh2+receptor+antagonists+from+a+%28E%29-2-cyano-3-%281H-indol-3-yl%29acrylamide+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValdenaire%26aufirst%3DA.%26aulast%3DPothier%26aufirst%3DJ.%26aulast%3DRenneberg%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DFretz%26aufirst%3DH.%2B.%26atitle%3DEvolution%2520of%2520novel%2520tricyclic%2520CRTh2%2520receptor%2520antagonists%2520from%2520a%2520%2528E%2529-2-cyano-3-%25281H-indol-3-yl%2529acrylamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D944%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Boie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slipetz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of the human prostanoid DP receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">18910</span><span class="NLM_x">â</span> <span class="NLM_lpage">18916</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=18910-18916&author=Y.+Boieauthor=N.+Sawyerauthor=D.+M.+Slipetzauthor=K.+M.+Mettersauthor=M.+Abramovitz&title=Molecular+cloning+and+characterization+of+the+human+prostanoid+DP+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoie%26aufirst%3DY.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DSlipetz%26aufirst%3DD.%2BM.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DAbramovitz%26aufirst%3DM.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520the%2520human%2520prostanoid%2520DP%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D18910%26epage%3D18916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Stubbs, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schratl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskar, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabroe, I.</span><span> </span><span class="NLM_article-title">Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">26012</span><span class="NLM_x">â</span> <span class="NLM_lpage">26020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=26012-26020&author=V.+E.+Stubbsauthor=P.+Schratlauthor=A.+Hartnellauthor=T.+J.+Williamsauthor=B.+A.+Peskarauthor=A.+Heinemannauthor=I.+Sabroe&title=Indomethacin+causes+prostaglandin+D%282%29-like+and+eotaxin-like+selective+responses+in+eosinophils+and+basophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStubbs%26aufirst%3DV.%2BE.%26aulast%3DSchratl%26aufirst%3DP.%26aulast%3DHartnell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DPeskar%26aufirst%3DB.%2BA.%26aulast%3DHeinemann%26aufirst%3DA.%26aulast%3DSabroe%26aufirst%3DI.%26atitle%3DIndomethacin%2520causes%2520prostaglandin%2520D%25282%2529-like%2520and%2520eotaxin-like%2520selective%2520responses%2520in%2520eosinophils%2520and%2520basophils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D26012%26epage%3D26020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sabroe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jopling, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponath, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span> </span><span class="NLM_article-title">Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">2946</span><span class="NLM_x">â</span> <span class="NLM_lpage">2955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=10072545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlyis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=2946-2955&author=I.+Sabroeauthor=A.+Hartnellauthor=L.+A.+Joplingauthor=S.+Belauthor=P.+D.+Ponathauthor=J.+E.+Peaseauthor=P.+D.+Collinsauthor=T.+J.+Williams&title=Differential+regulation+of+eosinophil+chemokine+signaling+via+CCR3+and+non-CCR3+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways</span></div><div class="casAuthors">Sabroe, Ian; Hartnell, Adele; Jopling, Louise A.; Bel, Sandra; Ponath, Paul D.; Pease, James E.; Collins, Paul D.; Williams, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2946-2955</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To investigate eosinophil stimulation by chemokines we developed a sensitive assay of leukocyte shape change, the gated autofluorescence/forward scatter assay.  Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation.  We examd. the actions of the chemokines eotaxin, eotaxin-2, monocyte chemoattractant protein-1 (MCP-1), MCP-3, MCP-4, RANTES, macrophage inflammatory protein-1Î± (MIP-1Î±), and IL-8 on leukocytes in mixed cell suspensions and focused on the responses of eosinophils to C-C chemokines.  Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.  Responses to MCP-4 were qual. different, showing marked reversal of shape change responses with agonist concn. and duration of treatment.  In contrast, MIP-1Î± induced a potent response in eosinophils from a small and previously undescribed subgroup of donors via a non-CCR3 pathway likely to be CCR1 mediated.  Incubation of leukocytes at 370C for 90 min in the absence of extracellular calcium up-regulated responses to MCP-4 and MIP-1Î± in the majority of donors, and there was a small increase in responses to eotaxin.  MIP-1Î± responsiveness in vivo may therefore be a function of both CCR1 expression levels and the regulated efficiency of coupling to intracellular signaling pathways.  The obsd. up-regulation of MIP-1Î± signaling via non-CCR3 pathways may play a role in eosinophil recruitment in inflammatory states such as occurs in the asthmatic lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCFIVxPlaQZ7Vg90H21EOLACvtfcHk0li62Il9lN2RaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlyis7w%253D&md5=5e51bfd041b76a8c8a761a07ee829342</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabroe%26aufirst%3DI.%26aulast%3DHartnell%26aufirst%3DA.%26aulast%3DJopling%26aufirst%3DL.%2BA.%26aulast%3DBel%26aufirst%3DS.%26aulast%3DPonath%26aufirst%3DP.%2BD.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26aulast%3DCollins%26aufirst%3DP.%2BD.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26atitle%3DDifferential%2520regulation%2520of%2520eosinophil%2520chemokine%2520signaling%2520via%2520CCR3%2520and%2520non-CCR3%2520pathways%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D2946%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fretz, H.; Fecher, A.; Hilpert, K.; Riederer, M. A.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydropyridoindole Derivatives as CRTH2 Receptor Antagonists for the Treatment of Prostaglandin-Mediated Diseases</span> PCT Int. Appl. WO 2005095397 A1 20051013,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=H.+Fretz&author=A.+Fecher&author=K.+Hilpert&author=M.+A.+Riederer&title=Preparation+of+Tetrahydropyridoindole+Derivatives+as+CRTH2+Receptor+Antagonists+for+the+Treatment+of+Prostaglandin-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520Tetrahydropyridoindole%2520Derivatives%2520as%2520CRTH2%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Prostaglandin-Mediated%2520Diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eavQrDNGGP-Xrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eavQrDNGGP-Xrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Asafu-Adjaye, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faustino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawakkul, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, D. A.</span><span> </span><span class="NLM_article-title">Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">â</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2Fj.jpba.2006.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=17300896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVGgtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=1854-1859&author=E.+B.+Asafu-Adjayeauthor=P.+J.+Faustinoauthor=M.+A.+Tawakkulauthor=L.+W.+Andersonauthor=L.+X.+Yuauthor=H.+Kwonauthor=D.+A.+Volpe&title=Validation+and+application+of+a+stability-indicating+HPLC+method+for+the+in+vitro+determination+of+gastric+and+intestinal+stability+of+venlafaxine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine</span></div><div class="casAuthors">Asafu-Adjaye, Ebenezer B.; Faustino, Patrick J.; Tawakkul, Mobin A.; Anderson, Lawrence W.; Yu, Lawrence X.; Kwon, Hyojong; Volpe, Donna A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1854-1859</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gastrointestinal stability of venlafaxine was evaluated in vitro in simulated gastric (SGF) and intestinal (SIF) fluids using a stability indicating HPLC method.  The method was validated using a 5 Î¼m Ascentis C18 column (150 mm Ã 4.6 mm) and mobile phase consisting of 30% acetonitrile in 20 mM potassium phosphate buffer (pH 6.5) delivered isocratically at a flow rate of 1 mL/min with UV detection at 228 nm.  Venlafaxine in USP simulated gastric and intestinal fluids (0.4 mg/mL) was incubated at 37Â° in a shaking water bath.  The gastric stability study samples were assayed at 0, 15, 30, and 60 min intervals while sampling for the intestinal stability study was at 0, 1, 2, and 3 h.  System suitability detns. gave R.S.D.s of 0.68, 0.5 and 3.9% for retention factor (k'), peak area and tailing factor, resp.  The method was shown to be accurate, precise, specific, and linear over the anal. range.  Intra- and inter-day precision was <5.3%.  Forced degrdn. studies of drug substance in basic media at 70Â° as well as in H2O2 for 1 h and ultra-violet photostability studies at 255 and 365 nm for 24 h did not produce any detectable degrdn. products.  Forced degrdn. studies of drug substance in acidic media at 70Â° for 1 h produced the dehydro-venlafaxine degradant.  Venlafaxine was stable in SGF (pH â¼1.2) for the 1-h incubation period and in SIF (pH 6.8) up to 3 h with <1.5% relative difference (RD) between the amt. of drug added and that found for all time points.  This stability expt. in simulated gastric and intestinal fluids suggests that drug loss in the gastrointestinal tract takes place by membrane permeation rather than a degrdn. process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1gAxjbfWNRbVg90H21EOLACvtfcHk0limyiz2DUkMgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVGgtbc%253D&md5=a2e3002ae107886c0a5e7c546ad12084</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DAsafu-Adjaye%26aufirst%3DE.%2BB.%26aulast%3DFaustino%26aufirst%3DP.%2BJ.%26aulast%3DTawakkul%26aufirst%3DM.%2BA.%26aulast%3DAnderson%26aufirst%3DL.%2BW.%26aulast%3DYu%26aufirst%3DL.%2BX.%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26atitle%3DValidation%2520and%2520application%2520of%2520a%2520stability-indicating%2520HPLC%2520method%2520for%2520the%2520in%2520vitro%2520determination%2520of%2520gastric%2520and%2520intestinal%2520stability%2520of%2520venlafaxine%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2007%26volume%3D43%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keldenich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schohe-Loop, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">In silico ADMET traffic lights as a tool for the prioritization of HTS hits</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">â</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1002%2Fcmdc.200600168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=16991174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVClsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1229-1236&author=M.+Lobellauthor=M.+Hendrixauthor=B.+Hinzenauthor=J.+Keldenichauthor=H.+Meierauthor=C.+Schmeckauthor=R.+Schohe-Loopauthor=T.+Wunbergauthor=A.+Hillisch&title=In+silico+ADMET+traffic+lights+as+a+tool+for+the+prioritization+of+HTS+hits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">In silico ADMET traffic lights as a tool for the prioritization of HTS hits</span></div><div class="casAuthors">Lobell, Mario; Hendrix, Martin; Hinzen, Berthold; Keldenich, Joerg; Meier, Heinrich; Schmeck, Carsten; Schohe-Loop, Rudolf; Wunberg, Tobias; Hillisch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1229-1236</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The need for in silico characterization of HTS hit structures as part of a data-driven hit-selection process is demonstrated.  A soln. is described in the form of an in silicon ADMET traffic light and PhysChem scoring system.  This has been extensively validated with inhouse data at Bayer, published data, and a collection of launched small-mol. oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrg56R2ER5WrVg90H21EOLACvtfcHk0limyiz2DUkMgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVClsb8%253D&md5=00d7c6b4d215d12873caa2809a4dbe56</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600168%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DHinzen%26aufirst%3DB.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DH.%26aulast%3DSchmeck%26aufirst%3DC.%26aulast%3DSchohe-Loop%26aufirst%3DR.%26aulast%3DWunberg%26aufirst%3DT.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DIn%2520silico%2520ADMET%2520traffic%2520lights%2520as%2520a%2520tool%2520for%2520the%2520prioritization%2520of%2520HTS%2520hits%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D1229%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tanimoto, N.; Hiramatsu, Y.; Mitsumori, S.; Inagaki, M.</span>, <span> </span><span class="NLM_article-title">Preparation of Indole Derivatives as PGD2 Receptor Antagonists</span>. PCT Int. Appl. WO 2003097598 A1 20031127,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=N.+Tanimoto&author=Y.+Hiramatsu&author=S.+Mitsumori&author=M.+Inagaki&title=Preparation+of+Indole+Derivatives+as+PGD2+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTanimoto%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Indole%2520Derivatives%2520as%2520PGD2%2520Receptor%2520Antagonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ruediger, E. H.; Deon, D., H.; Kadow, J. F.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydrocarbolines for Treatment of HIV Infection and AIDS</span>. U.S. Pat. Appl. Publ. US 20050267130 A1 20051201,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+H.+Ruediger&author=D.%2C+H.+Deon&author=J.+F.+Kadow&title=Preparation+of+Tetrahydrocarbolines+for+Treatment+of+HIV+Infection+and+AIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuediger%26aufirst%3DE.%2BH.%26atitle%3DPreparation%2520of%2520Tetrahydrocarbolines%2520for%2520Treatment%2520of%2520HIV%2520Infection%2520and%2520AIDS%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Bonjoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaba, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, C.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4299</span><span class="NLM_x">â</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4299-4302&author=J.+Bonjochauthor=F.+Diabaauthor=L.+Pagesauthor=D.+Perezauthor=L.+Socaauthor=M.+Miralpeixauthor=D.+Vilellaauthor=P.+Antonauthor=C.+Puig&title=Synthesis+and+structure%E2%80%93activity+relationships+of+gamma-carboline+derivatives+as+potent+and+selective+cysLT%281%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonjoch%26aufirst%3DJ.%26aulast%3DDiaba%26aufirst%3DF.%26aulast%3DPages%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DSoca%26aufirst%3DL.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DAnton%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520gamma-carboline%2520derivatives%2520as%2520potent%2520and%2520selective%2520cysLT%25281%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4299%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ivashchenko, A. A.; Ivashchenko, A. V.; Tkachenko, S. Y.; Okun, I. M.; Savchuk, N. F.; Mitkin, O. D.; Kravchenko, D. V.</span><span> </span><span class="NLM_article-title">Substituted 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as Novel Antihistaminic Agents and Processes for Preparation Thereof</span>. PCT Int. Appl. WO 2008115098 A2 20080925,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+A.+Ivashchenko&author=A.+V.+Ivashchenko&author=S.+Y.+Tkachenko&author=I.+M.+Okun&author=N.+F.+Savchuk&author=O.+D.+Mitkin&author=D.+V.+Kravchenko&title=Substituted+2%2C3%2C4%2C5-Tetrahydro-1H-pyrido%5B4%2C3-b%5Dindoles+as+Novel+Antihistaminic+Agents+and+Processes+for+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIvashchenko%26aufirst%3DA.%2BA.%26atitle%3DSubstituted%25202%252C3%252C4%252C5-Tetrahydro-1H-pyrido%255B4%252C3-b%255Dindoles%2520as%2520Novel%2520Antihistaminic%2520Agents%2520and%2520Processes%2520for%2520Preparation%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ivashchenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitâkin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisil, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolov, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachenko, S. E.</span> <span class="citation_source-journal">Izv. Vyssh. Uchebn. Zaved., Khim. Khim. Tekhnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ivashchenko%2C+A.+V.%3B+Mit%E2%80%99kin%2C+O.+D.%3B+Kisil%2C+V.+M.%3B+Frolov%2C+E.+B.%3B+Tkachenko%2C+S.+E.Izv.+Vyssh.+Uchebn.+Zaved.%2C+Khim.+Khim.+Tekhnol.+2009%2C+52%2C+78%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIvashchenko%26aufirst%3DA.%2BV.%26aulast%3DMit%25E2%2580%2599kin%26aufirst%3DO.%2BD.%26aulast%3DKisil%26aufirst%3DV.%2BM.%26aulast%3DFrolov%26aufirst%3DE.%2BB.%26aulast%3DTkachenko%26aufirst%3DS.%2BE.%26jtitle%3DIzv.%2520Vyssh.%2520Uchebn.%2520Zaved.%252C%2520Khim.%2520Khim.%2520Tekhnol.%26date%3D2009%26volume%3D52%26spage%3D78%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayaishi, O.</span><span> </span><span class="NLM_article-title">Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">13570</span><span class="NLM_x">â</span> <span class="NLM_lpage">13575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=13570-13575&author=T.+Shimizuauthor=A.+Yamashitaauthor=O.+Hayaishi&title=Specific+binding+of+prostaglandin+D2+to+rat+brain+synaptic+membrane.+Occurrence%2C+properties%2C+and+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DSpecific%2520binding%2520of%2520prostaglandin%2520D2%2520to%2520rat%2520brain%2520synaptic%2520membrane.%2520Occurrence%252C%2520properties%252C%2520and%2520distribution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D13570%26epage%3D13575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Fortini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modesti, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gensini, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri Serneri, G. G.</span><span> </span><span class="NLM_article-title">Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">â</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1016%2F0049-3848%2885%2990267-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=3001968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADyaL28XivVKgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1985&pages=319-328&author=A.+Fortiniauthor=P.+A.+Modestiauthor=R.+Abbateauthor=G.+F.+Gensiniauthor=G.+G.+Neri+Serneri&title=Heparin+does+not+interfere+with+prostacyclin+and+prostaglandin+D2+binding+to+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets</span></div><div class="casAuthors">Fortini, A.; Modesti, P. A.; Abbate, R.; Gensini, G. F.; Serneri, G. G. Neri</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-28</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">The no. and the affinity of binding sites for PGI2  [35121-78-9] and PGD2  [41598-07-6] were detd. in healthy subjects in the absence and in the presence of heparin  [9005-49-6].  Preliminary aggregation tests indicated that the heparin concn. tested (2 IU/mL) reduced the antiaggregating activity of PGI2 and PGD2.  Heparin, when preincubated with platelet suspension, did not induce any significant change in the no. per platelet or affinity (Kd) of PGI2 and PGD2 binding sites in comparison to control values.  Also, no significant binding modification was obsd. when heparin was preincubated with [3H]-PGI2 and [3H]-PGD2.  Apparently, heparin reduces the antiaggregating effects of PGI2 and PGD2 by directly potentiating platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi_QMvysJYibVg90H21EOLACvtfcHk0lj0qBX2QOuJQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XivVKgtA%253D%253D&md5=93bb24a3955d66f6ddb6acfa5dceac16</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0049-3848%2885%2990267-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0049-3848%252885%252990267-1%26sid%3Dliteratum%253Aachs%26aulast%3DFortini%26aufirst%3DA.%26aulast%3DModesti%26aufirst%3DP.%2BA.%26aulast%3DAbbate%26aufirst%3DR.%26aulast%3DGensini%26aufirst%3DG.%2BF.%26aulast%3DNeri%2BSerneri%26aufirst%3DG.%2BG.%26atitle%3DHeparin%2520does%2520not%2520interfere%2520with%2520prostacyclin%2520and%2520prostaglandin%2520D2%2520binding%2520to%2520platelets%26jtitle%3DThromb.%2520Res.%26date%3D1985%26volume%3D40%26spage%3D319%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervais, F. G.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">â</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400122f&amp;key=10.1038%2Fsj.bjp.0704973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400122f&amp;key=12466225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400122f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlSj" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=1163-1172&author=N.+Sawyerauthor=E.+Cauchonauthor=A.+Chateauneufauthor=R.+P.+Cruzauthor=D.+W.+Nicholsonauthor=K.+M.+Mettersauthor=G.+P.+O%E2%80%99Neillauthor=F.+G.+Gervais&title=Molecular+pharmacology+of+the+human+prostaglandin+D2+receptor%2C+CRTH2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2</span></div><div class="casAuthors">Sawyer, Nicole; Cauchon, Elizabeth; Chateauneuf, Anne; Cruz, Rani P. G.; Nicholson, Donald W.; Metters, Kathleen M.; O'Neill, Gary P.; Gervais, Francois G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1163-1172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The recombinant human prostaglandin D2 (PGD2) receptor, hCRTH2, has been expressed in HEK293(EBNA) and characterized with respect to radioligand binding and signal transduction properties.  High and low affinity binding sites for PGD2 were identified in the CRTH2 receptor population by satn. anal. with resp. equil. dissocn. consts. (KD) of 2.5 and 109 nM.  This revealed that the affinity of PGD2 for CRTH2 is eight times less than its affinity for the DP receptor.  Equil. competition binding assays revealed that of the compds. tested, only PGD2 and several related metabolites bound with high affinity to CRTH2 (Ki values ranging from 2.4 to 34.0 nM) with the following rank order of potency: PGD2 > 13,14-dihydro-15-keto PGD2 > 15-deoxy-Î12,14-PGJ2 > PGJ2 > Î12-PGJ2 > 15(S)-15-methyl-PGD2.  This is in sharp contrast with the rank order of potency obtained at DP: PGD2 > PGJ2 > Î12-PGJ2 > 15-deoxy-Î12,14-PGJ2 >>> 13,14-dihydro-15-keto-PGD2.  Functional studies demonstrated that PGD2 activation of recombinant CRTH2 results in decrease of intracellular cAMP in a pertussis toxin-sensitive manner.  Therefore, the authors showed that CRTH2 can functionally couple to the G-protein GÎ±i/o.  PGD2 and related metabolites were tested and their rank order of potency followed the results of the membrane binding assay.  By Northern blot anal., the authors showed that, besides hemopoietic cells, CRTH2 is expressed in many other tissues such as brain, heart, thymus, spleen and various tissues of the digestive system.  In addn., in situ hybridization studies revealed that CRTH2 mRNA is expressed in human eosinophils.  Finally, radioligand binding studies demonstrated that two eosinophilic cell lines, butyric acid-differentiated HL-60 and AML 14.3D10, also endogenously express CRTH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV1pbS5yK7J7Vg90H21EOLACvtfcHk0lgtPrkJhn7-bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlSj&md5=592b7cf5a686d37df38a4f5a19fb0255</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704973%26sid%3Dliteratum%253Aachs%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DCauchon%26aufirst%3DE.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DCruz%26aufirst%3DR.%2BP.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DGervais%26aufirst%3DF.%2BG.%26atitle%3DMolecular%2520pharmacology%2520of%2520the%2520human%2520prostaglandin%2520D2%2520receptor%252C%2520CRTH2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D1163%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/jm400122f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62168"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures and analytical data (Tables S1âS5) of synthesized compounds <b>11</b>â<b>21</b>, <b>23</b>, <b>25</b>, <b>27</b>, <b>29</b>â<b>32</b>, <b>34</b>, <b>36</b> and the respective precursors; method for the determination of the logÂ <i>D</i> values; experimental details for the biological assays used to assess the receptor selectivity, for the cytochrome P450 enzyme inhibition assays, and for the metabolic stability studies; and the detailed description of the pharmacokinetic studies in the rat and the dog. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400122f/suppl_file/jm400122f_si_001.pdf">jm400122f_si_001.pdf (790.57 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400122f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400122f%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400122f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                631KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679999e0cdb53dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
